<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- RR Donnelley Xcelerate Instance Document, based on XBRL 2.1  http://www.edgar-online.com/ -->
<!-- Version:  6.22.4 -->
<!-- Round: 6 -->
<!-- Creation date: 2015-03-02T21:59:39Z -->
<!-- Copyright (c) 2005-2013 R.R. Donnelley & Sons Company All Rights Reserved. -->
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2014-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:mnkd="http://www.mannkindcorp.com/20141231" xmlns:us-types="http://fasb.org/us-types/2014-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:country="http://xbrl.sec.gov/country/2013-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2014-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2014-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:utr="http://www.xbrl.org/2009/utr">
  <xbrll:schemaRef xlink:type="simple" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xlink:href="mnkd-20141231.xsd" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" />
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE126000--1410-K0014_STD_0_20100818_0_910720x966327" unitRef="pure" decimals="INF" id="id_5851737_13F820F9-DCDF-4EFD-95CF-F3F0A4A14516_2001_1">0.0575</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="eol_PE126000--1410-K0014_STD_0_20100818_0_910720x966327" unitRef="iso4217_USD_per_shares" decimals="2" id="id_5851737_13F820F9-DCDF-4EFD-95CF-F3F0A4A14516_2001_5">6.80</us-gaap:DebtInstrumentConvertibleConversionPrice1>
  <us-gaap:DebtInstrumentFaceAmount contextRef="eol_PE126000--1410-K0014_STD_0_20100818_0_910720x966327" unitRef="iso4217_USD" decimals="-5" id="id_5851737_13F820F9-DCDF-4EFD-95CF-F3F0A4A14516_2001_0">100000000</us-gaap:DebtInstrumentFaceAmount>
  <mnkd:UnitsSoldWarrantPortionConvertibleIntoCommonStock contextRef="eol_PE126000--1410-K0014_STD_0_20120208_0" unitRef="iso4217_USD_per_Right" decimals="1" id="id_5851737_429B49A9-C033-44B1-988D-CF2707D8A469_4001_3">0.6</mnkd:UnitsSoldWarrantPortionConvertibleIntoCommonStock>
  <mnkd:UnitsSoldUnderPublicOfferUnderwritten contextRef="eol_PE126000--1410-K0014_STD_0_20120208_0" unitRef="shares" decimals="0" id="id_5851737_429B49A9-C033-44B1-988D-CF2707D8A469_4001_0">35937500</mnkd:UnitsSoldUnderPublicOfferUnderwritten>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="eol_PE126000--1410-K0014_STD_0_20120208_0_910484x1005038" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_5851737_429B49A9-C033-44B1-988D-CF2707D8A469_5001_8">2.40</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="eol_PE126000--1410-K0014_STD_0_20120208_0_910484x1005038" unitRef="shares" decimals="INF" id="id_5851737_429B49A9-C033-44B1-988D-CF2707D8A469_5001_7">21562500</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:CommonStockSharesOutstanding contextRef="eol_PE126000--1410-K0014_STD_0_20120208_0_910940x1029276" unitRef="shares" decimals="INF" id="id_5851737_429B49A9-C033-44B1-988D-CF2707D8A469_6001_10">31250000</us-gaap:CommonStockSharesOutstanding>
  <mnkd:RestrictedCommonStockPricePerShare contextRef="eol_PE126000--1410-K0014_STD_0_20120208_0_910940x1029276" unitRef="iso4217_USD_per_shares" decimals="2" id="id_5851737_429B49A9-C033-44B1-988D-CF2707D8A469_6001_11">2.47</mnkd:RestrictedCommonStockPricePerShare>
  <mnkd:UnitsSoldByUnderwritingPrice contextRef="eol_PE126000--1410-K0014_STD_0_20120208_0_993561x1021251" unitRef="iso4217_USD_per_Right" decimals="3" id="id_5851737_429B49A9-C033-44B1-988D-CF2707D8A469_8001_5">2.256</mnkd:UnitsSoldByUnderwritingPrice>
  <mnkd:UnitsSoldUnderPublicOfferUnderwritten contextRef="eol_PE126000--1410-K0014_STD_0_20120208_0_993561x1021251" unitRef="shares" decimals="0" id="id_5851737_429B49A9-C033-44B1-988D-CF2707D8A469_8001_1">4687500</mnkd:UnitsSoldUnderPublicOfferUnderwritten>
  <mnkd:UnitsSoldByUnderwritingPrice contextRef="eol_PE126000--1410-K0014_STD_0_20120208_0_993561x942638" unitRef="iso4217_USD_per_Right" decimals="2" id="id_5851737_429B49A9-C033-44B1-988D-CF2707D8A469_9001_4">2.40</mnkd:UnitsSoldByUnderwritingPrice>
  <us-gaap:CommonStockSharesAuthorized contextRef="eol_PE126000--1410-K0014_STD_0_20120517_0" unitRef="shares" decimals="INF" id="id_5851737_B316B82F-D70C-4123-9E06-B689E0A34AE2_1001_1">350000000</us-gaap:CommonStockSharesAuthorized>
  <mnkd:FairValueOfUnitsIssued contextRef="eol_PE126000--1410-K0014_STD_0_20120517_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_5851737_1F9579ED-2A97-4E76-858E-96CCF293C188_1002_2">1.69</mnkd:FairValueOfUnitsIssued>
  <mnkd:FairValueInputDiscountForLackOfMarketability contextRef="eol_PE126000--1410-K0014_STD_0_20120517_0" unitRef="pure" decimals="4" id="id_5851737_1F9579ED-2A97-4E76-858E-96CCF293C188_1002_6">0.0042</mnkd:FairValueInputDiscountForLackOfMarketability>
  <mnkd:FairValueAssumptionRiskFreeInterestRate contextRef="eol_PE126000--1410-K0014_STD_0_20120517_0_905594x989565" unitRef="pure" decimals="4" id="id_5851737_1F9579ED-2A97-4E76-858E-96CCF293C188_2002_4">0.0018</mnkd:FairValueAssumptionRiskFreeInterestRate>
  <mnkd:FairValueAssumptionRiskFreeInterestRate contextRef="eol_PE126000--1410-K0014_STD_0_20120517_0_905594x989565_910484x1069197_910940x1029276" unitRef="pure" decimals="4" id="id_5851737_1F9579ED-2A97-4E76-858E-96CCF293C188_3002_3">0.0008</mnkd:FairValueAssumptionRiskFreeInterestRate>
  <mnkd:FairValueInputDiscountForLackOfMarketability contextRef="eol_PE126000--1410-K0014_STD_0_20120517_0_910484x1069197_910940x1029276" unitRef="pure" decimals="4" id="id_5851737_1F9579ED-2A97-4E76-858E-96CCF293C188_4002_5">0.0257</mnkd:FairValueInputDiscountForLackOfMarketability>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized contextRef="eol_PE126000--1410-K0014_STD_0_20130523_0_912473x1029406" unitRef="shares" decimals="-5" id="id_5851737_07F2120C-64E7-475F-BC14-5654ADF0B39E_1001_0">21500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
  <us-gaap:DebtInstrumentFaceAmount contextRef="eol_PE126000--1410-K0014_STD_0_20140228_0_901032x907457_906969x950672_910720x1029473_912827x1060185" unitRef="iso4217_USD" decimals="-5" id="id_5851737_D06A7A30-49A3-49EE-8F2A-658E7BC90093_2001_0">90000000</us-gaap:DebtInstrumentFaceAmount>
  <mnkd:CommonSharesIssuableUponConversionOfConvertibleDebt contextRef="eol_PE126000--1410-K0014_STD_0_20140228_0_901032x907457_910720x1029473_912827x1060185" unitRef="shares" decimals="INF" id="id_5851737_2364D554-6AC2-4CE9-BD31-D593280036E6_1001_1">12000000</mnkd:CommonSharesIssuableUponConversionOfConvertibleDebt>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE126000--1410-K0014_STD_0_20140228_0_906969x950672_910720x1029473_912827x1060185" unitRef="pure" decimals="INF" id="id_5851737_D06A7A30-49A3-49EE-8F2A-658E7BC90093_4001_1">0.0975</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <mnkd:RepaymentAsPercentageOfPrincipalAmount contextRef="eol_PE126000--1410-K0014_STD_0_20140228_0_906969x950672_910720x1029473_912827x1060185" unitRef="pure" decimals="2" id="id_5851737_D06A7A30-49A3-49EE-8F2A-658E7BC90093_4001_3">0.25</mnkd:RepaymentAsPercentageOfPrincipalAmount>
  <mnkd:DebtInstrumentContingentConvertibleAmount contextRef="eol_PE126000--1410-K0014_STD_0_20140228_0_910720x1029473_912827x1060185" unitRef="iso4217_USD" decimals="-5" id="id_5851737_2364D554-6AC2-4CE9-BD31-D593280036E6_2001_0">60000000</mnkd:DebtInstrumentContingentConvertibleAmount>
  <us-gaap:DebtInstrumentRepurchasedFaceAmount contextRef="eol_PE126000--1410-K0014_STD_0_20140506_0_906969x950672_910720x1029473_912827x1060185" unitRef="iso4217_USD" decimals="-5" id="id_5851737_71EFB260-873E-4B6A-82DF-7FBE9F7B0693_1001_0">20000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
  <mnkd:LoanCommitmentAssetFairValue contextRef="eol_PE126000--1410-K0014_STD_0_20140506_0_906969x950672_910720x1029473_912827x1060185" unitRef="iso4217_USD" decimals="-5" id="id_5851737_71EFB260-873E-4B6A-82DF-7FBE9F7B0693_1001_1">1200000</mnkd:LoanCommitmentAssetFairValue>
  <mnkd:PotentialMilestonePayments contextRef="eol_PE126000--1410-K0014_STD_0_20140811_0_1060593x1082326_911417x1029301" unitRef="iso4217_USD" decimals="-5" id="id_5851737_CE906C8B-48B8-40FE-95E9-87C0AE487D8B_4002_4">650000000</mnkd:PotentialMilestonePayments>
  <mnkd:PotentialMilestonePayments contextRef="eol_PE126000--1410-K0014_STD_0_20140811_0_1060593x1082327_911417x1029301" unitRef="iso4217_USD" decimals="-5" id="id_5851737_CE906C8B-48B8-40FE-95E9-87C0AE487D8B_5002_3">50000000</mnkd:PotentialMilestonePayments>
  <mnkd:PotentialMilestonePayments contextRef="eol_PE126000--1410-K0014_STD_0_20140811_0_1060593x1082329_911417x1029301" unitRef="iso4217_USD" decimals="-5" id="id_5851737_CE906C8B-48B8-40FE-95E9-87C0AE487D8B_6002_2">75000000</mnkd:PotentialMilestonePayments>
  <mnkd:PotentialMilestonePayments contextRef="eol_PE126000--1410-K0014_STD_0_20140811_0_911417x1029301" unitRef="iso4217_USD" decimals="-5" id="id_5851737_CE906C8B-48B8-40FE-95E9-87C0AE487D8B_7002_1">775000000</mnkd:PotentialMilestonePayments>
  <dei:EntityCommonStockSharesOutstanding contextRef="eol_PE126000--1410-K0014_STD_0_20150223_0" unitRef="shares" decimals="INF" id="id_5851737_2C560AAF-E0BB-4850-899A-5EF0237561E4_2_500008">408837603</dei:EntityCommonStockSharesOutstanding>
  <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="eol_PE126000--1410-K0014_STD_0_20040331_0_912473x1033376" unitRef="shares" decimals="INF" id="id_5851737_82C71537-FFD8-4EBE-ACB8-0B2CD6BF8AA1_4001_0">2000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
  <mnkd:AggregateAdjustmentOfForwardPurchaseContractToFairValue contextRef="eol_PE126000--1410-K0014_STD_0_20120317_0_905594x989565" unitRef="iso4217_USD" decimals="-5" id="id_5851737_B316B82F-D70C-4123-9E06-B689E0A34AE2_2002_2">13100000</mnkd:AggregateAdjustmentOfForwardPurchaseContractToFairValue>
  <mnkd:DebtInstrumentContingentConvertibleAmount contextRef="eol_PE126000--1410-K0014_STD_0_20140430_0_906969x1077046_910720x1029473_912827x1060185" unitRef="iso4217_USD" decimals="-5" id="id_5851737_80919C5C-DF57-4762-9A07-A493BBCF4FBF_1002_1">7500000</mnkd:DebtInstrumentContingentConvertibleAmount>
  <mnkd:RestrictedStockAgreedToBePurchasedByLender contextRef="eol_PE126000--1410-K0014_STD_0_20120630_0" unitRef="iso4217_USD" decimals="-5" id="id_5851737_429B49A9-C033-44B1-988D-CF2707D8A469_4002_12">77200000</mnkd:RestrictedStockAgreedToBePurchasedByLender>
  <mnkd:ContingentLiability contextRef="eol_PE126000--1410-K0014_STD_0_20130701_0_901032x907457_906969x1060390_912827x1060185" unitRef="iso4217_USD" decimals="-5" id="id_5851737_E941EE3E-9F14-426C-B30D-B1DCB488D1BF_1001_0">90000000</mnkd:ContingentLiability>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE126000--1410-K0014_STD_0_20130701_0_906969x1012963_910720x1029473_912827x1060185" unitRef="pure" decimals="INF" id="id_5851737_46B7884B-E135-4E43-AF45-2DBC8D53569C_2001_3">0.0975</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentFaceAmount contextRef="eol_PE126000--1410-K0014_STD_0_20130701_0_906969x1012963_910720x1029473_912827x1060185" unitRef="iso4217_USD" decimals="-5" id="id_5851737_46B7884B-E135-4E43-AF45-2DBC8D53569C_2001_0">160000000</us-gaap:DebtInstrumentFaceAmount>
  <mnkd:DebtInstrumentAmountOfTranches contextRef="eol_PE126000--1410-K0014_STD_0_20130701_0_906969x1012963_910720x1029473_912827x1060185" unitRef="iso4217_USD" decimals="-5" id="id_5851737_46B7884B-E135-4E43-AF45-2DBC8D53569C_2001_2">40000000</mnkd:DebtInstrumentAmountOfTranches>
  <us-gaap:OtherLongTermDebt contextRef="eol_PE126000--1410-K0014_STD_0_20130701_0_906969x1060390_910720x1029473_912827x1060185" unitRef="iso4217_USD" decimals="-5" id="id_5851737_6CE1651E-18D3-4A5D-AE0D-EA3123DF603D_2001_4">16300000</us-gaap:OtherLongTermDebt>
  <us-gaap:OtherLongTermDebtNoncurrent contextRef="eol_PE126000--1410-K0014_STD_0_20130701_0_906969x1060390_910720x1029473_912827x1060185" unitRef="iso4217_USD" decimals="-5" id="id_5851737_6CE1651E-18D3-4A5D-AE0D-EA3123DF603D_2001_1">13100000</us-gaap:OtherLongTermDebtNoncurrent>
  <us-gaap:OtherLongTermDebtCurrent contextRef="eol_PE126000--1410-K0014_STD_0_20130701_0_906969x1060390_910720x1029473_912827x1060185" unitRef="iso4217_USD" decimals="-5" id="id_5851737_6CE1651E-18D3-4A5D-AE0D-EA3123DF603D_2001_0">3200000</us-gaap:OtherLongTermDebtCurrent>
  <mnkd:LoanCommitmentAssetFairValue contextRef="eol_PE126000--1410-K0014_STD_0_20130701_0_910720x1029473" unitRef="iso4217_USD" decimals="-5" id="id_5851737_77A049CB-2EB9-4FF9-A1B3-6AD47C3DD041_3001_0">2900000</mnkd:LoanCommitmentAssetFairValue>
  <mnkd:OperatingLossCarryforwardsSubjectToLimitation contextRef="eol_PE126000--1410-K0014_STD_0_20040831_0" unitRef="iso4217_USD" decimals="-5" id="id_5851737_9AC30204-7B96-4D29-9AF1-1B18DEEF98BC_3002_4">216000000</mnkd:OperatingLossCarryforwardsSubjectToLimitation>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="eol_PE126000--1410-K0014_STD_0_20121031_0" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_5851737_CBBDCCC0-8AD4-4F5F-97E1-B9B080464600_1001_7">2.60</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
  <mnkd:UnitsSoldByUnderwritingPrice contextRef="eol_PE126000--1410-K0014_STD_0_20121031_0_901822x904951" unitRef="iso4217_USD_per_Right" decimals="2" id="id_5851737_CBBDCCC0-8AD4-4F5F-97E1-B9B080464600_2001_4">2.00</mnkd:UnitsSoldByUnderwritingPrice>
  <mnkd:RestrictedWarrantSalePrice contextRef="eol_PE126000--1410-K0014_STD_0_20121031_0_901822x904951_910940x1029276" unitRef="iso4217_USD_per_shares" decimals="3" id="id_5851737_816736E2-ECD6-4BF8-A053-BB15529DA75C_4001_3">0.125</mnkd:RestrictedWarrantSalePrice>
  <us-gaap:SaleOfStockPricePerShare contextRef="eol_PE126000--1410-K0014_STD_0_20121031_0_910940x1029276" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_5851737_816736E2-ECD6-4BF8-A053-BB15529DA75C_5001_2">2.59</us-gaap:SaleOfStockPricePerShare>
  <mnkd:RestrictedStockAgreedToBePurchasedByLender contextRef="eol_PE126000--1410-K0014_STD_0_20121031_0_910940x1029276" unitRef="iso4217_USD" decimals="-5" id="id_5851737_816736E2-ECD6-4BF8-A053-BB15529DA75C_5001_5">107400000</mnkd:RestrictedStockAgreedToBePurchasedByLender>
  <mnkd:DebtInstrumentAmendedOutstanding contextRef="eol_PE126000--1410-K0014_STD_0_20121031_0_910940x1029276" unitRef="iso4217_USD" decimals="-5" id="id_5851737_816736E2-ECD6-4BF8-A053-BB15529DA75C_5001_4">350000000</mnkd:DebtInstrumentAmendedOutstanding>
  <us-gaap:InterestPayableCurrentAndNoncurrent contextRef="eol_PE126000--1410-K0014_STD_0_20131031_0_906053x1051648_910940x910864" unitRef="iso4217_USD" decimals="-5" id="id_5851737_F3C41F07-348E-45E2-93F1-11D8A4C4766C_4004_6">7900000</us-gaap:InterestPayableCurrentAndNoncurrent>
  <mnkd:DebtInstrumentContingentConvertibleAmount contextRef="eol_PE126000--1410-K0014_STD_0_20140331_0_906969x1077046_910720x1029473_912827x1060185" unitRef="iso4217_USD" decimals="-5" id="id_5851737_80919C5C-DF57-4762-9A07-A493BBCF4FBF_1001_1">12500000</mnkd:DebtInstrumentContingentConvertibleAmount>
  <mnkd:DebtInstrumentContingentConvertibleAmount contextRef="eol_PE126000--1410-K0014_STD_0_20140331_0_906969x1077049_910720x1029473_912827x1060185" unitRef="iso4217_USD" decimals="-5" id="id_5851737_80919C5C-DF57-4762-9A07-A493BBCF4FBF_2001_0">40000000</mnkd:DebtInstrumentContingentConvertibleAmount>
  <dei:EntityPublicFloat contextRef="eol_PE126000--1410-K0014_STD_0_20140630_0" unitRef="iso4217_USD" decimals="0" id="id_5851737_2C560AAF-E0BB-4850-899A-5EF0237561E4_3_600009">2616079653</dei:EntityPublicFloat>
  <mnkd:NumberOfEmployees contextRef="eol_PE126000--1410-K0014_STD_0_20140630_0" unitRef="Employee" decimals="0" id="id_5851737_E2015A48-766A-4993-A668-692B8BFC8420_1001_0">124</mnkd:NumberOfEmployees>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE126000--1410-K0014_STD_0_20140923_0_904843x1047235_906969x950672_910720x1029473_912827x1060185" unitRef="pure" decimals="INF" id="id_5851737_D06A7A30-49A3-49EE-8F2A-658E7BC90093_3002_2">0.0875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="eol_PE126000--1410-K0014_STD_0_20140923_0_906969x950672_910720x1029473_912827x1060185" unitRef="iso4217_USD" decimals="-5" id="id_5851737_D06A7A30-49A3-49EE-8F2A-658E7BC90093_4002_6">175000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE126000--1410-K0014_STD_0_20140923_0_911417x1029301" unitRef="pure" decimals="INF" id="id_5851737_3A38DE82-5ACC-4AC7-9767-38F7C609095A_1001_0">0.085</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="eol_PE126000--1410-K0014_STD_0_20140923_0_911417x1029301" unitRef="iso4217_USD" decimals="-5" id="id_5851737_3D0F314A-4D99-4756-B607-E9EDE1B84617_1001_0">175000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1410-K0014_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_1006_900001">-313652000</us-gaap:StockholdersEquity>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE126000--1410-K0014_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_3001_40">2681000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisValueOfInstrumentsClassifiedInShareholdersEquity contextRef="eol_PE126000--1410-K0014_STD_0_20111231_0_900547x907189" unitRef="iso4217_USD" decimals="-3" id="id_5851737_209678D4-4A86-4A27-A605-EAFADF70C75D_1003_1">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisValueOfInstrumentsClassifiedInShareholdersEquity>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisValueOfInstrumentsClassifiedInShareholdersEquity contextRef="eol_PE126000--1410-K0014_STD_0_20111231_0_900547x907189_903654x1037100" unitRef="iso4217_USD" decimals="-3" id="id_5851737_209678D4-4A86-4A27-A605-EAFADF70C75D_1002_1">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisValueOfInstrumentsClassifiedInShareholdersEquity>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisValueOfInstrumentsClassifiedInShareholdersEquity contextRef="eol_PE126000--1410-K0014_STD_0_20111231_0_900547x907189_903654x1069097" unitRef="iso4217_USD" decimals="-3" id="id_5851737_209678D4-4A86-4A27-A605-EAFADF70C75D_1001_1">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisValueOfInstrumentsClassifiedInShareholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1410-K0014_STD_0_20111231_0_907910x1042177" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_1005_800001">-1935546000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE126000--1410-K0014_STD_0_20111231_0_907910x901931" unitRef="shares" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_1001_400001">131523000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1410-K0014_STD_0_20111231_0_907910x901931" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_1001_500001">1315000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1410-K0014_STD_0_20111231_0_907910x905139" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_1003_600001">1620535000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1410-K0014_STD_0_20111231_0_907910x910799" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_1004_700001">44000</us-gaap:StockholdersEquity>
  <us-gaap:CommonStockSharesAuthorized contextRef="eol_PE126000--1410-K0014_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_5851737_816736E2-ECD6-4BF8-A053-BB15529DA75C_3002_7">550000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:OwnshareLendingArrangementSharesOutstanding contextRef="eol_PE126000--1410-K0014_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_5851737_F1D52F0D-D81B-4CBE-BCA3-489F89664DF1_1003_0">9000000</us-gaap:OwnshareLendingArrangementSharesOutstanding>
  <us-gaap:OwnshareLendingArrangementSharesIssued contextRef="eol_PE126000--1410-K0014_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_5851737_F1D52F0D-D81B-4CBE-BCA3-489F89664DF1_1003_1">9000000</us-gaap:OwnshareLendingArrangementSharesIssued>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1410-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_3006_900017">-110679000</us-gaap:StockholdersEquity>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE126000--1410-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_2003_40">61840000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <mnkd:FairValueOfUnitsIssued contextRef="eol_PE126000--1410-K0014_STD_0_20121231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_5851737_1F9579ED-2A97-4E76-858E-96CCF293C188_1001_1">2.40</mnkd:FairValueOfUnitsIssued>
  <mnkd:EstimatedAmountsCreditExchangeReceivable contextRef="eol_PE126000--1410-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_5851737_7504F516-82F5-4005-AA88-2D2C18E518A7_1003_1">289000</mnkd:EstimatedAmountsCreditExchangeReceivable>
  <mnkd:SharesReservedForEmployeeStockPurchasePlan contextRef="eol_PE126000--1410-K0014_STD_0_20121231_0" unitRef="shares" decimals="0" id="id_5851737_82C71537-FFD8-4EBE-ACB8-0B2CD6BF8AA1_3002_2">700000</mnkd:SharesReservedForEmployeeStockPurchasePlan>
  <mnkd:IncreaseDecreaseInFairValueRecognizedInOtherIncome contextRef="eol_PE126000--1410-K0014_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-5" id="id_5851737_1F9579ED-2A97-4E76-858E-96CCF293C188_1001_0">12000000</mnkd:IncreaseDecreaseInFairValueRecognizedInOtherIncome>
  <mnkd:CommonStockLoanedUnderShareLendingAgreementShares contextRef="eol_PE126000--1410-K0014_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_5851737_0795CE6B-B194-471C-B435-49D38406C872_1001_0">9000000</mnkd:CommonStockLoanedUnderShareLendingAgreementShares>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisValueOfInstrumentsClassifiedInShareholdersEquity contextRef="eol_PE126000--1410-K0014_STD_0_20121231_0_900547x907189" unitRef="iso4217_USD" decimals="-3" id="id_5851737_209678D4-4A86-4A27-A605-EAFADF70C75D_3003_5">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisValueOfInstrumentsClassifiedInShareholdersEquity>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisValueOfInstrumentsClassifiedInShareholdersEquity contextRef="eol_PE126000--1410-K0014_STD_0_20121231_0_900547x907189_903654x1037100" unitRef="iso4217_USD" decimals="-3" id="id_5851737_209678D4-4A86-4A27-A605-EAFADF70C75D_3002_5">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisValueOfInstrumentsClassifiedInShareholdersEquity>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisValueOfInstrumentsClassifiedInShareholdersEquity contextRef="eol_PE126000--1410-K0014_STD_0_20121231_0_900547x907189_903654x1069097" unitRef="iso4217_USD" decimals="-3" id="id_5851737_209678D4-4A86-4A27-A605-EAFADF70C75D_3001_5">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisValueOfInstrumentsClassifiedInShareholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1410-K0014_STD_0_20121231_0_907910x1042177" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_3005_800017">-2104912000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE126000--1410-K0014_STD_0_20121231_0_907910x901931" unitRef="shares" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_3001_400017">286035000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1410-K0014_STD_0_20121231_0_907910x901931" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_3001_500017">2860000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1410-K0014_STD_0_20121231_0_907910x905139" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_3003_600017">1991379000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1410-K0014_STD_0_20121231_0_907910x910799" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_3004_700017">-6000</us-gaap:StockholdersEquity>
  <us-gaap:CommonStockSharesIssued contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="shares" decimals="INF" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_2_33">369391972</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesOutstanding contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="shares" decimals="INF" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_2_34">369391972</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_5851737_9C19EE16-DF23-445B-A862-EDFEC062A6AF_2001_1">3.90</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
  <us-gaap:CommonStockSharesAuthorized contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="shares" decimals="INF" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_2_32">550000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_5851737_6588D755-050B-44F0-8864-16C8409EB3BB_2001_1">4.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:OwnshareLendingArrangementSharesOutstanding contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="shares" decimals="INF" id="id_5851737_F1D52F0D-D81B-4CBE-BCA3-489F89664DF1_1002_0">9000000</us-gaap:OwnshareLendingArrangementSharesOutstanding>
  <us-gaap:PreferredStockSharesOutstanding contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="shares" decimals="INF" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_2_29">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_2_31">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesAuthorized contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="shares" decimals="INF" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_2_27">10000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="shares" decimals="INF" id="id_5851737_E84FAD55-531B-428C-B0AE-6971D2C206E2_2001_1">9115821</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:OwnshareLendingArrangementSharesIssued contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="shares" decimals="INF" id="id_5851737_F1D52F0D-D81B-4CBE-BCA3-489F89664DF1_1002_1">9000000</us-gaap:OwnshareLendingArrangementSharesIssued>
  <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_2_26">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesIssued contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="shares" decimals="INF" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_2_28">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="shares" decimals="INF" id="id_5851737_143C52D3-CB9D-4730-A9E6-7C6A29401131_2001_1">24237940</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_D7C2FD4B-67AF-4E28-9399-1141ADBCF3CB_1002_12">817000000</us-gaap:DeferredTaxAssetsValuationAllowance>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_B47B74A1-637B-402F-9DF6-5F07C8848820_2_9">111060000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:PreferredStockValue contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_2_25" />
  <us-gaap:LiabilitiesCurrent contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_2_18">127794000</us-gaap:LiabilitiesCurrent>
  <us-gaap:NotesPayableRelatedPartiesNoncurrent contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_2_20">49521000</us-gaap:NotesPayableRelatedPartiesNoncurrent>
  <us-gaap:InterestPayableCurrent contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_B53C2495-32A8-48CA-9D00-A1D0F731A2CA_2_2">2082000</us-gaap:InterestPayableCurrent>
  <us-gaap:CommonStockValue contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_2_30">3697000</us-gaap:CommonStockValue>
  <us-gaap:CommitmentsAndContingencies contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_2_23" />
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_2_36">-4000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:AccountsPayableCurrent contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_2_13">3860000</us-gaap:AccountsPayableCurrent>
  <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_2_37">-2296402000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:OtherLongTermDebtCurrent contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_2_15">102300000</us-gaap:OtherLongTermDebtCurrent>
  <us-gaap:ConvertibleLongTermNotesPayable contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_2_19">98439000</us-gaap:ConvertibleLongTermNotesPayable>
  <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_2_35">2261996000</us-gaap:AdditionalPaidInCapitalCommonStock>
  <us-gaap:AccruedLiabilitiesCurrent contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_2_14">21634000</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_2_38">-30713000</us-gaap:StockholdersEquity>
  <us-gaap:OtherLiabilitiesNoncurrent contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_2_21">13605000</us-gaap:OtherLiabilitiesNoncurrent>
  <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_B53C2495-32A8-48CA-9D00-A1D0F731A2CA_2_4">5706000</us-gaap:OtherAccruedLiabilitiesCurrent>
  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_2_39">258646000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:Liabilities contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_2_22">289359000</us-gaap:Liabilities>
  <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_B53C2495-32A8-48CA-9D00-A1D0F731A2CA_2_0">12193000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <us-gaap:ConstructionPayableCurrent contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_B53C2495-32A8-48CA-9D00-A1D0F731A2CA_2_3">342000</us-gaap:ConstructionPayableCurrent>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_2_2">70790000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:MoneyMarketFundsAtCarryingValue contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-5" id="id_5851737_4BEAA2B1-5876-4E56-B77F-B6885E3D62E4_2_1">67700000</us-gaap:MoneyMarketFundsAtCarryingValue>
  <us-gaap:PropertyPlantAndEquipmentNet contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_2_7">176557000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_170B1F7C-FAA5-41F4-ABB0-FDC547522E96_2001_1">40972000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
  <us-gaap:DeferredTaxAssetsGross contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_D7C2FD4B-67AF-4E28-9399-1141ADBCF3CB_1002_11">817000000</us-gaap:DeferredTaxAssetsGross>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_2_5">5485000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:DeferredTaxAssetsOther contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_D7C2FD4B-67AF-4E28-9399-1141ADBCF3CB_1002_10">2539000</us-gaap:DeferredTaxAssetsOther>
  <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_D7C2FD4B-67AF-4E28-9399-1141ADBCF3CB_1002_2">70091000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
  <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_D7C2FD4B-67AF-4E28-9399-1141ADBCF3CB_1002_7">41219000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
  <us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_D7C2FD4B-67AF-4E28-9399-1141ADBCF3CB_1002_9">837000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_B47B74A1-637B-402F-9DF6-5F07C8848820_2_8">287617000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_D7C2FD4B-67AF-4E28-9399-1141ADBCF3CB_1002_1">653896000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
  <us-gaap:NontradeReceivablesNoncurrent contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_2_8">298000</us-gaap:NontradeReceivablesNoncurrent>
  <us-gaap:Assets contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_2_10">258646000</us-gaap:Assets>
  <us-gaap:DeferredTaxAssetsNet contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_D7C2FD4B-67AF-4E28-9399-1141ADBCF3CB_1002_13">0</us-gaap:DeferredTaxAssetsNet>
  <us-gaap:DeferredTaxAssetsTaxDeferredExpense contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_D7C2FD4B-67AF-4E28-9399-1141ADBCF3CB_1002_6">3578000</us-gaap:DeferredTaxAssetsTaxDeferredExpense>
  <us-gaap:OtherAssetsNoncurrent contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_2_9">5516000</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:AssetsCurrent contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_2_6">76275000</us-gaap:AssetsCurrent>
  <mnkd:DeferredTaxAssetsCapitalizedCosts contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_D7C2FD4B-67AF-4E28-9399-1141ADBCF3CB_1002_8">7811000</mnkd:DeferredTaxAssetsCapitalizedCosts>
  <mnkd:EstimatedAmountsCreditExchangeReceivable contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_5851737_7504F516-82F5-4005-AA88-2D2C18E518A7_1002_1">282000</mnkd:EstimatedAmountsCreditExchangeReceivable>
  <mnkd:AccruedInterestOfRelatedPartyDebt contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-5" id="id_5851737_3EED8AC4-0141-4E1B-8811-B9F0A8DCFF5C_1002_0">600000</mnkd:AccruedInterestOfRelatedPartyDebt>
  <mnkd:LoanCommitmentAsset contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-5" id="id_5851737_975B510B-EA52-4383-832A-70184A02A19C_3001_0">5200000</mnkd:LoanCommitmentAsset>
  <mnkd:SharesReservedForEmployeeStockPurchasePlan contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="shares" decimals="0" id="id_5851737_82C71537-FFD8-4EBE-ACB8-0B2CD6BF8AA1_3003_2">700000</mnkd:SharesReservedForEmployeeStockPurchasePlan>
  <mnkd:CommonStockLoanedUnderShareLendingAgreementShares contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="shares" decimals="INF" id="id_5851737_0795CE6B-B194-471C-B435-49D38406C872_1002_0">9000000</mnkd:CommonStockLoanedUnderShareLendingAgreementShares>
  <mnkd:AvailableBorrowingsUnderLoanAgreement contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-5" id="id_5851737_3EED8AC4-0141-4E1B-8811-B9F0A8DCFF5C_1002_1">30100000</mnkd:AvailableBorrowingsUnderLoanAgreement>
  <mnkd:DeferredTaxAssetsCapitalizedResearchExpenses contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_D7C2FD4B-67AF-4E28-9399-1141ADBCF3CB_1002_3">30421000</mnkd:DeferredTaxAssetsCapitalizedResearchExpenses>
  <mnkd:DeferredTaxAssetsMilestoneRights contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_D7C2FD4B-67AF-4E28-9399-1141ADBCF3CB_1002_5">6608000</mnkd:DeferredTaxAssetsMilestoneRights>
  <mnkd:AccruedResearchAndClinicalTrialCosts contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_B53C2495-32A8-48CA-9D00-A1D0F731A2CA_2_1">1311000</mnkd:AccruedResearchAndClinicalTrialCosts>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0_907645x1039325" unitRef="iso4217_USD" decimals="-3" id="id_5851737_B47B74A1-637B-402F-9DF6-5F07C8848820_1002_5">11289000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0_907645x901833" unitRef="iso4217_USD" decimals="-3" id="id_5851737_B47B74A1-637B-402F-9DF6-5F07C8848820_2002_2">114099000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0_907645x905205" unitRef="iso4217_USD" decimals="-3" id="id_5851737_B47B74A1-637B-402F-9DF6-5F07C8848820_3002_1">54948000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0_907645x906950" unitRef="iso4217_USD" decimals="-3" id="id_5851737_B47B74A1-637B-402F-9DF6-5F07C8848820_4002_7">14756000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0_907645x907375" unitRef="iso4217_USD" decimals="-3" id="id_5851737_B47B74A1-637B-402F-9DF6-5F07C8848820_5002_0">5273000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0_907645x907438" unitRef="iso4217_USD" decimals="-3" id="id_5851737_B47B74A1-637B-402F-9DF6-5F07C8848820_6002_3">82189000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0_907645x908991" unitRef="iso4217_USD" decimals="-3" id="id_5851737_B47B74A1-637B-402F-9DF6-5F07C8848820_7002_6">17000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0_907645x948369" unitRef="iso4217_USD" decimals="-3" id="id_5851737_B47B74A1-637B-402F-9DF6-5F07C8848820_8002_4">5046000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0_907910x1042177" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_5005_800032">-2296402000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0_907910x901931" unitRef="shares" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_5001_400032">369392000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0_907910x901931" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_5001_500032">3697000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0_907910x905139" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_5003_600032">2261996000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0_907910x910799" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_5004_700032">-4000</us-gaap:StockholdersEquity>
  <mnkd:DebtInstrumentContingentConvertibleAmount contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0_910720x1029473_912827x1060185" unitRef="iso4217_USD" decimals="-5" id="id_5851737_6180B978-0728-4896-9559-A1ED213196A8_4002_1">6500000</mnkd:DebtInstrumentContingentConvertibleAmount>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0_910720x1077866" unitRef="iso4217_USD" decimals="-3" id="id_5851737_3EC37290-2B6A-4FC6-92D1-9D3BCE5F8872_1002_3">102300000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentFairValue contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0_910720x1077866" unitRef="iso4217_USD" decimals="-5" id="id_5851737_3EC37290-2B6A-4FC6-92D1-9D3BCE5F8872_1002_4">107000000</us-gaap:DebtInstrumentFairValue>
  <us-gaap:InterestPayableCurrentAndNoncurrent contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0_910720x966327" unitRef="iso4217_USD" decimals="-5" id="id_5851737_13F820F9-DCDF-4EFD-95CF-F3F0A4A14516_1003_2">2400000</us-gaap:InterestPayableCurrentAndNoncurrent>
  <us-gaap:DebtInstrumentFaceAmount contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0_910720x966327" unitRef="iso4217_USD" decimals="-3" id="id_5851737_9091A330-E532-4AC1-BB35-CFCB9B3A462B_1002_0">100000000</us-gaap:DebtInstrumentFaceAmount>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0_910720x966327" unitRef="iso4217_USD" decimals="-3" id="id_5851737_9091A330-E532-4AC1-BB35-CFCB9B3A462B_1002_2">98439000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentFairValue contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0_910720x966327" unitRef="iso4217_USD" decimals="-5" id="id_5851737_3EC37290-2B6A-4FC6-92D1-9D3BCE5F8872_1001_4">102200000</us-gaap:DebtInstrumentFairValue>
  <us-gaap:UnamortizedDebtIssuanceExpense contextRef="eol_PE126000--1410-K0014_STD_0_20131231_0_910720x966327" unitRef="iso4217_USD" decimals="-3" id="id_5851737_9091A330-E532-4AC1-BB35-CFCB9B3A462B_1002_1">1561000</us-gaap:UnamortizedDebtIssuanceExpense>
  <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity contextRef="eol_PE126000--1410-K0014_STD_0_20141230_0_901032x907457_906969x950672_910720x1029473" unitRef="iso4217_USD" decimals="-5" id="id_5851737_FED51AEC-139B-4170-8B4C-089025158484_2002_1">70000000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
  <us-gaap:CommonStockSharesIssued contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="shares" decimals="INF" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_1_33">406059089</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesOutstanding contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="shares" decimals="INF" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_1_34">406059089</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_5851737_9C19EE16-DF23-445B-A862-EDFEC062A6AF_1001_5">5.20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="shares" decimals="INF" id="id_5851737_143C52D3-CB9D-4730-A9E6-7C6A29401131_1001_7">21307827</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
  <us-gaap:CommonStockSharesAuthorized contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="shares" decimals="INF" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_1_32">550000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_5851737_6588D755-050B-44F0-8864-16C8409EB3BB_1001_6">4.53</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="shares" decimals="INF" id="id_5851737_143C52D3-CB9D-4730-A9E6-7C6A29401131_1001_8">18439472</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_5851737_6588D755-050B-44F0-8864-16C8409EB3BB_1001_8">4.42</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
  <us-gaap:OwnshareLendingArrangementSharesOutstanding contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="shares" decimals="INF" id="id_5851737_F1D52F0D-D81B-4CBE-BCA3-489F89664DF1_1001_0">9000000</us-gaap:OwnshareLendingArrangementSharesOutstanding>
  <us-gaap:PreferredStockSharesOutstanding contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="shares" decimals="INF" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_1_29">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_5851737_6588D755-050B-44F0-8864-16C8409EB3BB_1001_7">4.52</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_1_31">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:DerivativeNumberOfInstrumentsHeld contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="Derivative" decimals="INF" id="id_5851737_AD5B6C9F-D98C-4C0B-B8C7-35AF696E4FE9_5001_0">4</us-gaap:DerivativeNumberOfInstrumentsHeld>
  <us-gaap:PreferredStockSharesAuthorized contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="shares" decimals="INF" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_1_27">10000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="shares" decimals="INF" id="id_5851737_E84FAD55-531B-428C-B0AE-6971D2C206E2_1001_5">2610720</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:OwnshareLendingArrangementSharesIssued contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="shares" decimals="INF" id="id_5851737_F1D52F0D-D81B-4CBE-BCA3-489F89664DF1_1001_1">9000000</us-gaap:OwnshareLendingArrangementSharesIssued>
  <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_1_26">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesIssued contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="shares" decimals="INF" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_1_28">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="shares" decimals="INF" id="id_5851737_0A86A340-884E-4370-9269-837E6E0F3841_1004_3">15506488</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="shares" decimals="INF" id="id_5851737_143C52D3-CB9D-4730-A9E6-7C6A29401131_1001_6">21541664</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_D7C2FD4B-67AF-4E28-9399-1141ADBCF3CB_1001_12">882502000</us-gaap:DeferredTaxAssetsValuationAllowance>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_B47B74A1-637B-402F-9DF6-5F07C8848820_1_9">118221000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:PurchaseObligationDueInFifthYear contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_EUR" decimals="-5" id="id_5851737_FCCD56F1-2D11-4C3B-AABA-790C71601967_1_5">23300000</us-gaap:PurchaseObligationDueInFifthYear>
  <us-gaap:PurchaseObligationDueInSecondYear contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_EUR" decimals="-5" id="id_5851737_FCCD56F1-2D11-4C3B-AABA-790C71601967_1_2">23300000</us-gaap:PurchaseObligationDueInSecondYear>
  <us-gaap:PreferredStockValue contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_1_25" />
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-6" id="id_5851737_6180B978-0728-4896-9559-A1ED213196A8_3001_9">20000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
  <us-gaap:LiabilitiesCurrent contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_1_18">403353000</us-gaap:LiabilitiesCurrent>
  <us-gaap:PurchaseObligationDueInThirdYear contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_EUR" decimals="-5" id="id_5851737_FCCD56F1-2D11-4C3B-AABA-790C71601967_1_3">23300000</us-gaap:PurchaseObligationDueInThirdYear>
  <us-gaap:NotesPayableRelatedPartiesNoncurrent contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_1_20">49521000</us-gaap:NotesPayableRelatedPartiesNoncurrent>
  <us-gaap:InterestPayableCurrent contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_B53C2495-32A8-48CA-9D00-A1D0F731A2CA_1_2">2396000</us-gaap:InterestPayableCurrent>
  <us-gaap:CommonStockValue contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_1_30">4061000</us-gaap:CommonStockValue>
  <us-gaap:CommitmentsAndContingencies contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_1_23" />
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_1_36">-14000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:AccountsPayableCurrent contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_1_13">7394000</us-gaap:AccountsPayableCurrent>
  <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_1_37">-2494784000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:PurchaseObligationDueInFourthYear contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_EUR" decimals="-5" id="id_5851737_FCCD56F1-2D11-4C3B-AABA-790C71601967_1_4">23300000</us-gaap:PurchaseObligationDueInFourthYear>
  <us-gaap:OtherLongTermDebtCurrent contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_1_15">72995000</us-gaap:OtherLongTermDebtCurrent>
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-6" id="id_5851737_6180B978-0728-4896-9559-A1ED213196A8_3001_11">35000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
  <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_1_35">2416967000</us-gaap:AdditionalPaidInCapitalCommonStock>
  <us-gaap:AccruedLiabilitiesCurrent contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_1_14">26206000</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_1_38">-73770000</us-gaap:StockholdersEquity>
  <us-gaap:OtherLiabilitiesNoncurrent contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_1_21">15335000</us-gaap:OtherLiabilitiesNoncurrent>
  <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_B53C2495-32A8-48CA-9D00-A1D0F731A2CA_1_4">7539000</us-gaap:OtherAccruedLiabilitiesCurrent>
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-6" id="id_5851737_6180B978-0728-4896-9559-A1ED213196A8_3001_10">20000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_1_39">394439000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-6" id="id_5851737_6180B978-0728-4896-9559-A1ED213196A8_3001_7">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
  <us-gaap:DeferredRevenueCurrent contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_1_17">197403000</us-gaap:DeferredRevenueCurrent>
  <us-gaap:ConvertibleNotesPayableCurrent contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_1_16">99355000</us-gaap:ConvertibleNotesPayableCurrent>
  <us-gaap:LineOfCredit contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-6" id="id_5851737_6180B978-0728-4896-9559-A1ED213196A8_3001_6">80000000</us-gaap:LineOfCredit>
  <us-gaap:Liabilities contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_1_22">468209000</us-gaap:Liabilities>
  <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_B53C2495-32A8-48CA-9D00-A1D0F731A2CA_1_0">14928000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <us-gaap:ConstructionPayableCurrent contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_B53C2495-32A8-48CA-9D00-A1D0F731A2CA_1_3">1343000</us-gaap:ConstructionPayableCurrent>
  <us-gaap:PurchaseObligation contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_EUR" decimals="-5" id="id_5851737_FCCD56F1-2D11-4C3B-AABA-790C71601967_1_0">120100000</us-gaap:PurchaseObligation>
  <us-gaap:PurchaseObligationDueInNextTwelveMonths contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_EUR" decimals="-5" id="id_5851737_FCCD56F1-2D11-4C3B-AABA-790C71601967_1_1">23200000</us-gaap:PurchaseObligationDueInNextTwelveMonths>
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-6" id="id_5851737_6180B978-0728-4896-9559-A1ED213196A8_3001_8">5000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
  <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-5" id="id_5851737_7FAF602C-F3A9-4FAB-AF36-38600B592E2F_1001_0">30100000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_1_2">120841000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:MoneyMarketFundsAtCarryingValue contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-5" id="id_5851737_4BEAA2B1-5876-4E56-B77F-B6885E3D62E4_1_1">118500000</us-gaap:MoneyMarketFundsAtCarryingValue>
  <us-gaap:PropertyPlantAndEquipmentNet contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_1_7">192127000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_170B1F7C-FAA5-41F4-ABB0-FDC547522E96_1001_6">33495000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
  <us-gaap:DeferredTaxAssetsGross contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_D7C2FD4B-67AF-4E28-9399-1141ADBCF3CB_1001_11">882502000</us-gaap:DeferredTaxAssetsGross>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_1_5">20206000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_170B1F7C-FAA5-41F4-ABB0-FDC547522E96_1001_7">33253000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
  <us-gaap:DeferredTaxAssetsOther contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_D7C2FD4B-67AF-4E28-9399-1141ADBCF3CB_1001_10">3010000</us-gaap:DeferredTaxAssetsOther>
  <us-gaap:DeferredTaxAssetsDeferredIncome contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_D7C2FD4B-67AF-4E28-9399-1141ADBCF3CB_1001_4">19217000</us-gaap:DeferredTaxAssetsDeferredIncome>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-8" id="id_5851737_9AC30204-7B96-4D29-9AF1-1B18DEEF98BC_3001_0">1800000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
  <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_D7C2FD4B-67AF-4E28-9399-1141ADBCF3CB_1001_2">73227000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
  <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_D7C2FD4B-67AF-4E28-9399-1141ADBCF3CB_1001_7">43691000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
  <us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_D7C2FD4B-67AF-4E28-9399-1141ADBCF3CB_1001_9">131000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther>
  <us-gaap:InventoryFinishedGoodsNetOfReserves contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_106F945B-CD98-4091-AE4A-4760A3AF9F02_1_2">95000</us-gaap:InventoryFinishedGoodsNetOfReserves>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_B47B74A1-637B-402F-9DF6-5F07C8848820_1_8">310348000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_170B1F7C-FAA5-41F4-ABB0-FDC547522E96_1001_8">30356000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_D7C2FD4B-67AF-4E28-9399-1141ADBCF3CB_1001_1">699997000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
  <us-gaap:NontradeReceivablesNoncurrent contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_1_8">311000</us-gaap:NontradeReceivablesNoncurrent>
  <us-gaap:Assets contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_1_10">394439000</us-gaap:Assets>
  <us-gaap:DeferredTaxAssetsNet contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_D7C2FD4B-67AF-4E28-9399-1141ADBCF3CB_1001_13">0</us-gaap:DeferredTaxAssetsNet>
  <us-gaap:DeferredTaxAssetsTaxDeferredExpense contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_D7C2FD4B-67AF-4E28-9399-1141ADBCF3CB_1001_6">768000</us-gaap:DeferredTaxAssetsTaxDeferredExpense>
  <us-gaap:InventoryNet contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_1_4">9670000</us-gaap:InventoryNet>
  <us-gaap:InventoryRawMaterialsNetOfReserves contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_106F945B-CD98-4091-AE4A-4760A3AF9F02_1_0">4856000</us-gaap:InventoryRawMaterialsNetOfReserves>
  <us-gaap:AccountsReceivableNetCurrent contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_1_3">50436000</us-gaap:AccountsReceivableNetCurrent>
  <us-gaap:OtherAssetsNoncurrent contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_1_9">848000</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:AssetsCurrent contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_0D6A962D-06EC-4D63-929D-BE42657BCDFA_1_6">201153000</us-gaap:AssetsCurrent>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-8" id="id_5851737_9AC30204-7B96-4D29-9AF1-1B18DEEF98BC_3001_1">1400000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
  <us-gaap:InventoryWorkInProcessNetOfReserves contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_106F945B-CD98-4091-AE4A-4760A3AF9F02_1_1">4719000</us-gaap:InventoryWorkInProcessNetOfReserves>
  <us-gaap:PrepaidExpenseCurrent contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-5" id="id_5851737_49C93C37-DD38-49BA-AC4A-5DA328249DD4_1_1">15000000</us-gaap:PrepaidExpenseCurrent>
  <mnkd:DeferredTaxAssetsCapitalizedCosts contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_D7C2FD4B-67AF-4E28-9399-1141ADBCF3CB_1001_8">8624000</mnkd:DeferredTaxAssetsCapitalizedCosts>
  <mnkd:WeightedAverageGrantDateFairValueOfRestrictedStockUnitsExpectedToVest contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_5851737_031A067D-0E9E-4A90-9AB4-0CBCCE394F5F_1001_1">5.23</mnkd:WeightedAverageGrantDateFairValueOfRestrictedStockUnitsExpectedToVest>
  <mnkd:EstimatedAmountsCreditExchangeReceivable contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="0" id="id_5851737_7504F516-82F5-4005-AA88-2D2C18E518A7_1001_1">816000</mnkd:EstimatedAmountsCreditExchangeReceivable>
  <mnkd:ShareBasedCompensationArrangementRestrictedStockUnitsNumberOfUnitsExpectedToVest contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="shares" decimals="0" id="id_5851737_031A067D-0E9E-4A90-9AB4-0CBCCE394F5F_1001_0">2386061</mnkd:ShareBasedCompensationArrangementRestrictedStockUnitsNumberOfUnitsExpectedToVest>
  <mnkd:AccruedInterestOfRelatedPartyDebt contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-5" id="id_5851737_3EED8AC4-0141-4E1B-8811-B9F0A8DCFF5C_1001_0">3500000</mnkd:AccruedInterestOfRelatedPartyDebt>
  <mnkd:SharesReservedForEmployeeStockPurchasePlan contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="shares" decimals="0" id="id_5851737_82C71537-FFD8-4EBE-ACB8-0B2CD6BF8AA1_3004_2">700000</mnkd:SharesReservedForEmployeeStockPurchasePlan>
  <mnkd:DerivativeFairValueLiabilitySharesIssuableToLender contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="shares" decimals="-5" id="id_5851737_93D7B7DA-B18A-40AF-A289-39A2EF83E457_1_1">16500000</mnkd:DerivativeFairValueLiabilitySharesIssuableToLender>
  <mnkd:CommonStockLoanedUnderShareLendingAgreementShares contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="shares" decimals="INF" id="id_5851737_0795CE6B-B194-471C-B435-49D38406C872_1003_0">9000000</mnkd:CommonStockLoanedUnderShareLendingAgreementShares>
  <mnkd:PotentialProceedsFromWarrantExercises contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-5" id="id_5851737_7FAF602C-F3A9-4FAB-AF36-38600B592E2F_1001_1">19500000</mnkd:PotentialProceedsFromWarrantExercises>
  <mnkd:AvailableBorrowingsUnderLoanAgreement contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-5" id="id_5851737_3EED8AC4-0141-4E1B-8811-B9F0A8DCFF5C_1001_1">30100000</mnkd:AvailableBorrowingsUnderLoanAgreement>
  <mnkd:DeferredTaxAssetsCapitalizedResearchExpenses contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_D7C2FD4B-67AF-4E28-9399-1141ADBCF3CB_1001_3">28516000</mnkd:DeferredTaxAssetsCapitalizedResearchExpenses>
  <mnkd:DeferredTaxAssetsMilestoneRights contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_D7C2FD4B-67AF-4E28-9399-1141ADBCF3CB_1001_5">5321000</mnkd:DeferredTaxAssetsMilestoneRights>
  <us-gaap:Liabilities contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_1033890x1060390_900547x907189" unitRef="iso4217_USD" decimals="-5" id="id_5851737_58DFDE34-36ED-4806-A925-893A2876207F_2001_2">13100000</us-gaap:Liabilities>
  <us-gaap:LiabilitiesFairValueDisclosure contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_1033890x1060390_900547x907189" unitRef="iso4217_USD" decimals="-5" id="id_5851737_58DFDE34-36ED-4806-A925-893A2876207F_2001_1">27900000</us-gaap:LiabilitiesFairValueDisclosure>
  <mnkd:LoanCommitmentAssetFairValue contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_900547x907189_906969x950672_910720x1029473" unitRef="iso4217_USD" decimals="-5" id="id_5851737_97298917-5983-4AC5-B4F5-0BB66C83C636_1001_0">2900000</mnkd:LoanCommitmentAssetFairValue>
  <mnkd:CommitmentAssetsMarketYields contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_900547x907189_906969x950672_910720x1029473" unitRef="pure" decimals="3" id="id_5851737_97298917-5983-4AC5-B4F5-0BB66C83C636_1001_1">0.118</mnkd:CommitmentAssetsMarketYields>
  <mnkd:ContingentLiability contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_901032x907457_906969x1060390_910720x1029473_912827x1060185" unitRef="iso4217_USD" decimals="-5" id="id_5851737_8E2708B6-CB0A-4BC4-AFE3-3EFC0FE53166_1001_0">90000000</mnkd:ContingentLiability>
  <mnkd:AggregateOfferingPriceUnderEachAgreement contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_901032x907457_945025x943266" unitRef="iso4217_USD" decimals="-5" id="id_5851737_7FAF602C-F3A9-4FAB-AF36-38600B592E2F_2001_2">50000000</mnkd:AggregateOfferingPriceUnderEachAgreement>
  <mnkd:LineOfCreditFacilityRestrictedBorrowingCapacity contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_901032x909105_906969x950672_910720x1029473_912827x1060185_961988x969356" unitRef="iso4217_USD" decimals="-5" id="id_5851737_E270DAF7-D512-4E33-8254-5268B5486DC4_1001_0">25000000</mnkd:LineOfCreditFacilityRestrictedBorrowingCapacity>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_901822x902721" unitRef="iso4217_USD" decimals="-5" id="id_5851737_0AC0FCA5-3152-4C3A-8492-0C1D889C22E8_1001_1">10600000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_901822x907138" unitRef="iso4217_USD" decimals="-5" id="id_5851737_0AC0FCA5-3152-4C3A-8492-0C1D889C22E8_2001_0">9000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
  <mnkd:DerivativeFairValueLiabilitySharesIssuableToLender contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_905594x1021475_910484x1069197_910940x1029276" unitRef="shares" decimals="-5" id="id_5851737_93D7B7DA-B18A-40AF-A289-39A2EF83E457_1001_0">14700000</mnkd:DerivativeFairValueLiabilitySharesIssuableToLender>
  <mnkd:ForwardPurchaseContractFairValue contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_905594x1021475_910484x1069197_910940x1029276" unitRef="iso4217_USD" decimals="-5" id="id_5851737_93D7B7DA-B18A-40AF-A289-39A2EF83E457_1001_3">900000</mnkd:ForwardPurchaseContractFairValue>
  <mnkd:ForwardPurchaseContractFairValue contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_905594x989565_910484x1069197_910940x1029276" unitRef="iso4217_USD" decimals="-5" id="id_5851737_93D7B7DA-B18A-40AF-A289-39A2EF83E457_2001_4">1100000</mnkd:ForwardPurchaseContractFairValue>
  <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_905668x1057783" unitRef="iso4217_USD" decimals="-5" id="id_5851737_4B6F5794-E9E7-4B4D-9C95-5F693ECC0A52_1001_1">13200000</us-gaap:DerivativeFairValueOfDerivativeAsset>
  <us-gaap:LongTermLoansPayable contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_906053x1068897_911417x1029301" unitRef="iso4217_USD" decimals="-5" id="id_5851737_03AE6AA1-363E-4109-BC0D-C39F23C11FFD_2001_3">3000000</us-gaap:LongTermLoansPayable>
  <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_906053x1068897_911417x1029301" unitRef="iso4217_USD" decimals="-5" id="id_5851737_26292A2B-AB52-412F-9BF3-C6A1D3BB3506_4002_5">175000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
  <us-gaap:DeferredRevenue contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_906053x1068897_911417x1029301" unitRef="iso4217_USD" decimals="-5" id="id_5851737_03AE6AA1-363E-4109-BC0D-C39F23C11FFD_2001_1">150000000</us-gaap:DeferredRevenue>
  <mnkd:PotentialMilestonePaymentsToBeReceived contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_906053x1068897_911417x1029301" unitRef="iso4217_USD" decimals="-5" id="id_5851737_03AE6AA1-363E-4109-BC0D-C39F23C11FFD_2001_2">50000000</mnkd:PotentialMilestonePaymentsToBeReceived>
  <us-gaap:LongTermDebtPercentageBearingFixedInterestRate contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_906053x953384_910940x910864" unitRef="pure" decimals="INF" id="id_5851737_D96BB647-38A8-43C1-802E-855461D66638_6001_2">0.0584</us-gaap:LongTermDebtPercentageBearingFixedInterestRate>
  <us-gaap:InterestPayableCurrentAndNoncurrent contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_906053x953384_910940x910864" unitRef="iso4217_USD" decimals="-5" id="id_5851737_D96BB647-38A8-43C1-802E-855461D66638_6001_3">3500000</us-gaap:InterestPayableCurrentAndNoncurrent>
  <us-gaap:LineOfCredit contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_906053x953384_910940x910864" unitRef="iso4217_USD" decimals="-5" id="id_5851737_D96BB647-38A8-43C1-802E-855461D66638_6001_0">49500000</us-gaap:LineOfCredit>
  <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_906053x953384_910940x910864" unitRef="iso4217_USD" decimals="-5" id="id_5851737_D96BB647-38A8-43C1-802E-855461D66638_6001_1">30100000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
  <us-gaap:DebtInstrumentRepurchasedFaceAmount contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_906969x1012963_910720x1029473_912827x1060185" unitRef="iso4217_USD" decimals="-5" id="id_5851737_77A049CB-2EB9-4FF9-A1B3-6AD47C3DD041_1002_1">160000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
  <us-gaap:OtherLongTermDebt contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_906969x1060390_910720x1029473_912827x1060185" unitRef="iso4217_USD" decimals="-5" id="id_5851737_8E2708B6-CB0A-4BC4-AFE3-3EFC0FE53166_2001_1">16300000</us-gaap:OtherLongTermDebt>
  <us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_906969x1060390_910720x1029473_912827x1060185" unitRef="iso4217_USD" decimals="-5" id="id_5851737_8E2708B6-CB0A-4BC4-AFE3-3EFC0FE53166_2001_5">8900000</us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent>
  <us-gaap:OtherLongTermDebtNoncurrent contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_906969x1060390_910720x1029473_912827x1060185" unitRef="iso4217_USD" decimals="-5" id="id_5851737_8E2708B6-CB0A-4BC4-AFE3-3EFC0FE53166_2001_3">13100000</us-gaap:OtherLongTermDebtNoncurrent>
  <us-gaap:OtherLongTermDebtCurrent contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_906969x1060390_910720x1029473_912827x1060185" unitRef="iso4217_USD" decimals="-5" id="id_5851737_8E2708B6-CB0A-4BC4-AFE3-3EFC0FE53166_2001_2">3100000</us-gaap:OtherLongTermDebtCurrent>
  <us-gaap:OtherDeferredCompensationArrangementsLiabilityCurrent contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_906969x1060390_910720x1029473_912827x1060185" unitRef="iso4217_USD" decimals="-5" id="id_5851737_8E2708B6-CB0A-4BC4-AFE3-3EFC0FE53166_2001_4">4200000</us-gaap:OtherDeferredCompensationArrangementsLiabilityCurrent>
  <mnkd:ContingentLiability contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_906969x1060390_910720x1029473_912827x1060185" unitRef="iso4217_USD" decimals="-5" id="id_5851737_A9A14771-211A-486F-92BA-41AF20629C04_2001_0">1900000</mnkd:ContingentLiability>
  <mnkd:DebtInstrumentContingentConvertibleAmount contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_906969x1077046_910720x1029473_912827x1060185" unitRef="iso4217_USD" decimals="-5" id="id_5851737_0BF15F05-6701-40FB-AE4A-793DCF13F994_5001_1">20000000</mnkd:DebtInstrumentContingentConvertibleAmount>
  <mnkd:DebtInstrumentContingentConvertibleAmount contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_906969x1077048_910720x1029473_912827x1060185" unitRef="iso4217_USD" decimals="-5" id="id_5851737_0BF15F05-6701-40FB-AE4A-793DCF13F994_6001_2">33500000</mnkd:DebtInstrumentContingentConvertibleAmount>
  <mnkd:DebtInstrumentContingentConvertibleAmount contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_906969x1077049_910720x1029473_912827x1060185" unitRef="iso4217_USD" decimals="-5" id="id_5851737_0BF15F05-6701-40FB-AE4A-793DCF13F994_7001_3">40000000</mnkd:DebtInstrumentContingentConvertibleAmount>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_906969x934075_910720x1029473_912827x1060185" unitRef="pure" decimals="4" id="id_5851737_CC353A6E-734B-4173-9BE2-03BC87EFDAA8_1001_0">0.1163</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_906969x950672_910720x1029473_912827x1060185" unitRef="pure" decimals="INF" id="id_5851737_19943F55-599E-46BD-8055-9900DB92ADAC_1001_3">8.75</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentFaceAmount contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_906969x950672_910720x1029473_912827x1060185" unitRef="iso4217_USD" decimals="-5" id="id_5851737_19943F55-599E-46BD-8055-9900DB92ADAC_1001_2">20000000</us-gaap:DebtInstrumentFaceAmount>
  <us-gaap:DebtInstrumentRepurchasedFaceAmount contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_906969x950672_910720x1029473_912827x1060185" unitRef="iso4217_USD" decimals="-5" id="id_5851737_77A049CB-2EB9-4FF9-A1B3-6AD47C3DD041_2002_2">20000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_907645x1039325" unitRef="iso4217_USD" decimals="-3" id="id_5851737_B47B74A1-637B-402F-9DF6-5F07C8848820_1001_5">10465000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_907645x901833" unitRef="iso4217_USD" decimals="-3" id="id_5851737_B47B74A1-637B-402F-9DF6-5F07C8848820_2001_2">114131000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_907645x905205" unitRef="iso4217_USD" decimals="-3" id="id_5851737_B47B74A1-637B-402F-9DF6-5F07C8848820_3001_1">54948000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_907645x906950" unitRef="iso4217_USD" decimals="-3" id="id_5851737_B47B74A1-637B-402F-9DF6-5F07C8848820_4001_7">39580000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_907645x907375" unitRef="iso4217_USD" decimals="-3" id="id_5851737_B47B74A1-637B-402F-9DF6-5F07C8848820_5001_0">5273000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_907645x907438" unitRef="iso4217_USD" decimals="-3" id="id_5851737_B47B74A1-637B-402F-9DF6-5F07C8848820_6001_3">80919000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_907645x908991" unitRef="iso4217_USD" decimals="-3" id="id_5851737_B47B74A1-637B-402F-9DF6-5F07C8848820_7001_6">17000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_907645x948369" unitRef="iso4217_USD" decimals="-3" id="id_5851737_B47B74A1-637B-402F-9DF6-5F07C8848820_8001_4">5015000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_907910x1042177" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_7005_800044">-2494784000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_907910x901931" unitRef="shares" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_7001_400044">406059000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_907910x901931" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_7001_500044">4061000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_907910x905139" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_7003_600044">2416967000</us-gaap:StockholdersEquity>
  <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_907910x905139" unitRef="iso4217_USD" decimals="-5" id="id_5851737_4B6F5794-E9E7-4B4D-9C95-5F693ECC0A52_2001_2">15000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_907910x910799" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_7004_700044">-14000</us-gaap:StockholdersEquity>
  <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_910113x986444" unitRef="iso4217_USD" decimals="-5" id="id_5851737_4B6F5794-E9E7-4B4D-9C95-5F693ECC0A52_3001_0">28200000</us-gaap:DerivativeFairValueOfDerivativeAsset>
  <mnkd:ForwardPurchaseContractFairValue contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_910484x1069197_910940x1029276" unitRef="iso4217_USD" decimals="-5" id="id_5851737_93D7B7DA-B18A-40AF-A289-39A2EF83E457_3001_2">2000000</mnkd:ForwardPurchaseContractFairValue>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_910720x1029473_912827x1060185" unitRef="pure" decimals="INF" id="id_5851737_19943F55-599E-46BD-8055-9900DB92ADAC_2001_1">9.75</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentFaceAmount contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_910720x1029473_912827x1060185" unitRef="iso4217_USD" decimals="-5" id="id_5851737_19943F55-599E-46BD-8055-9900DB92ADAC_2001_0">60000000</us-gaap:DebtInstrumentFaceAmount>
  <mnkd:LoanCommitmentAssetFairValue contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_910720x1029473_912827x1060185" unitRef="iso4217_USD" decimals="-6" id="id_5851737_77A049CB-2EB9-4FF9-A1B3-6AD47C3DD041_4002_3">0</mnkd:LoanCommitmentAssetFairValue>
  <mnkd:DebtInstrumentContingentConvertibleAmount contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_910720x1029473_912827x1060185" unitRef="iso4217_USD" decimals="-5" id="id_5851737_0BF15F05-6701-40FB-AE4A-793DCF13F994_8001_0">93500000</mnkd:DebtInstrumentContingentConvertibleAmount>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_910720x1077866" unitRef="iso4217_USD" decimals="-3" id="id_5851737_3EC37290-2B6A-4FC6-92D1-9D3BCE5F8872_2002_1">73000000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentFairValue contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_910720x1077866" unitRef="iso4217_USD" decimals="-5" id="id_5851737_3EC37290-2B6A-4FC6-92D1-9D3BCE5F8872_2002_2">75100000</us-gaap:DebtInstrumentFairValue>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_910720x966327" unitRef="pure" decimals="INF" id="id_5851737_93BF2236-34CE-4342-B4E7-933F20C3A092_4001_1">0.0575</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:InterestPayableCurrentAndNoncurrent contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_910720x966327" unitRef="iso4217_USD" decimals="-5" id="id_5851737_13F820F9-DCDF-4EFD-95CF-F3F0A4A14516_1002_2">2400000</us-gaap:InterestPayableCurrentAndNoncurrent>
  <us-gaap:DebtInstrumentFaceAmount contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_910720x966327" unitRef="iso4217_USD" decimals="-3" id="id_5851737_9091A330-E532-4AC1-BB35-CFCB9B3A462B_1001_0">100000000</us-gaap:DebtInstrumentFaceAmount>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_910720x966327" unitRef="iso4217_USD" decimals="-3" id="id_5851737_9091A330-E532-4AC1-BB35-CFCB9B3A462B_1001_2">99355000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentFairValue contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_910720x966327" unitRef="iso4217_USD" decimals="-5" id="id_5851737_3EC37290-2B6A-4FC6-92D1-9D3BCE5F8872_2001_2">102900000</us-gaap:DebtInstrumentFairValue>
  <us-gaap:UnamortizedDebtIssuanceExpense contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_910720x966327" unitRef="iso4217_USD" decimals="-3" id="id_5851737_9091A330-E532-4AC1-BB35-CFCB9B3A462B_1001_1">645000</us-gaap:UnamortizedDebtIssuanceExpense>
  <us-gaap:DeferredRevenue contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_911417x1029301" unitRef="iso4217_USD" decimals="-5" id="id_5851737_22BE3FEF-030D-4E69-A866-2E5364446AAB_1001_0">150000000</us-gaap:DeferredRevenue>
  <mnkd:PotentialMilestonePayments contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_911417x1029301" unitRef="iso4217_USD" decimals="-5" id="id_5851737_26292A2B-AB52-412F-9BF3-C6A1D3BB3506_5002_2">725000000</mnkd:PotentialMilestonePayments>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_912160x907907" unitRef="iso4217_USD" decimals="-5" id="id_5851737_9AC30204-7B96-4D29-9AF1-1B18DEEF98BC_4001_7">39000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_912160x912202" unitRef="iso4217_USD" decimals="-5" id="id_5851737_9AC30204-7B96-4D29-9AF1-1B18DEEF98BC_5001_6">48000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_912473x1029406" unitRef="shares" decimals="INF" id="id_5851737_0A86A340-884E-4370-9269-837E6E0F3841_1002_2">1390805</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_912473x1029406" unitRef="shares" decimals="INF" id="id_5851737_0A86A340-884E-4370-9269-837E6E0F3841_1002_3">15506488</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_912473x1029406" unitRef="shares" decimals="INF" id="id_5851737_0A86A340-884E-4370-9269-837E6E0F3841_1002_1">7380839</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_912473x1033376" unitRef="shares" decimals="INF" id="id_5851737_82C71537-FFD8-4EBE-ACB8-0B2CD6BF8AA1_4004_0">3073931</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_912473x978282" unitRef="shares" decimals="INF" id="id_5851737_0A86A340-884E-4370-9269-837E6E0F3841_1001_2">1219915</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_912473x978282" unitRef="shares" decimals="INF" id="id_5851737_0A86A340-884E-4370-9269-837E6E0F3841_1001_1">13629994</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_912473x994805" unitRef="shares" decimals="INF" id="id_5851737_0A86A340-884E-4370-9269-837E6E0F3841_1003_1">530831</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:WarrantsAndRightsOutstanding contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_937864x1068343" unitRef="iso4217_USD" decimals="-5" id="id_5851737_429B49A9-C033-44B1-988D-CF2707D8A469_7003_14">19500000</us-gaap:WarrantsAndRightsOutstanding>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="eol_PE126000--1410-K0014_STD_0_20141231_0_946648x921908" unitRef="shares" decimals="INF" id="id_5851737_893E50A8-91EA-4793-8123-020E978ECBA1_1001_0">552516</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger contextRef="eol_PE126000--1410-K0014_STD_1_20100818_0_910720x966327" unitRef="pure" decimals="2" id="id_5851737_13F820F9-DCDF-4EFD-95CF-F3F0A4A14516_1001_7">1.50</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
  <us-gaap:DebtInstrumentConvertibleThresholdTradingDays contextRef="eol_PE126000--1410-K0014_STD_1_20100818_0_910720x966327" unitRef="D" decimals="INF" id="id_5851737_13F820F9-DCDF-4EFD-95CF-F3F0A4A14516_1001_8">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
  <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays contextRef="eol_PE126000--1410-K0014_STD_1_20100818_0_910720x966327" id="id_5851737_13F820F9-DCDF-4EFD-95CF-F3F0A4A14516_1001_9">P30D</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays>
  <us-gaap:DebtInstrumentRedemptionPricePercentage contextRef="eol_PE126000--1410-K0014_STD_1_20100818_0_910720x966327" unitRef="pure" decimals="INF" id="id_5851737_13F820F9-DCDF-4EFD-95CF-F3F0A4A14516_1001_6">1.00</us-gaap:DebtInstrumentRedemptionPricePercentage>
  <us-gaap:DebtInstrumentConvertibleConversionRatio1 contextRef="eol_PE126000--1410-K0014_STD_1_20100818_0_910720x966327" unitRef="pure" decimals="4" id="id_5851737_13F820F9-DCDF-4EFD-95CF-F3F0A4A14516_1001_3">147.0859</us-gaap:DebtInstrumentConvertibleConversionRatio1>
  <us-gaap:DebtIssuanceCosts contextRef="eol_PE126000--1410-K0014_STD_1_20100818_0_910720x966327" unitRef="iso4217_USD" decimals="-5" id="id_5851737_A3AA8EE1-D866-4202-BA59-1536B8717AB3_1001_0">4200000</us-gaap:DebtIssuanceCosts>
  <mnkd:PrincipalAmountPerShare contextRef="eol_PE126000--1410-K0014_STD_1_20100818_0_910720x966327" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_5851737_13F820F9-DCDF-4EFD-95CF-F3F0A4A14516_1001_4">1000</mnkd:PrincipalAmountPerShare>
  <mnkd:ProceedsFromIssuanceOfCommonStockAndWarrants contextRef="eol_PE126000--1410-K0014_STD_1_20120208_0" unitRef="iso4217_USD" decimals="-5" id="id_5851737_429B49A9-C033-44B1-988D-CF2707D8A469_1_6">80600000</mnkd:ProceedsFromIssuanceOfCommonStockAndWarrants>
  <mnkd:WarrantsExercisableExpirationPeriod contextRef="eol_PE126000--1410-K0014_STD_1_20120208_0_910484x1005038" id="id_5851737_429B49A9-C033-44B1-988D-CF2707D8A469_1001_9">P4Y</mnkd:WarrantsExercisableExpirationPeriod>
  <mnkd:UnitsSoldUnderPublicOfferUnderwrittenCompositionDescription contextRef="eol_PE126000--1410-K0014_STD_1_20120208_0_910940x936286" id="id_5851737_429B49A9-C033-44B1-988D-CF2707D8A469_2001_2">Each unit consisting of  one share of common stock and a warrant to purchase 0.6 of a share of common  stock</mnkd:UnitsSoldUnderPublicOfferUnderwrittenCompositionDescription>
  <us-gaap:ForwardContractIndexedToIssuersEquityShares contextRef="eol_PE126000--1410-K0014_STD_1_20120517_0" unitRef="shares" decimals="INF" id="id_5851737_B316B82F-D70C-4123-9E06-B689E0A34AE2_1_0">250000000</us-gaap:ForwardContractIndexedToIssuersEquityShares>
  <us-gaap:DebtInstrumentMaturityDate contextRef="eol_PE126000--1410-K0014_STD_1_20140228_0_906969x950672_910720x1029473_912827x1060185" id="id_5851737_D06A7A30-49A3-49EE-8F2A-658E7BC90093_1001_4">2019-12-31</us-gaap:DebtInstrumentMaturityDate>
  <mnkd:ProfitLossSharingAgreementAllocationPercentage contextRef="eol_PE126000--1410-K0014_STD_1_20140811_0_906053x1068897_911417x1029301" unitRef="pure" decimals="2" id="id_5851737_CE906C8B-48B8-40FE-95E9-87C0AE487D8B_2002_5">0.65</mnkd:ProfitLossSharingAgreementAllocationPercentage>
  <mnkd:ProfitLossSharingAgreementAllocationPercentage contextRef="eol_PE126000--1410-K0014_STD_1_20140811_0_911417x1029301" unitRef="pure" decimals="2" id="id_5851737_CE906C8B-48B8-40FE-95E9-87C0AE487D8B_3002_6">0.35</mnkd:ProfitLossSharingAgreementAllocationPercentage>
  <us-gaap:FairValueInputsDiscountRate contextRef="eol_PE126000--1410-K0014_STD_1_20130701_0_900547x907189_904933x910565_906969x950672_910720x1029473" unitRef="pure" decimals="3" id="id_5851737_3AA3F10F-E8A1-4988-8AD1-6981226115CA_3002_1">0.119</us-gaap:FairValueInputsDiscountRate>
  <mnkd:NumberOfEqualTranches contextRef="eol_PE126000--1410-K0014_STD_1_20130701_0_906969x1012963_910720x1029473_912827x1060185" unitRef="Tranche" decimals="INF" id="id_5851737_46B7884B-E135-4E43-AF45-2DBC8D53569C_1001_1">4</mnkd:NumberOfEqualTranches>
  <us-gaap:FairValueInputsDiscountRate contextRef="eol_PE126000--1410-K0014_STD_1_20130701_0_906969x1060390_910720x1029473_912827x1060185" unitRef="pure" decimals="3" id="id_5851737_6CE1651E-18D3-4A5D-AE0D-EA3123DF603D_1001_2">0.175</us-gaap:FairValueInputsDiscountRate>
  <us-gaap:FairValueInputsEntityCreditRisk contextRef="eol_PE126000--1410-K0014_STD_1_20130701_0_906969x1060390_910720x1029473_912827x1060185" unitRef="pure" decimals="2" id="id_5851737_6CE1651E-18D3-4A5D-AE0D-EA3123DF603D_1001_3">0.05</us-gaap:FairValueInputsEntityCreditRisk>
  <us-gaap:GainLossOnDispositionOfIntangibleAssets contextRef="eol_PE126000--1410-K0014_STD_1_20140718_0" unitRef="iso4217_USD" decimals="-5" id="id_5851737_497D4A75-8662-4C4E-B281-1AD5852CC688_1_2">7900000</us-gaap:GainLossOnDispositionOfIntangibleAssets>
  <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="eol_PE126000--1410-K0014_STD_1_20140718_0" unitRef="iso4217_USD" decimals="-5" id="id_5851737_497D4A75-8662-4C4E-B281-1AD5852CC688_1_1">1400000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
  <mnkd:TotalConsiderationReceived contextRef="eol_PE126000--1410-K0014_STD_1_20140718_0" unitRef="iso4217_USD" decimals="-5" id="id_5851737_497D4A75-8662-4C4E-B281-1AD5852CC688_1_0">9300000</mnkd:TotalConsiderationReceived>
  <us-gaap:FairValueInputsDiscountRate contextRef="eol_PE126000--1410-K0014_STD_1_20121018_0" unitRef="pure" decimals="3" id="id_5851737_48D21C2B-581C-4650-965F-B3C18D345C27_1_1">0.023</us-gaap:FairValueInputsDiscountRate>
  <us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE126000--1410-K0014_STD_1_20121018_0" unitRef="pure" decimals="4" id="id_5851737_48D21C2B-581C-4650-965F-B3C18D345C27_1_0">0.0011</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
  <mnkd:PercentageOfNetProceedFromSaleOfNotes contextRef="eol_PE126000--1410-K0014_STD_1_20140923_0_911417x1029301" unitRef="pure" decimals="INF" id="id_5851737_DAD79ABD-9244-4698-8A23-82D067162C67_1001_0">1.00</mnkd:PercentageOfNetProceedFromSaleOfNotes>
  <us-gaap:FairValueInputsDiscountRate contextRef="eol_PE126000--1410-K0014_STD_1_20121220_0" unitRef="pure" decimals="3" id="id_5851737_48D21C2B-581C-4650-965F-B3C18D345C27_2_1">0.015</us-gaap:FairValueInputsDiscountRate>
  <us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE126000--1410-K0014_STD_1_20121220_0" unitRef="pure" decimals="4" id="id_5851737_48D21C2B-581C-4650-965F-B3C18D345C27_2_0">0.0000</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:FairValueInputsDiscountRate contextRef="eol_PE126000--1410-K0014_STD_1_20131231_0_900547x907189_904933x910565_906969x1077046_910720x1029473" unitRef="pure" decimals="3" id="id_5851737_3AA3F10F-E8A1-4988-8AD1-6981226115CA_2004_5">0.127</us-gaap:FairValueInputsDiscountRate>
  <mnkd:LoanCommitmentAssetWriteOff contextRef="eol_PE126000--1410-K0014_STD_1_20141230_0_906969x950672_910720x1029473" unitRef="iso4217_USD" decimals="-5" id="id_5851737_FED51AEC-139B-4170-8B4C-089025158484_1002_2">1800000</mnkd:LoanCommitmentAssetWriteOff>
  <us-gaap:FairValueInputsDiscountRate contextRef="eol_PE126000--1410-K0014_STD_1_20141231_0_900547x907189_904933x910565_906969x1021115_910720x1029473" unitRef="pure" decimals="3" id="id_5851737_3AA3F10F-E8A1-4988-8AD1-6981226115CA_1003_3">0.122</us-gaap:FairValueInputsDiscountRate>
  <us-gaap:FairValueInputsDiscountRate contextRef="eol_PE126000--1410-K0014_STD_1_20141231_0_900547x907189_904933x910565_906969x1077046_910720x1029473" unitRef="pure" decimals="3" id="id_5851737_3AA3F10F-E8A1-4988-8AD1-6981226115CA_2003_2">0.123</us-gaap:FairValueInputsDiscountRate>
  <us-gaap:FairValueInputsDiscountRate contextRef="eol_PE126000--1410-K0014_STD_1_20141231_0_900547x907189_904933x910565_906969x950672_910720x1029473" unitRef="pure" decimals="3" id="id_5851737_3AA3F10F-E8A1-4988-8AD1-6981226115CA_3003_4">0.118</us-gaap:FairValueInputsDiscountRate>
  <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="eol_PE126000--1410-K0014_STD_28_20090228_0_906053x953384_910940x910864" unitRef="pure" decimals="2" id="id_5851737_F3C41F07-348E-45E2-93F1-11D8A4C4766C_2002_1">0.03</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
  <us-gaap:DebtInstrumentDescriptionOfVariableRateBasis contextRef="eol_PE126000--1410-K0014_STD_28_20090228_0_906053x953384_910940x910864" id="id_5851737_F3C41F07-348E-45E2-93F1-11D8A4C4766C_2002_2">One-year LIBOR</us-gaap:DebtInstrumentDescriptionOfVariableRateBasis>
  <mnkd:PercentageOfCommonStockSharesOutstanding contextRef="eol_PE126000--1410-K0014_STD_31_20040331_0" unitRef="pure" decimals="2" id="id_5851737_82C71537-FFD8-4EBE-ACB8-0B2CD6BF8AA1_1_3">0.01</mnkd:PercentageOfCommonStockSharesOutstanding>
  <mnkd:PercentageOfShareReservedForShareBasedCompensation contextRef="eol_PE126000--1410-K0014_STD_31_20040331_0_901032x907457" unitRef="pure" decimals="2" id="id_5851737_82C71537-FFD8-4EBE-ACB8-0B2CD6BF8AA1_1001_4">0.10</mnkd:PercentageOfShareReservedForShareBasedCompensation>
  <mnkd:EmployeeStockPurchasePlanAnnualIncreaseInReservedShares contextRef="eol_PE126000--1410-K0014_STD_31_20040331_0_912473x1033376" unitRef="shares" decimals="INF" id="id_5851737_82C71537-FFD8-4EBE-ACB8-0B2CD6BF8AA1_2001_1">700000</mnkd:EmployeeStockPurchasePlanAnnualIncreaseInReservedShares>
  <mnkd:NetOperatingLossCarryforwardAnnualLimitation contextRef="eol_PE126000--1410-K0014_STD_31_20040831_0" unitRef="iso4217_USD" decimals="-5" id="id_5851737_9AC30204-7B96-4D29-9AF1-1B18DEEF98BC_2_5">13000000</mnkd:NetOperatingLossCarryforwardAnnualLimitation>
  <mnkd:LoanAgreementWithRelatedParty contextRef="eol_PE126000--1410-K0014_STD_31_20071031_0_910940x910864" unitRef="iso4217_USD" decimals="-5" id="id_5851737_F3C41F07-348E-45E2-93F1-11D8A4C4766C_3001_0">350000000</mnkd:LoanAgreementWithRelatedParty>
  <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="eol_PE126000--1410-K0014_STD_31_20121031_0" unitRef="shares" decimals="INF" id="id_5851737_CBBDCCC0-8AD4-4F5F-97E1-B9B080464600_1_0">40000000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
  <mnkd:AdditionalPurchaseOfCommonStock contextRef="eol_PE126000--1410-K0014_STD_31_20121031_0" unitRef="shares" decimals="INF" id="id_5851737_CBBDCCC0-8AD4-4F5F-97E1-B9B080464600_1_3">4500000</mnkd:AdditionalPurchaseOfCommonStock>
  <mnkd:AdditionalCommonsStockSharesIssuedDuringPeriod contextRef="eol_PE126000--1410-K0014_STD_31_20121031_0" unitRef="shares" decimals="INF" id="id_5851737_CBBDCCC0-8AD4-4F5F-97E1-B9B080464600_1_2">6000000</mnkd:AdditionalCommonsStockSharesIssuedDuringPeriod>
  <mnkd:WarrantExpirationMonthYear contextRef="eol_PE126000--1410-K0014_STD_31_20121031_0" id="id_5851737_CBBDCCC0-8AD4-4F5F-97E1-B9B080464600_1_8">2013-10</mnkd:WarrantExpirationMonthYear>
  <mnkd:CommonStockPurchase contextRef="eol_PE126000--1410-K0014_STD_31_20121031_0" unitRef="shares" decimals="0" id="id_5851737_CBBDCCC0-8AD4-4F5F-97E1-B9B080464600_1_1">30000000</mnkd:CommonStockPurchase>
  <mnkd:CommonStockIssuableUponExerciseOfWarrantsConversionRatio contextRef="eol_PE126000--1410-K0014_STD_31_20121031_0" unitRef="pure" decimals="2" id="id_5851737_CBBDCCC0-8AD4-4F5F-97E1-B9B080464600_1_6">0.75</mnkd:CommonStockIssuableUponExerciseOfWarrantsConversionRatio>
  <mnkd:NetProceedsFromPublicOffering contextRef="eol_PE126000--1410-K0014_STD_31_20121031_0" unitRef="iso4217_USD" decimals="-5" id="id_5851737_CBBDCCC0-8AD4-4F5F-97E1-B9B080464600_1_5">86300000</mnkd:NetProceedsFromPublicOffering>
  <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="eol_PE126000--1410-K0014_STD_31_20121031_0_901822x902719_902891x909228" unitRef="shares" decimals="INF" id="id_5851737_816736E2-ECD6-4BF8-A053-BB15529DA75C_1001_0">40000000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
  <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="eol_PE126000--1410-K0014_STD_31_20121031_0_901822x904951_902891x909228" unitRef="shares" decimals="INF" id="id_5851737_816736E2-ECD6-4BF8-A053-BB15529DA75C_2001_1">40000000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
  <us-gaap:ProceedsFromWarrantExercises contextRef="eol_PE126000--1410-K0014_STD_31_20131031_0" unitRef="iso4217_USD" decimals="-5" id="id_5851737_CBBDCCC0-8AD4-4F5F-97E1-B9B080464600_2_9">89700000</us-gaap:ProceedsFromWarrantExercises>
  <us-gaap:DebtInstrumentMaturityDate contextRef="eol_PE126000--1410-K0014_STD_31_20131031_0_906053x1051648_910940x910864" id="id_5851737_F3C41F07-348E-45E2-93F1-11D8A4C4766C_1004_4">2020-01-05</us-gaap:DebtInstrumentMaturityDate>
  <mnkd:PrincipalIndebtednessCancelledUnderLoanArrangementAsPaymentForAggregateExercisePriceOfWarrants contextRef="eol_PE126000--1410-K0014_STD_31_20131031_0_906053x1051648_910940x910864" unitRef="iso4217_USD" decimals="-5" id="id_5851737_F3C41F07-348E-45E2-93F1-11D8A4C4766C_1004_5">78000000</mnkd:PrincipalIndebtednessCancelledUnderLoanArrangementAsPaymentForAggregateExercisePriceOfWarrants>
  <mnkd:LoanAgreementWithRelatedParty contextRef="eol_PE126000--1410-K0014_STD_31_20131031_0_910940x910864" unitRef="iso4217_USD" decimals="-5" id="id_5851737_F3C41F07-348E-45E2-93F1-11D8A4C4766C_3004_0">370000000</mnkd:LoanAgreementWithRelatedParty>
  <us-gaap:ForwardContractIndexedToIssuersEquityShares contextRef="eol_PE126000--1410-K0014_STD_31_20121231_0" unitRef="shares" decimals="INF" id="id_5851737_816736E2-ECD6-4BF8-A053-BB15529DA75C_2_6">350000000</us-gaap:ForwardContractIndexedToIssuersEquityShares>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="pure" decimals="4" id="id_5851737_4891FC0B-C69B-476B-9ABC-3A53D8C25AD9_2_4">0.7583</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_5851737_9C0D5787-E738-4506-A65E-31334D531A9D_2_0">3.26</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="pure" decimals="3" id="id_5851737_B6F3E2C8-A6E4-4D0D-8044-F1D8F2BFBEF5_2_5">0.000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_2_23">-128732000</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="pure" decimals="2" id="id_5851737_4891FC0B-C69B-476B-9ABC-3A53D8C25AD9_2_6">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="pure" decimals="2" id="id_5851737_B6F3E2C8-A6E4-4D0D-8044-F1D8F2BFBEF5_2_1">0.00</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
  <us-gaap:FairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="pure" decimals="2" id="id_5851737_28589D0C-FD0E-48FE-BFEF-904A5C3A7E4B_2_0">0.65</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="shares" decimals="INF" id="id_5851737_82C71537-FFD8-4EBE-ACB8-0B2CD6BF8AA1_3_5">463290</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="shares" decimals="-3" id="id_5851737_4373895D-6E6F-41A5-A449-A8691F7E803C_2_14">299591000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="pure" decimals="3" id="id_5851737_B6F3E2C8-A6E4-4D0D-8044-F1D8F2BFBEF5_2_4">-0.307</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
  <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="pure" decimals="3" id="id_5851737_B6F3E2C8-A6E4-4D0D-8044-F1D8F2BFBEF5_2_3">-0.043</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="pure" decimals="4" id="id_5851737_4891FC0B-C69B-476B-9ABC-3A53D8C25AD9_2_0">0.0094</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" id="id_5851737_8F1A5AC1-8BCD-4B25-9FA2-DD3AB5888390_2_2">P7Y22D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_5851737_4373895D-6E6F-41A5-A449-A8691F7E803C_2_13">-0.64</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="pure" decimals="INF" id="id_5851737_B6F3E2C8-A6E4-4D0D-8044-F1D8F2BFBEF5_2_0">0.350</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="pure" decimals="4" id="id_5851737_4891FC0B-C69B-476B-9ABC-3A53D8C25AD9_2_5">0.8626</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="pure" decimals="4" id="id_5851737_4891FC0B-C69B-476B-9ABC-3A53D8C25AD9_2_1">0.0182</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="shares" decimals="INF" id="id_5851737_127E2ACD-5D85-413D-A09E-8F8110ADED0E_2_4">78475367</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_6006_900024">48888000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_6006_900019">-4801000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-5" id="id_5851737_4FEAEA63-925D-4828-849A-287F8F314E3B_2_0">66800000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_90D3F4A0-1EBD-40FE-9C68-173795AC8270_2_6">2000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="INF" id="id_5851737_7A23EAFD-38E9-4829-ABCF-DAE75D55D931_2_1">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_2_17">965000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4373895D-6E6F-41A5-A449-A8691F7E803C_2_10">-191490000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_6006_900027">1263000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_6006_900018">2270000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:OperatingIncomeLoss contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4373895D-6E6F-41A5-A449-A8691F7E803C_2_5">-169401000</us-gaap:OperatingIncomeLoss>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_90D3F4A0-1EBD-40FE-9C68-173795AC8270_2_7">-191488000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:DebtConversionOriginalDebtAmount1 contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_2_44">6500000</us-gaap:DebtConversionOriginalDebtAmount1>
  <us-gaap:PaymentsOfDebtIssuanceCosts contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_2_34">598000</us-gaap:PaymentsOfDebtIssuanceCosts>
  <us-gaap:OtherNonoperatingIncomeExpense contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4373895D-6E6F-41A5-A449-A8691F7E803C_2_6">-635000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_6006_900029">2000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
  <us-gaap:RepaymentsOfSeniorDebt contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_2_31">115000000</us-gaap:RepaymentsOfSeniorDebt>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_2_25">7987000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:OtherNoncashIncomeExpense contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_2_12">-2000</us-gaap:OtherNoncashIncomeExpense>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4373895D-6E6F-41A5-A449-A8691F7E803C_2_12">-191490000</us-gaap:NetIncomeLoss>
  <us-gaap:InvestmentIncomeInterest contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4373895D-6E6F-41A5-A449-A8691F7E803C_2_9">8000</us-gaap:InvestmentIncomeInterest>
  <us-gaap:InterestPaid contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_2_43">13452000</us-gaap:InterestPaid>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_6006_900028">45186000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_2_37">4801000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
  <us-gaap:InterestPaidCapitalized contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_2_46">7886000</us-gaap:InterestPaidCapitalized>
  <us-gaap:ConstructionInProgressExpendituresIncurredButNotYetPaid contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_2_45">856000</us-gaap:ConstructionInProgressExpendituresIncurredButNotYetPaid>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_6006_900030">998000</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_5CF4DCBF-958A-4C2E-84FF-736CEF523791_2_0">45186000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_FF1422D9-4F07-4EC2-A2EF-D2BD529666C7_2_10">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-5" id="id_5851737_9DDD7803-FC6B-4DBD-94E8-64434E7A1B04_2_0">11500000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:InterestCostsCapitalized contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-5" id="id_5851737_1322FBBF-CCB2-4059-9D68-2AC5451BAB41_2_1">400000</us-gaap:InterestCostsCapitalized>
  <us-gaap:InterestExpense contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-5" id="id_5851737_1322FBBF-CCB2-4059-9D68-2AC5451BAB41_2_0">21500000</us-gaap:InterestExpense>
  <us-gaap:OperatingExpenses contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4373895D-6E6F-41A5-A449-A8691F7E803C_2_4">169401000</us-gaap:OperatingExpenses>
  <us-gaap:ProceedsFromIssuanceOfDebt contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_2_32">119500000</us-gaap:ProceedsFromIssuanceOfDebt>
  <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4373895D-6E6F-41A5-A449-A8691F7E803C_2_7">6309000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-5" id="id_5851737_78F5C120-82A4-4A68-A5A4-4EFB90BCC73A_2_1">14900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
  <us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-5" id="id_5851737_6C5177C9-5366-4D13-941E-B0303FCF50EA_2_0">900000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
  <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_FF1422D9-4F07-4EC2-A2EF-D2BD529666C7_2_7">7470000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
  <us-gaap:InterestExpenseDebt contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4373895D-6E6F-41A5-A449-A8691F7E803C_2_8">15153000</us-gaap:InterestExpenseDebt>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_2_39">8950000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_FF1422D9-4F07-4EC2-A2EF-D2BD529666C7_2_8">0</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
  <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_2_20">3675000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
  <us-gaap:OperatingLeasesRentExpenseNet contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_5851737_215C1445-5489-4219-BC45-8D91F36914C4_2_0">645000</us-gaap:OperatingLeasesRentExpenseNet>
  <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_FF1422D9-4F07-4EC2-A2EF-D2BD529666C7_2_1">0</us-gaap:CurrentFederalTaxExpenseBenefit>
  <us-gaap:DeferredOtherTaxExpenseBenefit contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_FF1422D9-4F07-4EC2-A2EF-D2BD529666C7_2_9">-66849000</us-gaap:DeferredOtherTaxExpenseBenefit>
  <us-gaap:DepreciationAndAmortization contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_2_3">14057000</us-gaap:DepreciationAndAmortization>
  <us-gaap:EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-5" id="id_5851737_8F1A5AC1-8BCD-4B25-9FA2-DD3AB5888390_2_1">2300000</us-gaap:EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions>
  <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_2_38">145669000</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
  <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_FF1422D9-4F07-4EC2-A2EF-D2BD529666C7_2_2">0</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="INF" id="id_5851737_7A23EAFD-38E9-4829-ABCF-DAE75D55D931_2_0">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
  <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_2_27">-7987000</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
  <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4373895D-6E6F-41A5-A449-A8691F7E803C_2_2">109719000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
  <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_FF1422D9-4F07-4EC2-A2EF-D2BD529666C7_2_3">0</us-gaap:CurrentForeignTaxExpenseBenefit>
  <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_FF1422D9-4F07-4EC2-A2EF-D2BD529666C7_2_4">0</us-gaap:CurrentIncomeTaxExpenseBenefit>
  <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_5851737_A5EFB79E-1DD7-45F0-A8F1-82325FD3AE31_2_0">533000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
  <us-gaap:GeneralAndAdministrativeExpense contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4373895D-6E6F-41A5-A449-A8691F7E803C_2_3">59682000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_2_19">-1071000</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:ProceedsFromWarrantExercises contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_2_30">94147000</us-gaap:ProceedsFromWarrantExercises>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_2_4">45186000</us-gaap:ShareBasedCompensation>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-5" id="id_5851737_78F5C120-82A4-4A68-A5A4-4EFB90BCC73A_2_0">13900000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-5" id="id_5851737_9C0D5787-E738-4506-A65E-31334D531A9D_2_2">3100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
  <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_FF1422D9-4F07-4EC2-A2EF-D2BD529666C7_2_6">59379000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
  <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_2_22">591000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
  <mnkd:StockIssuedDuringPeriodValueWarrantExercises contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_6006_900021">172149000</mnkd:StockIssuedDuringPeriodValueWarrantExercises>
  <mnkd:IncomeTaxExpenseBenefitNet contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_FF1422D9-4F07-4EC2-A2EF-D2BD529666C7_2_11">0</mnkd:IncomeTaxExpenseBenefitNet>
  <mnkd:CancellationOfPrincipalOnNotePayableToRelatedParty contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_2_47">78000000</mnkd:CancellationOfPrincipalOnNotePayableToRelatedParty>
  <mnkd:StateResearchAndDevelopmentCreditExchangeReceivable contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_2_14">466000</mnkd:StateResearchAndDevelopmentCreditExchangeReceivable>
  <mnkd:GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_2_5">-817000</mnkd:GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment>
  <mnkd:StockIssuedDuringPeriodValueForDebtExchange contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_6006_900023">5501000</mnkd:StockIssuedDuringPeriodValueForDebtExchange>
  <mnkd:PaymentsForUseOfAircrafts contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_5851737_EE6F1B00-1AF9-470E-B601-EE07C528EEDD_2_0">82000</mnkd:PaymentsForUseOfAircrafts>
  <mnkd:ProceedsFromIssuanceOfCommonStockAndWarrantsNet contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_2_29">52421000</mnkd:ProceedsFromIssuanceOfCommonStockAndWarrantsNet>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0_900196x900353" unitRef="shares" decimals="INF" id="id_5851737_127E2ACD-5D85-413D-A09E-8F8110ADED0E_1002_1">25415366</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0_900196x902719" unitRef="shares" decimals="INF" id="id_5851737_127E2ACD-5D85-413D-A09E-8F8110ADED0E_2002_3">9115821</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0_900196x904951" unitRef="shares" decimals="INF" id="id_5851737_127E2ACD-5D85-413D-A09E-8F8110ADED0E_3002_2">19706240</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0_900196x907138" unitRef="shares" decimals="INF" id="id_5851737_127E2ACD-5D85-413D-A09E-8F8110ADED0E_4002_0">24237940</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0_901032x907457" id="id_5851737_4891FC0B-C69B-476B-9ABC-3A53D8C25AD9_1002_3">P5Y9M7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0_901032x909105" id="id_5851737_4891FC0B-C69B-476B-9ABC-3A53D8C25AD9_2002_2">P2Y7M21D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0_904892x1063447" unitRef="iso4217_USD" decimals="-3" id="id_5851737_57D2ECBE-392C-4E6E-B247-92B8CD9C9C0C_1002_0">45181000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0_904892x921908" unitRef="iso4217_USD" decimals="-3" id="id_5851737_57D2ECBE-392C-4E6E-B247-92B8CD9C9C0C_2002_1">5000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0_905668x928369" unitRef="iso4217_USD" decimals="-3" id="id_5851737_110C905F-68E2-4183-AA9B-0466B600C0DE_1002_1">24777000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0_905668x974237" unitRef="iso4217_USD" decimals="-3" id="id_5851737_110C905F-68E2-4183-AA9B-0466B600C0DE_2002_0">20409000</us-gaap:AllocatedShareBasedCompensationExpense>
  <mnkd:BorrowingRate contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0_906053x953384_910940x910864" unitRef="pure" decimals="4" id="id_5851737_F3C41F07-348E-45E2-93F1-11D8A4C4766C_2003_3">0.0584</mnkd:BorrowingRate>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0_907910x1042177" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_6005_800031">-191490000</us-gaap:NetIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0_907910x901931" unitRef="shares" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_6001_400027">557000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0_907910x901931" unitRef="shares" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_6001_400024">9824000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0_907910x901931" unitRef="shares" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_6001_400019">1870000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0_907910x901931" unitRef="shares" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_6001_400018">880000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0_907910x901931" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_6001_500024">99000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0_907910x901931" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_6001_500019">20000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0_907910x901931" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_6001_500027">5000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0_907910x901931" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_6001_500018">9000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <mnkd:StockIssuedDuringPeriodSharesWarrantExercises contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0_907910x901931" unitRef="shares" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_6001_400020">66353000</mnkd:StockIssuedDuringPeriodSharesWarrantExercises>
  <mnkd:StockIssuedDuringPeriodSharesForDebtExchange contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0_907910x901931" unitRef="shares" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_6001_400022">1095000</mnkd:StockIssuedDuringPeriodSharesForDebtExchange>
  <mnkd:StockIssuedDuringPeriodValueWarrantExercises contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0_907910x901931" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_6001_500021">664000</mnkd:StockIssuedDuringPeriodValueWarrantExercises>
  <mnkd:StockIssuedDuringPeriodSharesIssuedRelatedToLegalSettlement contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0_907910x901931" unitRef="shares" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_6001_400025">2778000</mnkd:StockIssuedDuringPeriodSharesIssuedRelatedToLegalSettlement>
  <mnkd:StockIssuedDuringPeriodValueIssuedRelatedToLegalSettlement contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0_907910x901931" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_6001_500026">28000</mnkd:StockIssuedDuringPeriodValueIssuedRelatedToLegalSettlement>
  <mnkd:StockIssuedDuringPeriodValueForDebtExchange contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0_907910x901931" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_6001_500023">12000</mnkd:StockIssuedDuringPeriodValueForDebtExchange>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0_907910x905139" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_6003_600024">48789000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0_907910x905139" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_6003_600019">-4821000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0_907910x905139" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_6003_600027">1258000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0_907910x905139" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_6003_600018">2261000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0_907910x905139" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_6003_600028">45186000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0_907910x905139" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_6003_600030">998000</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
  <mnkd:StockIssuedDuringPeriodValueWarrantExercises contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0_907910x905139" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_6003_600021">171485000</mnkd:StockIssuedDuringPeriodValueWarrantExercises>
  <mnkd:StockIssuedDuringPeriodValueIssuedRelatedToLegalSettlement contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0_907910x905139" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_6003_600026">-28000</mnkd:StockIssuedDuringPeriodValueIssuedRelatedToLegalSettlement>
  <mnkd:StockIssuedDuringPeriodValueForDebtExchange contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0_907910x905139" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_6003_600023">5489000</mnkd:StockIssuedDuringPeriodValueForDebtExchange>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0_907910x910799" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_6004_700029">2000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
  <us-gaap:AmortizationOfFinancingCosts contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0_912827x1060185" unitRef="iso4217_USD" decimals="-3" id="id_5851737_D65369DE-2D89-43B7-9DB3-60A1295CEEA4_1002_0">42000</us-gaap:AmortizationOfFinancingCosts>
  <us-gaap:AmortizationOfDebtDiscountPremium contextRef="eol_PE126000--1410-K0014_STD_365_20131231_0_912827x1060185" unitRef="iso4217_USD" decimals="-3" id="id_5851737_D65369DE-2D89-43B7-9DB3-60A1295CEEA4_1002_1">1113000</us-gaap:AmortizationOfDebtDiscountPremium>
  <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_EE9DB2FA-A3FD-464B-8789-3682B60D2F8C_1_0">&lt;div&gt;
 &lt;p style="margin-top:0px;margin-bottom:0px"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;6. Accrued expenses and
 other current liabilities&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;Accrued expenses
 and other current liabilities are comprised of the following (in
 thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="font-size:6px;margin-top:0px;margin-bottom:0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
 &lt;tr&gt;
 &lt;td width="84%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="6" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Salary and related
 expenses&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;14,928&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;12,193&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Research and clinical trial
 costs&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1,311&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Accrued interest&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;2,396&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;2,082&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Construction in
 progress&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1,343&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;342&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Other&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;7,539&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;5,706&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Accrued expenses and other
 current liabilities&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;26,206&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;21,634&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
  <us-gaap:CollaborativeArrangementDisclosureTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_8CCD70BA-ED07-4B93-8D6F-3B99BAE6F1AB_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;b&gt;9.
 Collaboration arrangement&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;On
 August&amp;#xA0;11, 2014, the Company and Sanofi entered into a license
 and collaboration agreement, which became effective on
 September&amp;#xA0;23, 2014. Under the terms of the Sanofi License
 Agreement, the Company granted to Sanofi exclusive, worldwide
 licenses to certain of the Company&amp;#x2019;s patents, trademarks and
 know-how for the development and commercialization of AFREZZA.
 Under the terms of the Sanofi License Agreement, Sanofi has the
 exclusive right and responsibility to develop AFREZZA worldwide,
 subject to certain development activities that will be performed by
 the Company. Sanofi will also be obligated to use commercially
 reasonable efforts to file for, obtain and maintain marketing
 approvals for AFREZZA in certain major markets and countries. In
 addition, Sanofi will have exclusive, worldwide rights to
 commercialize AFREZZA and will be obligated to use commercially
 reasonable efforts to market, promote and commercialize AFREZZA in
 all countries in the world where regulatory approval for AFREZZA
 has been received. Pursuant to the terms of a supply agreement that
 the Company entered into with Sanofi concurrently with the Sanofi
 License Agreement, the Company will be responsible for the
 manufacture and supply to Sanofi of its requirements of
 AFREZZA.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Under the
 Sanofi License Agreement, Sanofi paid the Company an up-front cash
 payment of $150.0 million in the third quarter of 2014. If certain
 manufacturing, regulatory and sales milestones are achieved, the
 Company will also be eligible to receive up to $775.0 million in
 milestone payments, of which $75.0 million relates to certain
 development and manufacturing milestone events, $50.0 million
 relates to the filing and completion of regulatory approvals and
 $650.0 million relates to the achievement of certain product sales
 milestones. As of December&amp;#xA0;31, 2014, the Company earned and
 recorded a total of $50.0 million in milestone payments in
 connection with the satisfaction of manufacturing milestones
 specified in the Sanofi agreement, which were received subsequent
 to December&amp;#xA0;31, 2014. In addition, worldwide profits and
 losses, which are determined based on the difference between the
 net sales of AFREZZA and the costs and expenses incurred by the
 Company and Sanofi that are specifically attributable or related to
 the development, improvement, regulatory filings, manufacturing,
 and commercialization of AFREZZA will be shared 65% by Sanofi and
 35% by the Company. In accordance with the terms of the Sanofi
 License Agreement, profit and loss sharing commenced in the fourth
 quarter of 2014.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;In
 conjunction with the Sanofi License Agreement, on August&amp;#xA0;11,
 2014, we entered into the Sanofi Supply Agreement which provides
 that the Company will be the exclusive manufacturer and supplier of
 AFREZZA until the specified conditions are met, upon which a
 portion of the manufacturing activities may be assumed by
 Sanofi.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;On
 September&amp;#xA0;23, 2014, the Company entered into the Sanofi Loan
 Facility, consisting of a senior secured revolving promissory note
 (the &amp;#x201C;Note&amp;#x201D;) and a guaranty and security agreement (the
 &amp;#x201C;Security Agreement&amp;#x201D;) with an affiliate of Sanofi which
 provides the Company with a secured loan facility of up to $175.0
 million to fund the Company&amp;#x2019;s share of net losses under the
 Sanofi License Agreement. In the event of certain future defaults
 under the Sanofi Loan facility agreement for which we are not able
 to obtain waivers, the lender under the Sanofi Loan Facility may
 accelerate all of our repayment obligations, and take control of
 our pledged assets, potentially requiring us to renegotiate the
 terms of our indebtedness on terms less favorable to us, or to
 immediately cease operations.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The
 obligations of the Company under the Sanofi Loan Facility are
 guaranteed by the Company&amp;#x2019;s wholly-owned subsidiary, MannKind
 LLC, and are secured by a first priority security interest in
 certain insulin inventory located in the United States and any
 contractual rights and obligations pursuant to which the Company
 purchases or has purchased such insulin, and a second priority
 security interest in the Company&amp;#x2019;s assets that secure the
 Company&amp;#x2019;s obligations under the Facility Agreement, as
 amended. In addition, the Company granted to Sanofi, as additional
 security for the obligations under the Sanofi Loan Facility, a
 first priority mortgage on the Company&amp;#x2019;s facility in
 Valencia, California.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Advances
 under the Sanofi Loan Facility bear interest at a rate of
 8.5%&amp;#xA0;per annum and are payable in-kind and compounded
 quarterly and added to the outstanding principal balance under the
 Sanofi Loan Facility. The Company is required to make mandatory
 prepayments on the outstanding loans under the Sanofi Loan Facility
 from its share of any Profits (as defined in the Sanofi License
 Agreement) under the Sanofi License Agreement within 30 days of
 receipt of its share of any such Profits. No advances may be made
 under the Sanofi Loan Agreement if Deerfield has commenced
 enforcement proceedings in connection with an event of default
 under the Facility Agreement.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The
 outstanding principal of all loans under the Sanofi Loan Facility,
 if not prepaid, will become due and payable on September&amp;#xA0;23,
 2024 unless accelerated pursuant to the terms of the Sanofi Loan
 Facility. Additionally, if the Company sells its Valencia facility,
 the Company is required to prepay the loans under the Sanofi Loan
 Facility in an amount equal to 100% of the net cash proceeds of the
 sale within five business days of receipt.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The Sanofi
 Loan Facility includes customary representations, warranties and
 covenants by the Company, including restrictions on its ability to
 incur additional indebtedness, grant certain liens and make certain
 changes to its organizational documents. Events of default under
 the Sanofi Loan Facility include: the Company&amp;#x2019;s failure to
 timely make payments due under the Sanofi Loan Facility;
 inaccuracies in the Company&amp;#x2019;s representations and warranties
 to the noteholder; the Company&amp;#x2019;s failure to comply with any
 of its covenants under any of the Sanofi Loan Facility or certain
 other related security agreements and documents entered into in
 connection with the Sanofi Loan Facility, subject to a cure period
 with respect to most covenants; the Company&amp;#x2019;s insolvency or
 the occurrence of certain bankruptcy-related events; termination by
 Sanofi of the Sanofi License Agreement as a result of the
 Company&amp;#x2019;s breach of the Sanofi License Agreement; and the
 failure of any material provision under any of the Sanofi Loan
 Facility or certain other related security agreements and documents
 entered into in connection with the Sanofi Loan Facility to remain
 in full force and effect. If one or more events of default occurs
 and is continuing, Sanofi may terminate its obligation to make
 advances under the Sanofi Loan Facility, and, if certain specified
 events of default (including the Company&amp;#x2019;s failure to timely
 make payments due under the Sanofi Loan Facility; the
 Company&amp;#x2019;s failure to comply with the negative covenants under
 the Sanofi Loan Facility limiting the Company&amp;#x2019;s ability to
 incur additional indebtedness or grant certain liens; the
 Company&amp;#x2019;s insolvency or the occurrence of certain
 bankruptcy-related events; termination by Sanofi of the Sanofi
 License Agreement as a result of the Company&amp;#x2019;s breach of the
 non-compete provisions of the Sanofi License Agreement; or the
 failure of any material provision under any of the Sanofi Loan
 Facility or certain other related security agreements and documents
 entered into in connection with the Sanofi Loan Facility to remain
 in full force and effect) occur and are continuing, the noteholder
 may accelerate all of the Company&amp;#x2019;s repayment obligations
 under the Sanofi Loan Facility and otherwise exercise any of its
 remedies as a secured creditor. There can be no assurance that the
 noteholder would not choose to exercise these rights in the event
 such events were to occur.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The Company
 analyzed the up-front cash payment of $150.0 million under the
 provisions of ASC 605,&amp;#xA0;&lt;i&gt;Revenue Recognition&lt;/i&gt;, to
 determine whether the up-front cash payment, or a portion thereof,
 could be recognized as revenue. ASC 605 provides that revenue is
 recognized when there is persuasive evidence that an arrangement
 exists, delivery has occurred or services have been rendered, the
 price is fixed or determinable and collection is reasonably
 assured. In addition, revenue arrangements with multiple elements
 are divided into separate units of accounting if certain criteria
 are met, including whether the delivered element has stand-alone
 value to the customer. When deliverables are separable,
 consideration received is allocated to the separate units of
 accounting based on the relative selling price of each deliverable
 and the appropriate revenue recognition principles are applied to
 each unit.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The
 assessment of multiple element arrangements requires judgment in
 order to determine the appropriate units of accounting and the
 points in time that, or periods over which, revenue should be
 recognized. Under the terms of the Sanofi License Agreement, Sanofi
 Supply Agreement and the Sanofi Loan Facility the Company
 determined that the arrangement contained significant deliverables
 including (i)&amp;#xA0;licenses to develop and commercialize AFREZZA
 and to use the Company&amp;#x2019;s trademarks, (ii)&amp;#xA0;development
 activities, and (iii)&amp;#xA0;manufacture and supply services for
 AFREZZA. Due to the proprietary nature of the manufacturing
 services being provided by the Company, the Company determined that
 all of the significant deliverables should be combined into a
 single unit of accounting. The Company believes that the
 manufacturing services are proprietary due to the fact that over
 the past twelve years, the Company has developed proprietary
 knowledge and patented equipment and tools that are used in the
 manufacturing process of AFREZZA. Due to the complexities of
 particle formulation and the specialized knowledge and equipment
 needed to handle the AFREZZA powder, neither Sanofi nor any
 third-party contract manufacturing organization currently possesses
 the capability of manufacturing AFREZZA.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;In order for
 revenue to be recognized, the seller&amp;#x2019;s price to the buyer
 must be fixed and determinable. Given that as of December&amp;#xA0;31,
 2014, the Company did not have the ability to estimate the amount
 of costs that would potentially be incurred under the loss share
 provision related to the Sanofi License Agreement and the Sanofi
 Supply Agreement, the Company believes this requirement for revenue
 recognition has not been met.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;As such, the
 Company did not recognize any revenue pursuant to the Sanofi
 License Agreement the Sanofi Supply Agreement for the year ended
 December&amp;#xA0;31, 2014. The Company recorded the $150.0 million
 up-front payment and $50.0&amp;#xA0;million milestone receivable as
 deferred payments from collaboration. As of December&amp;#xA0;31, 2014,
 the Company&amp;#x2019;s portion of the loss sharing was $3.0 million,
 which resulted in the reclassification from current deferred
 payments from collaboration to other long term liabilities.
 Subsequent to December&amp;#xA0;31, 2014 the Company borrowed $3.0
 million under the Sanofi Loan Facility to finance the portion of
 the Company&amp;#x2019;s loss.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;


 &lt;/div&gt;</us-gaap:CollaborativeArrangementDisclosureTextBlock>
  <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_0091E0C3-7342-406C-A6DF-FBE7386CC049_1_0">&lt;div&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;14. Commitments and
 contingencies&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Operating
 Leases&lt;/i&gt; &amp;#x2014; The Company leases certain facilities and
 equipment under various operating leases, which expire at various
 dates through 2014 and beyond. Future payments are deemed
 insignificant.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;Rent expense
 under all operating leases, including office space and equipment,
 for the years ended December&amp;#xA0;31, 2014, 2013, and 2012 was
 approximately $737,000, $645,000, and $675,000
 respectively.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Leases&lt;/i&gt;
 &amp;#x2014; The Company&amp;#x2019;s capital leases were not material for
 the years ended December&amp;#xA0;31, 2014, 2013 and 2012.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Guarantees
 and Indemnifications&lt;/i&gt; &amp;#x2014; In the ordinary course of its
 business, the Company makes certain indemnities, commitments and
 guarantees under which it may be required to make payments in
 relation to certain transactions. The Company, as permitted under
 Delaware law and in accordance with its Bylaws, indemnifies its
 officers and directors for certain events or occurrences, subject
 to certain limits, while the officer or director is or was serving
 at the Company&amp;#x2019;s request in such capacity. The term of the
 indemnification period is for the officer&amp;#x2019;s or
 director&amp;#x2019;s lifetime. The maximum amount of potential future
 indemnification is unlimited; however, the Company has a director
 and officer insurance policy that may enable it to recover a
 portion of any future amounts paid. The Company believes the fair
 value of these indemnification agreements is minimal. The Company
 has not recorded any liability for these indemnities in the
 accompanying consolidated balance sheets. However, the Company
 accrues for losses for any known contingent liability, including
 those that may arise from indemnification provisions, when future
 payment is probable. No such losses have been recorded to
 date.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Litigation&lt;/i&gt; &amp;#x2014; The Company is subject to legal
 proceedings and claims which arise in the ordinary course of its
 business. As of December&amp;#xA0;31, 2014, the Company believes that
 the final disposition of such matters will not have a material
 adverse effect on the financial position, results of operations or
 cash flows of the Company and no accrual has been recorded. The
 Company maintains liability insurance coverage to protect the
 Company&amp;#x2019;s assets from losses arising out of or involving
 activities associated with ongoing and normal business operations.
 In accordance with ASC 450 &lt;i&gt;Contingencies&lt;/i&gt;, the Company
 records a provision for a liability when it is both probable that a
 liability has been incurred and the amount of the loss can be
 reasonably estimated. The Company&amp;#x2019;s policy is to accrue for
 legal expenses in connection with legal proceeding and claims as
 they are incurred.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Contingencies
 &amp;#x2014;&lt;/i&gt; In connection with the Facility Agreement, on
 July&amp;#xA0;1, 2013 the Company also entered into a Milestone Rights
 Purchase Agreement (the &amp;#x201C;Milestone Agreement&amp;#x201D;) with
 Deerfield Private Design Fund and Horizon Sant&amp;#xE9; FLML S&amp;#xC1;RL
 (collectively, the &amp;#x201C;Milestone Purchasers&amp;#x201D;), pursuant to
 which the Company sold the Milestone Purchasers certain rights (the
 &amp;#x201C;Milestone Rights&amp;#x201D;) to receive payments of up to $90.0
 million upon the occurrence of specified strategic and sales
 milestones, including the first commercial sale of an AFREZZA
 product in the United States and the achievement of specified net
 sales figures (see Note 17 &amp;#x2013; Facility Agreement).&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
  <us-gaap:DebtDisclosureTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_5B5DB5DC-D0AA-4070-965F-D56C7430A365_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;b&gt;17.
 Facility Agreement&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Under the
 Facility Agreement, which was initially entered into in 2013
 between the Company and Deerfield, the Company borrowed a total of
 $180.0 million through the issuance of multiple tranches of notes
 during 2013 and 2014. In addition to the $6.5 million of principal
 that was converted during 2013, Deerfield elected to convert an
 additional $93.5 million of principal into shares of the
 Company&amp;#x2019;s common stock during 2014 which was recorded net of
 discount and debt issuance costs of $6.8 million.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The Facility
 Agreement principal repayment schedule is comprised of payments
 beginning on the third anniversary of each issued tranche
 commencing on July 1, 2016 and ending December&amp;#xA0;9, 2019, for a
 total amount of $80.0&amp;#xA0;million. There are no principal payments
 to be made for the year ended December&amp;#xA0;31, 2015. Future
 principal payments for the years ended December&amp;#xA0;31, 2016,
 2017, 2018, and 2019 are $5.0&amp;#xA0;million, $20.0&amp;#xA0;million,
 $20.0&amp;#xA0;million, and $35.0&amp;#xA0;million,
 respectively.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;As of
 December&amp;#xA0;31, 2014, the total principal amount outstanding
 related to the 2019 notes is $60.0 million with a fixed interest
 rate of 9.75% and $20.0 million debt related to the Tranche B notes
 at a fixed interest rate of 8.75%.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;In
 conjunction with the Facility Agreement, we entered into a
 Milestone Rights Agreement with Deerfield which requires us to make
 contingent payments to Deerfield, totaling up to $90.0 million,
 upon the Company achieving specified commercialization milestones.
 We calculated a fair value of $16.3 million related to the
 Milestone Payments and recorded it as a Milestone Rights liability
 which will be reduced as the various Milestones are met. During
 2014, the Milestone Rights liability was reduced by $3.1 million
 upon the Company achieving the first milestone and as of
 December&amp;#xA0;31, 2014, the remaining $13.1 million has been
 allocated between a $4.2 million current Milestone Rights liability
 in other current liabilities and an $8.9 million long-term
 Milestone Rights liability in other liabilities.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;In addition,
 as of December&amp;#xA0;31, 2013, we had a commitment asset balance of
 $5.2 million. During 2014, the commitment asset fair value
 increased by $2.9 million due to Deerfield&amp;#x2019;s commitment to
 lend additional funds under the Tranche B notes and decreased by
 $6.3 million due to the issuance of Tranche 4 notes and Tranche B
 notes. The remaining $1.8 million commitment asset balance was
 written-off by the Company, upon expiration of access to further
 borrowings.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Accretion of
 debt issuance cost and debt discount in connection with the
 Deerfield financing during the year ended December&amp;#xA0;31, 2014
 and 2013 are as follows (in thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="86%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="6" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Accretion expense- debt
 issuance cost&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;326&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;42&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Accretion expense- debt
 discount&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;7,550&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;1,113&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;On
 July&amp;#xA0;1, 2013, the Company entered into the Facility Agreement
 providing for the sale of up to $160.0&amp;#xA0;million of 2019 notes
 to Deerfield in four equal tranches of $40.0 million principal
 amount. The 2019 notes accrue interest at a rate of 9.75%&amp;#xA0;per
 annum until maturity in 2019 or their earlier repayment,
 repurchase, or conversion. As of December&amp;#xA0;31, 2014, Deerfield
 had purchased the four tranches of 2019 notes in the aggregate
 principal amount of $160.0 million.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;On
 February&amp;#xA0;28, 2014, the Company entered into the First
 Amendment, which modified the terms of the Facility Agreement to
 provide for the issuance of Tranche B notes to Deerfield. Pursuant
 to the terms of the First Amendment and the subsequent occurrence
 of certain events specified in the First Amendment, prior to
 December&amp;#xA0;30, 2014, the Company may request that Deerfield
 purchase up to $90.0 million aggregate principal amount of
 Tranche&amp;#xA0;B notes. The Tranche B notes initially accrued
 interest at the rate of 9.75%&amp;#xA0;per year on the outstanding
 principal amount, subject to reduction to 8.75% if the Company
 entered into a collaboration with a third party to commercialize
 AFREZZA. Pursuant to the terms of the First Amendment, the interest
 rate was subsequently reduced to 8.75% on September&amp;#xA0;23, 2014
 following completion of the U.S. Federal Trade Commission&amp;#x2019;s
 review of the transactions contemplated by the Sanofi License
 Agreement under the Hart-Scott-Rodino Act and the completion of
 documentation related to the $175.0 million secured loan facility
 being provided to the Company. The interest on the outstanding
 principal amount of notes under the Facility Agreement is payable
 in cash quarterly in arrears on the last business day of March,
 June, September and December of each year. The Company is required
 to repay 25% of the original principal amount of any Tranche B
 notes on the third, fourth, fifth and sixth anniversaries of the
 applicable issue dates of such notes, provided that the entire
 outstanding principal amount of all Tranche B notes will become due
 and payable no later than December&amp;#xA0;31, 2019. The Tranche B
 notes can be prepaid without penalty or premium commencing two
 years after issuance thereof. On May&amp;#xA0;6, 2014, Deerfield
 purchased an aggregate principal amount of $20.0 million in Tranche
 B notes in accordance with the provisions of the Facility
 Agreement, as amended.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The Facility
 Agreement includes customary representations, warranties and
 covenants, including, a restriction on the incurrence of additional
 indebtedness, and a financial covenant which requires the
 Company&amp;#x2019;s cash and cash equivalents, which includes available
 borrowings on the principal stockholder note, on the last day of
 each fiscal quarter to not be less than $25.0 million. As discussed
 in Note&amp;#xA0;1 &amp;#x2014; Basis of Presentation, the Company will need
 to raise additional capital to support its current operating
 plans.&amp;#xA0;Due to the uncertainties related to maintaining
 sufficient resources to comply with the aforementioned covenant,
 the 2019 notes have been classified as current liabilities in the
 accompanying balance sheet as of December&amp;#xA0;31, 2014. In the
 event of&amp;#xA0;non-compliance,&amp;#xA0;there can be no assurances that
 the holders of the 2019 notes will not exercise remedies available
 to them, which may include, among other things, the issuance of a
 notice of acceleration.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;In addition,
 pursuant to the First Amendment, the outstanding first tranche of
 2019 notes (the &amp;#x201C;Tranche 1 notes&amp;#x201D;) and third tranche of
 2019 notes (the &amp;#x201C;Tranche 3 notes&amp;#x201D;) held by Deerfield
 were amended and restated to permit Deerfield to convert up to an
 additional $60.0 million principal amount under such 2019 notes
 into the Company&amp;#x2019;s common stock after the effective date of
 the First Amendment. The Company also agreed to register for resale
 up to 12,000,000 shares of the Company&amp;#x2019;s common stock
 issuable upon conversion of the outstanding 2019 notes, as amended
 and restated, as of the date of the First Amendment. In March 2014,
 Deerfield elected to convert the full $40.0 million of outstanding
 principal amount of the Tranche 3 notes and $12.5 million principal
 amount of the Tranche 1 notes. In April 2014, Deerfield elected to
 convert the remaining $7.5 million principal amount of the Tranche
 1 notes.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;On
 August&amp;#xA0;11, 2014, the Company entered into a second amendment
 to the Facility Agreement to permit the incurrence of additional
 secured debt under the Sanofi Loan Facility. In the event of
 certain future defaults under the foregoing agreements for which we
 are not able to obtain waivers, the holders of the 2019 notes and
 Tranche B notes may accelerate all of our repayment obligations,
 and take control of our pledged assets, potentially requiring us to
 renegotiate the terms of our indebtedness on terms less favorable
 to us, or to immediately cease operations.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-LEFT: 28px; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Milestone
 Rights&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;In connection
 with the execution of the Facility Agreement, on July&amp;#xA0;1, 2013,
 the Company issued Milestone Rights to the Milestone Purchasers.
 The Milestone Rights provide the Milestone Purchasers certain
 rights to receive payments of up to $90.0 million upon the
 occurrence of specified strategic and sales milestones, including
 the first commercial sale of an AFREZZA product and the achievement
 of specified net sales figures.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The Milestone
 Agreement includes customary representations and warranties and
 covenants by the Company, including restrictions on transfers of
 intellectual property related to AFREZZA. The Milestone Rights are
 subject to acceleration in the event the Company transfers its
 intellectual property related to AFREZZA in violation of the terms
 of the Milestone Agreement.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The Company
 analyzed the Milestone Rights under the provisions of ASC
 815&amp;#xA0;&lt;i&gt;Derivatives
 and Hedging,&lt;/i&gt;&amp;#xA0;and determined that the
 instruments do not meet the definition of a freestanding
 derivative. Since the Company has not elected to apply the fair
 value option to the Milestone Rights, the Company has initially
 recorded the Milestone Rights at their estimated fair value and
 accounted for the Milestone Rights as a liability by applying the
 indexed debt guidance contained in paragraphs ASC 470-10-25-3 and
 35-4.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The initial
 fair value estimate of the Milestone Rights was calculated using
 the income approach in which the cash flows associated with the
 specified contractual payments were adjusted for both the expected
 timing and the probability of achieving the milestones discounted
 to present value using a selected market discount rate. The
 Milestone Rights were initially recorded as a short-term liability
 equal to $3.2 million included in Accrued expenses and other
 current liabilities in the accompanying condensed consolidated
 balance sheet and a long term liability equal to $13.1 million
 included in Other liabilities. In determining the fair value of the
 Milestone Rights, the 13 individual milestone payments were
 adjusted for both (i)&amp;#xA0;the expected timing and (ii)&amp;#xA0;the
 probability of achieving the milestones, and then discounted to
 present value using a discount rate of 17.5%. Once the initial
 valuation of each specified milestone payment was determined, the
 individual milestone payments were then aggregated to arrive at a
 total fair value of $16.3 million. The discount rate was based on
 the estimated cost of equity which was derived using the capital
 asset pricing model. In addition, a 5% risk premium was added to
 the computation of the cost of equity to adjust for non-systemic
 risk factors, such as the Company&amp;#x2019;s lack of product
 diversification and history of financial losses, which were not
 captured in other model inputs.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;As of
 December&amp;#xA0;31, 2014, the first milestone triggering event was
 achieved following the Company&amp;#x2019;s entry into the Sanofi
 License Agreement, which resulted in a $1.9 million incremental
 charge to interest expense due to the increase in carrying value of
 the liability to the required $5.0 million payment, which was paid
 to Deerfield pursuant to the terms of the Milestone
 Agreement.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The Milestone
 Rights liability will be remeasured as the specified milestone
 events are achieved. Specifically, as each milestone event is
 achieved, the portion of the initially recorded Milestone Rights
 liability that pertains to such milestone event being achieved will
 be remeasured to the amount of the related milestone payment. The
 resulting change in the balance of the Milestone Rights liability
 due to such remeasurement will be recorded in the Company&amp;#x2019;s
 Statement of Operations as interest expense. Furthermore, the
 Milestone Rights liability will be reduced upon each such milestone
 payment being paid. As a result, each milestone payment would be
 effectively allocated between a reduction of the initially recorded
 Milestone Rights liability and an expense representing a return on
 a portion of the Milestone Rights liability paid to the Milestone
 Purchasers for the achievement of the related milestone
 event.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The Company
 identified and evaluated a number of embedded features in the
 Milestone Rights to determine if they represented embedded
 derivatives requiring bifurcation and separate accounting pursuant
 to ASC 815. There were no features in the Milestone Rights that
 required bifurcation and separate accounting.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-LEFT: 28px; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Commitment
 Asset&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;In connection
 with the issuance of the Tranche 1 notes and the Milestone Rights,
 the Company recorded a commitment asset (the &amp;#x201C;Commitment
 Asset&amp;#x201D;) on July&amp;#xA0;1, 2013.&amp;#xA0;As a result of the First
 Amendment, the Company recorded an additional Tranche B notes
 commitment asset (the &amp;#x201C;Tranche B Commitment Asset&amp;#x201D;)
 with an estimated fair value equal to $2.9 million. The Commitment
 Asset is derecognized and recorded as a debt discount on the 2019
 notes and Tranche B notes when issued and amortized using the
 effective interest rate method over the life of the respective
 notes. Prior to derecognition occurring, the Company monitors the
 Commitment Asset on an ongoing basis to determine whether an
 impairment indicator is present that would result in a full or
 partial write down of the Commitment Asset as a result of events
 that may lead to the subsequent tranches of notes not being issued.
 On December&amp;#xA0;30, 2014, the Company elected not to draw on the
 $70.0 million of funding remaining under the Facility Agreement, as
 amended, from the sale of the Tranche B notes. Consequently, the
 remaining carrying value of the Tranche B Commitment Asset of $1.8
 million was written off and recorded as interest
 expense.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-LEFT: 28px; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Amendment
 to the outstanding Tranche 1 notes and Tranche 3
 notes&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The amendment
 and restatement of the outstanding Tranche 1 notes and Tranche 3
 notes, pursuant to the First Amendment, did not represent a
 troubled debt restructuring of the 2019 notes because the First
 Amendment did not result in Deerfield granting a concession to the
 Company. In addition, the First Amendment did not result in a
 substantial modification to the terms of the Tranche 1 notes and
 Tranche 3 notes.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The impact of
 the First Amendment to the Tranche 1 notes and Tranche 3 notes is
 being accounted for as a prospective yield adjustment.
 Specifically, the value of the Tranche B Commitment Asset was
 considered a fee received from the creditor as consideration for
 the First Amendment and is being amortized as an adjustment of
 interest expense over the remaining term of the Tranche 1 notes and
 Tranche 3 notes using the effective interest method. Further, the
 value of the Tranche B Commitment Asset, which decreased the amount
 of debt discount in the Tranche 1 notes and Tranche 3 notes, was
 allocated between the Tranche 1 notes and Tranche 3 notes in a
 manner that resulted in the Tranche 1 notes and Tranche 3 notes
 having a new effective interest rate of 11.63%.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-LEFT: 28px; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Security
 Agreement&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;In connection
 with the Facility Agreement, the Company and its subsidiary,
 MannKind LLC, entered into a Guaranty and Security Agreement (the
 &amp;#x201C;Security Agreement&amp;#x201D;) with Deerfield and HS
 (collectively, the &amp;#x201C;Purchasers&amp;#x201D;), pursuant to which the
 Company and MannKind LLC each granted the Purchasers a security
 interest in substantially all of their respective assets, including
 respective intellectual property, accounts, receivables, equipment,
 general intangibles, inventory and investment property, and all of
 the proceeds and products of the foregoing. The Security Agreement
 includes customary covenants by the Company and MannKind LLC,
 remedies of the Purchasers and representations and warranties by
 the Company and MannKind LLC. The security interests granted by us
 and MannKind LLC will terminate upon repayment of the 2019 notes
 and tranche B notes, if applicable, in full. Our obligations under
 the Facility Agreement and the Milestone Agreement are also secured
 by certain mortgages on the Company&amp;#x2019;s facilities in Danbury,
 Connecticut and Valencia, California.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-LEFT: 28px; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Embedded
 Derivatives&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The Company
 identified and evaluated a number of embedded features in the notes
 issued under the Facility Agreement to determine if they
 represented embedded derivatives that are required to be separated
 from the notes and accounted for as freestanding instruments
 pursuant to ASC 815. In 2013, we analyzed the Tranche 1 notes,
 Tranche 2 notes, and Tranche 3 notes and identified embedded
 derivatives in each respective Tranche of notes which required
 separate accounting under ASC 815; however all of the embedded
 derivatives were determined to have a&amp;#xA0;&lt;i&gt;de minimis&lt;/i&gt;&amp;#xA0;value. In addition, we issued
 the Tranche B and Tranche 4 notes during 2014 and performed a
 similar analysis on each respective Tranche of notes. Based on our
 analysis, we determined that the Tranche B notes contained embedded
 derivatives that required to be separated from the Tranche 4 notes;
 however such embedded derivatives were determined to have
 a&amp;#xA0;&lt;i&gt;de
 minimis&lt;/i&gt;&amp;#xA0;value.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;At
 December&amp;#xA0;31, 2014, all of the embedded derivatives identified
 in the Tranche 1 notes, Tranche B notes, and Tranche 4 notes were
 deemed to have a&amp;#xA0;&lt;i&gt;de minimis&amp;#xA0;&lt;/i&gt;value.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-LEFT: 28px; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Conversion
 Option&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;During 2014,
 Deerfield elected to convert a total of $93.5 million of principal,
 which consisted of $20.0&amp;#xA0;million, $33.5 million, and $40.0
 million of Tranche 1 notes, Tranche 2 notes, and Tranche 3 notes,
 respectively, into an aggregate 17,323,080 shares of common stock.
 In conjunction with the conversion by Deerfield, we recorded an
 aggregate expense of $6.4 million for the difference between the
 principal amount of the notes converted and their carrying amount
 (which included unamortized discount and debt issuance costs) which
 consisted of $1.2 million, $3.0 million, and $2.2 million related
 to the Tranche 1 notes, Tranche 2 notes, and Tranche 3 notes,
 respectively. Further, upon Deerfield converting $40.0 million of
 Tranche 3 notes and $20.0&amp;#xA0;million of Tranche 1 notes,
 Deerfield has reached the conversion limits (i.e.,
 &amp;#x201C;Applicable Limits&amp;#x201D;) with respect to the Facility
 Agreement and therefore, no additional amount of the 2019 notes is
 convertible.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
  <us-gaap:EarningsPerSharePolicyTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_5542C00F-9D05-420A-A13C-339DE382EAF6_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Net Loss Per
 Share of Common Stock&lt;/i&gt; &amp;#x2014; Basic net loss per common share
 is computed by dividing net loss by the weighted-average number of
 common shares outstanding during the period. Diluted net loss per
 common share is computed by dividing the net loss by the sum of the
 weighted-average number of common shares outstanding during the
 period plus the potential dilutive effect of stock options,
 restricted stock units, warrants, and shares that could be issued
 upon conversion of the senior convertible notes outstanding during
 the period calculated in accordance with the treasury stock method,
 but are excluded if their effect is anti-dilutive. Because the
 impact of these items is anti-dilutive during periods of net loss,
 there was no difference between basic and diluted loss per common
 share for the years ended December&amp;#xA0;31, 2014, 2013 and
 2012.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
  <us-gaap:EarningsPerShareTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_6850E643-89D4-442B-BBCA-F2E1BCF78D9F_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;b&gt;12. Net
 loss per common share&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Basic net
 loss per share excludes dilution for potentially dilutive
 securities and is computed by dividing loss by the weighted average
 number of common shares outstanding during the period excluding the
 shares loaned under the share lending arrangement (see Note 11). As
 of December&amp;#xA0;31, 2014, 2013 and 2012, 9,000,000 shares of the
 Company&amp;#x2019;s common stock, which were loaned to a share borrower
 pursuant to the terms of a share lending agreement, as described in
 Note&amp;#xA0;11, were issued and are outstanding, and holders of the
 borrowed shares have all the rights of a holder of the
 Company&amp;#x2019;s common stock. However, because the share borrower
 must return all borrowed shares to the Company (or, in certain
 circumstances, the cash value thereof), the borrowed shares are not
 considered outstanding for the purpose of computing and reporting
 basic or diluted earnings (loss) per share. Diluted net loss per
 share reflects the potential dilution that could occur if
 securities or other contracts to issue common stock were exercised
 or converted into common stock. Potentially dilutive securities are
 excluded from the computation of diluted net loss per share for all
 of the periods presented in the accompanying statements of
 operations because the reported net loss in each of these periods
 results in their inclusion being antidilutive. Antidilutive
 securities, which consist of stock options, restricted stock units,
 warrants, and shares that could be issued upon conversion of the
 senior convertible notes, that are not included in the diluted net
 loss per share calculation and exclude the 9,000,000&amp;#xA0;shares of
 the Company&amp;#x2019;s common stock loaned under the share lending
 arrangement as of December&amp;#xA0;31, 2014, 2013 and 2012.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Potentially
 dilutive securities outstanding are summarized as
 follows:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="66%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="10" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Exercise of common stock
 options&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;21,541,664&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;24,237,940&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;18,674,539&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Conversion of senior
 convertible notes into common stock&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;17,323,080&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;25,415,366&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;19,826,113&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Exercise of common stock
 warrants&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;9,987,876&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;19,706,240&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;86,062,440&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Vesting of restricted
 stock units&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;2,610,720&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;9,115,821&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;3,761,031&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;51,463,340&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;78,475,367&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;128,324,123&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;br class="Apple-interchange-newline" /&gt;

 &lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
  <us-gaap:InterestExpensePolicyTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_F3BB98C8-69D3-4C03-A95E-3D49B1F36AA0_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Interest
 Expense&lt;/i&gt; &amp;#x2014; Interest costs are expensed as incurred, except
 to the extent such interest is related to construction in progress,
 in which case interest is capitalized. Interest expense, net of
 interest capitalized, for the years ended December&amp;#xA0;31, 2014,
 2013 and 2012 was $20.4 million, $21.5 million and $21.6 million,
 respectively. Interest costs capitalized for the years ended
 December&amp;#xA0;31, 2014, 2013, and 2012 were $0.8 million, $0.4
 million, and $0.3 million, respectively.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:InterestExpensePolicyTextBlock>
  <us-gaap:InventoryPolicyTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_600267EC-26D4-40DA-B677-1F10D9332AE4_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Inventories&lt;/i&gt; &amp;#x2014; Inventories are stated at the lower
 of cost or market. The Company determines the cost of inventory
 using the first-in, first-out, or FIFO, method. The Company
 capitalizes inventory costs associated with the Company&amp;#x2019;s
 products based on management&amp;#x2019;s judgment that future economic
 benefit is expected to be realized; otherwise, such costs are
 expensed as research and development. The Company periodically
 analyzes its inventory levels to identify inventory that may expire
 or has a cost basis in excess of its estimated realizable value,
 and writes-down such inventories as appropriate. In addition, the
 Company&amp;#x2019;s products are subject to strict quality control and
 monitoring which the Company performs throughout the manufacturing
 process. If certain batches or units of product no longer meet
 quality specifications or become obsolete due to expiration, the
 Company will record a charge to write down such unmarketable
 inventory to its estimated realizable value.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:InventoryPolicyTextBlock>
  <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_B5CCE0F5-9599-4058-A554-6E658FF5A956_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The
 Company&amp;#x2019;s effective income tax rate differs from the
 statutory federal income tax rate as follows for the years ended
 December&amp;#xA0;31, 2014, 2013 and 2012:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="82%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Federal tax benefit
 rate&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;35.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;35.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;35.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;State tax benefit, net of
 federal benefit&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Permanent items&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.9&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Intercompany transfer of
 intellectual property&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(4.1&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(4.3&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(4.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Valuation
 allowance&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(31.8&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(30.7&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(31.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Effective income tax
 rate&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
  <us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_7BD29A9A-DD2B-45E6-AA20-BFBE87A6394A_1_0">&lt;div&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;Total
 stock-based compensation expense recognized in the accompanying
 statements of operations is as follows (in thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="font-size:6px;margin-top:0px;margin-bottom:0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
 &lt;tr&gt;
 &lt;td width="76%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="10" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;Year Ended
 December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Employee-related&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;48,622&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;45,181&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;13,224&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Consultant-related&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;5&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;68&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Total&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;48,622&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;45,186&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;13,292&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock>
  <us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_23E5066B-A865-44C6-A1A7-0538201EF0DF_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The Company
 calculated the fair value of employee stock options granted during
 the years ended December&amp;#xA0;31, 2014, 2013 and 2012 using the
 following assumptions:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="48%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Year Ended
 December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Risk-free interest
 rate&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1.64%&amp;#xA0;&amp;#x2014;&amp;#xA0;2.11%&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.94%&amp;#xA0;&amp;#x2014;&amp;#xA0;1.82%&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.32%&amp;#xA0;&amp;#x2014;1.16%&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Expected lives&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5.77&amp;#xA0;&amp;#x2014;&amp;#xA0;6.09&amp;#xA0;years&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2.64&amp;#xA0;&amp;#x2014;&amp;#xA0;5.77&amp;#xA0;years&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1.4&amp;#xA0;&amp;#x2014;&amp;#xA0;6.1
 years&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Volatility&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;73.98%&amp;#xA0;&amp;#x2014;&amp;#xA0;84.85%&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;75.83%&amp;#xA0;&amp;#x2014;&amp;#xA0;86.26%&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;70%&amp;#xA0;&amp;#x2014;&amp;#xA0;84%&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Dividends&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="shares" decimals="INF" id="id_5851737_E84FAD55-531B-428C-B0AE-6971D2C206E2_1_4">476521</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="pure" decimals="4" id="id_5851737_4891FC0B-C69B-476B-9ABC-3A53D8C25AD9_1_4">0.7398</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_5851737_6588D755-050B-44F0-8864-16C8409EB3BB_1_3">3.37</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
  <dei:DocumentType contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_07B4ADC0-F6C5-41A3-9832-DCB21B153B06_1_0">10-K</dei:DocumentType>
  <dei:EntityRegistrantName contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_2C560AAF-E0BB-4850-899A-5EF0237561E4_1_400001">MANNKIND CORP</dei:EntityRegistrantName>
  <dei:EntityWellKnownSeasonedIssuer contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_2C560AAF-E0BB-4850-899A-5EF0237561E4_1_400004">Yes</dei:EntityWellKnownSeasonedIssuer>
  <dei:TradingSymbol contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_2C560AAF-E0BB-4850-899A-5EF0237561E4_1_400000">MNKD</dei:TradingSymbol>
  <us-gaap:CompensationRelatedCostsPolicyTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_C7D23715-C0BE-4E5F-B696-B318C5CAE42C_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Stock-Based
 Compensation&lt;/i&gt; &amp;#x2014; As of December&amp;#xA0;31, 2014, the Company
 had three active stock-based compensation plans, which are
 described more fully in Note 12. The Company accounts for all
 share-based payments to employees, including grants of stock awards
 and the compensatory elements of the employee stock purchase plan
 in accordance with ASC 718&lt;i&gt;.&lt;/i&gt; ASC 718 &lt;i&gt;Compensation &amp;#x2014;
 Stock Compensation&lt;/i&gt; (&amp;#x201C;ASC 718&amp;#x201D;) requires all
 share-based payments to employees, including grants of stock
 options, restricted stock units, performance-based awards and the
 compensatory elements of employee stock purchase plans, to be
 recognized in the statement of operations based upon the fair value
 of the awards at the grant date. The Company uses the Black-Scholes
 option valuation model to estimate the grant date fair value of
 employee stock options and the compensatory elements of employee
 stock purchase plans. Option valuation models require the input of
 assumptions, including the expected life of the stock-based awards,
 the estimated stock price volatility, the risk-free interest rate,
 and the expected dividend yield. Beginning in the third quarter of
 2014, the Company began to assess both historical and implied
 volatility in order to determine its estimated volatility rate.
 Implied volatility is now considered due to the change in the
 Company&amp;#x2019;s business, which occurred with the approval for the
 sale of AFREEZA. The expected volatility assumption is based on an
 assessment of the historical volatility and the implied volatility
 of the Company&amp;#x2019;s common stock, derived from an analysis of
 historical traded and quoted options on the Company&amp;#x2019;s common
 stock. Restricted stock units are valued based on the market price
 on the grant date. The Company evaluates stock awards with
 performance conditions as to the probability that the performance
 conditions will be met and estimates the date at which the
 performance conditions will be met in order to properly recognize
 stock-based compensation expense over the requisite service
 period.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:CompensationRelatedCostsPolicyTextBlock>
  <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_4CB0278B-C7AE-4F42-9DE2-4B9C0FDA3813_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Comprehensive Loss&lt;/i&gt; &amp;#x2014; Other comprehensive loss is
 recorded in accordance with ASC 220-10-45 &lt;i&gt;Comprehensive
 Income,&lt;/i&gt; which requires that all components of comprehensive
 loss be reported in the financial statements in the period in which
 they are recognized. Other comprehensive loss includes certain
 changes in stockholders&amp;#x2019; equity that are excluded from net
 income. Specifically, the Company includes unrealized gains and
 losses on its available-for-sale securities and cumulative
 translation gains and losses in other comprehensive
 loss.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
  <us-gaap:CommitmentsAndContingenciesPolicyTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_4864677E-DCDD-4CB7-B904-40DFE4C596F4_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Contingencies&lt;/i&gt; &amp;#x2014; Contingencies are recorded in
 accordance with ASC 450 &lt;i&gt;Contingencies.&lt;/i&gt; Accordingly, the
 Company records a loss contingency for a liability when it is both
 probable that a liability has been incurred and the amount of the
 loss can be reasonably estimated. These accruals represent
 management&amp;#x2019;s best estimate of probable loss. Disclosure also
 is provided when it is reasonably possible that a loss will be
 incurred or when it is reasonably possible that the amount of a
 loss will exceed the recorded provision. On a quarterly basis, the
 Company reviews the status of each significant matter and assesses
 its potential financial exposure.&amp;#xA0;Significant judgment is
 required in both the determination of probability and the
 determination as to whether an exposure is reasonably estimable.
 Because of uncertainties related to these matters, accruals are
 based only on the best information available at the time. As
 additional information becomes available, the Company reassesses
 the potential liability related to pending claims and litigation
 and may revise its estimates. These revisions in the estimates of
 the potential liabilities could have a material impact on our
 consolidated results of operations and financial
 position.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
  <us-gaap:IncomeTaxPolicyTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_B956E5B5-DE50-4C50-971E-F346CA113A35_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Income
 Taxes&lt;/i&gt; &amp;#x2014; The provisions for federal, foreign, state, and
 local income taxes are calculated on pre-tax income based on
 current tax law and include the cumulative effect of any changes in
 tax rates from those used previously in determining deferred tax
 assets and liabilities. Deferred income tax assets and liabilities
 are measured using enacted tax rates expected to apply to taxable
 income in the year in which the temporary differences are expected
 to be recovered or settled. A valuation allowance is recorded to
 reduce net deferred income tax assets to amounts that are more
 likely than not to be realized.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Income tax
 positions are considered for uncertainty in accordance with ASC
 740-10-25 &lt;i&gt;Income Taxes,&lt;/i&gt; The Company believes that its income
 tax filing positions and deductions will be sustained on audit and
 does not anticipate any adjustments that will result in a material
 change to its financial position. Therefore, no liabilities for
 uncertain income tax positions have been recorded. If a tax
 position does not meet the minimum statutory threshold to avoid
 payment of penalties, the Company recognizes an expense for the
 amount of the penalty in the period the tax position is claimed in
 the tax return of the Company. The Company recognizes interest
 accrued related to unrecognized tax benefits in income tax expense,
 if any. Penalties, if probable and reasonably estimable, are
 recognized as a component of income tax expense.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Significant
 management judgment is involved in determining the provision for
 income taxes, deferred tax assets, deferred tax liabilities, and
 any valuation allowance recorded against deferred tax assets. Due
 to uncertainties related to the realization of the Company&amp;#x2019;s
 deferred tax assets as a result of its history of operating losses,
 a valuation allowance has been established against the total
 deferred tax asset balance. The valuation allowance is based on
 management&amp;#x2019;s estimates of taxable income by jurisdiction in
 which the Company operates and the period over which deferred tax
 assets will be recoverable. In the event that actual results differ
 from these estimates or the Company adjusts these estimates in
 future periods, a change in the valuation allowance may be needed,
 which could materially impact the Company&amp;#x2019;s financial
 position and results of operations.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
  <us-gaap:ReceivablesPolicyTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_CDC0AB20-E3E2-4230-98BA-AFFD688519C7_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;State
 Research and Development Credit Exchange Receivable&lt;/i&gt; &amp;#x2014; The
 State of Connecticut provides certain companies with the
 opportunity to exchange certain research and development income tax
 credit carryforwards for cash in exchange for foregoing the
 carryforward of the research and development credits. The program
 provides for an exchange of research and development income tax
 credits for cash equal to 65% of the value of corporation tax
 credit available for exchange. Estimated amounts receivable under
 the program are recorded as a reduction of research and development
 expenses.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:ReceivablesPolicyTextBlock>
  <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_23BDF6B0-4008-4E62-97F3-63B36B04DED7_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Potentially
 dilutive securities outstanding are summarized as
 follows:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="66%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Exercise of common stock
 options&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;21,541,664&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;24,237,940&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;18,674,539&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Conversion of senior
 convertible notes into common stock&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;17,323,080&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;25,415,366&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;19,826,113&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Exercise of common stock
 warrants&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;9,987,876&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;19,706,240&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;86,062,440&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Vesting of restricted stock
 units&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,610,720&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;9,115,821&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,761,031&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;51,463,340&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;78,475,367&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;128,324,123&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
  <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_7E81A0CF-6707-422F-94F2-EBD3099517CF_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Inventories
 consist of the following (in thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="88%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Raw materials&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4,856&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Work-in-process&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4,719&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Finished goods&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;95&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total
 inventories&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;9,670&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
  <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_DC6D2CC3-7B59-4810-ABC6-DAEE25751621_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The following
 table summarizes information about stock options
 outstanding:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="69%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;Number&lt;br /&gt;
 of&lt;br /&gt;
 Shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;Weighted&lt;br /&gt;
 Average&lt;br /&gt;
 Exercise&lt;br /&gt;
 Price&lt;br /&gt;
 per&amp;#xA0;Share&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;Aggregate&lt;br /&gt;
 Intrinsic&lt;br /&gt;
 Value&amp;#xA0;($000)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Outstanding at
 January&amp;#xA0;1, 2014&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;24,237,940&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;4.35&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;40,972&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Granted&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;1,326,800&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;7.21&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Exercised&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(3,250,149&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;3.37&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Forfeit&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(417,223&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;4.54&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Expired&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(355,704&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;12.48&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Outstanding at
 December&amp;#xA0;31, 2014&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;21,541,664&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;4.53&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;33,495&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Vested and expected to
 vest at December&amp;#xA0;31, 2014&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;21,307,827&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;4.52&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;33,253&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Exercisable at
 December&amp;#xA0;31, 2014&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;18,439,472&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;4.42&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;30,356&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="shares" decimals="INF" id="id_5851737_143C52D3-CB9D-4730-A9E6-7C6A29401131_1_5">355704</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_5851737_9C0D5787-E738-4506-A65E-31334D531A9D_3_0">4.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <dei:EntityFilerCategory contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_2C560AAF-E0BB-4850-899A-5EF0237561E4_1_400007">Large Accelerated Filer</dei:EntityFilerCategory>
  <dei:EntityVoluntaryFilers contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_2C560AAF-E0BB-4850-899A-5EF0237561E4_1_400006">No</dei:EntityVoluntaryFilers>
  <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_A4121426-B23A-431F-9D80-732EE7473906_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The following
 table summarizes information about the Company&amp;#x2019;s stock-based
 award plans as of December&amp;#xA0;31, 2014:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="65%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Outstanding&lt;br /&gt;
 Options&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Outstanding&lt;br /&gt;
 Restricted&lt;br /&gt;
 Stock Units&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Shares&amp;#xA0;Available&lt;br /&gt;
 for&lt;br /&gt;
 Future Issuance&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2004 Equity Incentive
 Plan&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;13,629,994&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1,219,915&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2013 Equity Incentive
 Plan&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;7,380,839&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1,390,805&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;15,506,488&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2004 Non-Employee
 Directors&amp;#x2019; Stock Option Plan&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;530,831&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;21,541,664&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,610,720&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;15,506,488&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
  <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="pure" decimals="3" id="id_5851737_B6F3E2C8-A6E4-4D0D-8044-F1D8F2BFBEF5_1_5">0.000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_0AC0FCA5-3152-4C3A-8492-0C1D889C22E8_1_2">P2Y10M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
  <us-gaap:FairValueInstrumentsClassifiedInShareholdersEquityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_5D88F866-F876-44A9-9F2F-F52DE9E5C300_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The following
 roll-forward provides a summary of the changes in fair value of the
 Company&amp;#x2019;s Level 3 forward purchase contracts during the year
 ended December&amp;#xA0;31, 2012 (in thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="61%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="11%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="11%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="11%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;The&amp;#xA0;February&amp;#xA0;2012&lt;br /&gt;
 Forward Purchase&lt;br /&gt;
 Contract&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;The&amp;#xA0;October&amp;#xA0;2012&lt;br /&gt;
 Forward&amp;#xA0;Purchase&lt;br /&gt;
 Contract&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Beginning
 Balance&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Issuance&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1,080&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;28,237&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;29,317&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Adjustments to fair value
 included in other income (expense)&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;12,011&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(13,248&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(1,237&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Transfers to additional
 paid-in-capital&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(13,091&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(14,989&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(28,080&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Ending Balance&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:FairValueInstrumentsClassifiedInShareholdersEquityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock>
  <us-gaap:InventoryDisclosureTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_F3B47554-97A3-49E7-AE46-8C329403F2B8_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 12px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;4.&amp;#xA0;Inventories&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Inventories
 consist of the following (in thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="88%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Raw materials&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4,856&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Work-in-process&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4,719&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Finished goods&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;95&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total
 inventories&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;9,670&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
  <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_1_23">4086000</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
  <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_6FB366DA-EA0A-4DCC-AC94-20603E6D7DDA_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;b&gt;7.
 Related-party arrangements&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;In October
 2007, the Company entered into a $350.0 million loan arrangement
 with its principal stockholder. The Loan Arrangement has been
 amended from time to time. In February 2009, the promissory note
 underlying the Loan Arrangement was revised as a result of the
 principal stockholder being licensed as a finance lender under the
 California Finance Lenders Law. Accordingly, the lender was revised
 to The Mann Group. Until January&amp;#xA0;1, 2013, interest on
 outstanding principal amounts accrued at a fixed rate equal to the
 one-year LIBOR rate as reported by the&amp;#xA0;&lt;i&gt;Wall Street
 Journal&amp;#xA0;&lt;/i&gt;on the
 date of such advance plus 3%&amp;#xA0;per annum. Based on the amended
 terms of the agreement, the rate was fixed at 5.84% going forward.
 On October&amp;#xA0;31, 2013, the promissory note was amended to, among
 other things, extend the maturity date of the loan to
 January&amp;#xA0;5, 2020, extend the date through which the Company can
 borrow under the Loan Arrangement to December&amp;#xA0;31, 2019,
 increase the aggregate borrowing amount under the Loan Arrangement
 from $350.0 million to $370.0 million, provide that repayments or
 cancellations of principal under the Loan Arrangement will not be
 available for reborrowing and to cancel $78.0 million of principal
 indebtedness under the Loan Arrangement as payment for the
 aggregate exercise price of warrants, in accordance with the Common
 Stock and Warrant Purchase Agreement entered into with The Mann
 Group on October&amp;#xA0;18, 2012 (the &amp;#x201C;Mann Group
 Warrants&amp;#x201D;). In addition, the Company and The Mann Group
 agreed to capitalize into principal $7.9&amp;#xA0;million of accrued
 interest that became due and payable upon cancellation of the $78.0
 million of principal indebtedness.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;As of
 December&amp;#xA0;31, 2014, the total principal amount outstanding
 under the Loan Arrangement was $49.5&amp;#xA0;million, and the amount
 available for future borrowings was $30.1 million. Interest, at a
 fixed rate of 5.84%, is due and payable quarterly in arrears
 on&amp;#xA0;the first day of each calendar quarter for the preceding
 quarter, or at such other time as the Company and The Mann Group
 mutually agree. All or any portion of accrued and unpaid interest
 that becomes due and payable may be paid-in-kind and capitalized as
 additional borrowings at any time and has been classified as
 non-current. As of December&amp;#xA0;31, 2014, the Company had accrued
 $3.5&amp;#xA0;million of interest in long term other liabilities
 related to the Loan Arrangement. The Mann Group can require the
 Company to prepay up to $200.0 million in advances that have been
 outstanding for at least 12&amp;#xA0;months (less approximately $105.0
 million aggregate principal amount that has been cancelled in
 connection with two common stock purchase agreements). If The Mann
 Group exercises this right, the Company will have 90 days after The
 Mann Group provides written notice (or the number of days to
 maturity of the note if less than 90&amp;#xA0;days) to prepay such
 advances. However, pursuant to a letter agreement entered into in
 August 2010, The Mann Group has agreed to not require the Company
 to prepay amounts outstanding under the amended and restated
 promissory note if the prepayment would require the Company to use
 its working capital resources. In addition, The Mann Group entered
 into a subordination agreement with Deerfield pursuant to which The
 Mann Group agreed with Deerfield not to demand or accept any
 payment under the Loan Arrangement until the Company&amp;#x2019;s
 payment obligations to Deerfield under the Facility Agreement have
 been satisfied in full. Subject to the foregoing, in the event of a
 default under our loan arrangement with The Mann Group, all unpaid
 principal and interest either becomes immediately due and payable
 or may be accelerated at The Mann Group&amp;#x2019;s option, and the
 interest rate will increase to the one-year LIBOR rate calculated
 on the date of the initial advance or in effect on the date of
 default, whichever is greater, plus 5%&amp;#xA0;per annum. All
 borrowings under the Loan Arrangement are unsecured. The Loan
 Arrangement contains no financial covenants.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;As of
 December&amp;#xA0;31, 2014 and 2013, the Company had accrued and unpaid
 interest of $3.5&amp;#xA0;million and $0.6&amp;#xA0;million, in long term
 other liabilities respectively, which related to the amount
 outstanding and had $30.1&amp;#xA0;million of available borrowings.
 Interest expense on the Company&amp;#x2019;s note payable to our
 principal stockholder for the years ended December&amp;#xA0;31, 2014,
 2013, and 2012 was $2.9 million, $6.3 million, and
 $10.5&amp;#xA0;million, respectively.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;In connection
 with certain meetings of the Company&amp;#x2019;s board of directors and
 on other occasions when the Company&amp;#x2019;s business necessitated
 air travel for the Company&amp;#x2019;s principal stockholder and other
 Company employees, the Company utilized the principal
 stockholder&amp;#x2019;s private aircraft, and the Company paid the
 charter company that manages the aircraft on behalf of the
 Company&amp;#x2019;s majority shareholder approximately $79,000,
 $82,000, and $200,000, respectively, for the years ended
 December&amp;#xA0;31, 2014, 2013, and 2012 on the basis of the
 corresponding cost of commercial airfare.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The Company
 has entered into indemnification agreements with each of its
 directors and executive officers, in addition to the
 indemnification provided for in its amended and restated
 certificate of incorporation and amended and restated bylaws (see
 Note 13).&lt;/font&gt;&lt;/p&gt;


 &lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
  <us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_BE532E52-458E-46B3-9EC8-A2A4C9A68CC2_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The following
 is a summary of the carrying values and estimated fair values of
 the 2015 notes and the facility financing obligation (i.e., the
 2019 notes and Trance B notes) (in millions):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="69%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,
 2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,
 2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Carrying&lt;br /&gt;
 value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Estimated&lt;br /&gt;
 fair value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Carrying&lt;br /&gt;
 value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Estimated&lt;br /&gt;
 fair value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2015 notes&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;99.4&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;102.9&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;98.4&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;102.2&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Facility financing
 obligation&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;73.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;75.1&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;102.3&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;107.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="pure" decimals="2" id="id_5851737_086354D1-E64C-4DDB-8AF0-2517BB863C11_1_1">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_5851737_9C19EE16-DF23-445B-A862-EDFEC062A6AF_1_2">7.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="shares" decimals="INF" id="id_5851737_E84FAD55-531B-428C-B0AE-6971D2C206E2_1_3">6982707</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="pure" decimals="2" id="id_5851737_4891FC0B-C69B-476B-9ABC-3A53D8C25AD9_1_6">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="shares" decimals="INF" id="id_5851737_143C52D3-CB9D-4730-A9E6-7C6A29401131_1_4">417223</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
  <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="pure" decimals="2" id="id_5851737_B6F3E2C8-A6E4-4D0D-8044-F1D8F2BFBEF5_1_1">0.00</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
  <us-gaap:FairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="pure" decimals="2" id="id_5851737_28589D0C-FD0E-48FE-BFEF-904A5C3A7E4B_1_0">0.55</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:LineOfCreditFacilityExpirationDate1 contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_6180B978-0728-4896-9559-A1ED213196A8_1_5">2019-12-09</us-gaap:LineOfCreditFacilityExpirationDate1>
  <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_88AE6FB2-A63C-4601-8025-1E744CF4490F_1_0">&lt;div&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;Accrued expenses
 and other current liabilities are comprised of the following (in
 thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="font-size:6px;margin-top:0px;margin-bottom:0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
 &lt;tr&gt;
 &lt;td width="84%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="6" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Salary and related
 expenses&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;14,928&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;12,193&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Research and clinical trial
 costs&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1,311&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Accrued interest&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;2,396&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;2,082&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Construction in
 progress&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1,343&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;342&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Other&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;7,539&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;5,706&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Accrued expenses and other
 current liabilities&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;26,206&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;21,634&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
  <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_7B6BA1E2-F43E-4E7F-84A5-A8A6B3354A4C_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The provision
 for income taxes consists of the following (in
 thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="73%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Year Ended
 December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Current&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;U.S. federal&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;U.S. state&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Non-U.S.&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total current&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Deferred&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;U.S. federal&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;57,873&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;59,379&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;51,540&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;U.S. state&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;7,631&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;7,470&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;9,199&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Non-U.S.&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Valuation
 Allowance&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(65,504&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(66,849&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(60,739&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total deferred&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="shares" decimals="INF" id="id_5851737_143C52D3-CB9D-4730-A9E6-7C6A29401131_1_2">1326800</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="shares" decimals="INF" id="id_5851737_E84FAD55-531B-428C-B0AE-6971D2C206E2_1_2">954127</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="shares" decimals="INF" id="id_5851737_82C71537-FFD8-4EBE-ACB8-0B2CD6BF8AA1_4_5">305076</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
  <us-gaap:UseOfEstimates contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_E2695EFF-7246-496F-A4B4-2888F938C36B_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Financial
 Statement Estimates&lt;/i&gt; &amp;#x2014; The preparation of financial
 statements in conformity with accounting principles generally
 accepted in the United States of America (&amp;#x201C;GAAP&amp;#x201D;)
 requires management to make estimates and assumptions that affect
 the amounts reported in the financial statements and accompanying
 notes. Actual results could differ from those estimates. Management
 considers many factors in selecting appropriate financial
 accounting policies, and in developing the estimates and
 assumptions that are used in the preparation of the financial
 statements. Management must apply significant judgment in this
 process. The more significant estimates reflected in these
 accompanying financial statements involve assessing long-lived
 assets for impairment, accrued expenses, including clinical study
 expenses, valuation of forward purchase contracts, valuation of the
 facility financing obligation, commitment asset, milestone rights,
 valuation of stock-based compensation and the determination of the
 provision for income taxes and corresponding deferred tax assets
 and liabilities and any valuation allowance recorded against net
 deferred tax assets.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:UseOfEstimates>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="shares" decimals="-3" id="id_5851737_4373895D-6E6F-41A5-A449-A8691F7E803C_1_14">385229000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <dei:DocumentPeriodEndDate contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_07B4ADC0-F6C5-41A3-9832-DCB21B153B06_1_2">2014-12-31</dei:DocumentPeriodEndDate>
  <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_341743CF-FE6D-47FE-A606-8FF4C68E61E3_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Cash and
 Cash Equivalents&lt;/i&gt; &amp;#x2014; The Company considers all highly
 liquid investments with original or remaining maturities of 90 days
 or less at the time of purchase, that are readily convertible into
 cash to be cash equivalents. As of&amp;#xA0;December&amp;#xA0;31,
 2014&amp;#xA0;and&amp;#xA0;2013, cash equivalents were comprised of cash
 and money market accounts with maturities less than 90 days from
 the date of purchase.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
  <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="pure" decimals="3" id="id_5851737_B6F3E2C8-A6E4-4D0D-8044-F1D8F2BFBEF5_1_4">-0.318</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
  <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="pure" decimals="3" id="id_5851737_B6F3E2C8-A6E4-4D0D-8044-F1D8F2BFBEF5_1_3">-0.041</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
  <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_B241A8EC-99E7-4C7E-9920-5126FFE2350C_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Property and
 Equipment&lt;/i&gt; &amp;#x2014; Property and equipment are recorded at cost
 and depreciated using the straight-line method over the estimated
 useful lives of the related assets. Leasehold improvements are
 amortized over the term of the lease or the service lives of the
 improvements, whichever is shorter. Maintenance and repairs are
 expensed as incurred. Assets under construction are not depreciated
 until placed into service.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
  <us-gaap:QuarterlyFinancialInformationTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_DCCA97C7-AE73-4599-A46A-B60246FC55A6_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;b&gt;18.
 Selected quarterly financial data (unaudited)&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Summarized
 quarterly financial data for the years ended December&amp;#xA0;31, 2014
 and 2013 are set forth in the following tables:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="60%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;March&amp;#xA0;31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;June&amp;#xA0;30&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;September&amp;#xA0;30&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;December&amp;#xA0;31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="14" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;(In thousands, except
 per share data)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Net loss&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(52,056&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(73,365&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(36,520&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(36,439&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Net loss per share
 &amp;#x2014;&amp;#xA0;basic and diluted&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(0.14&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(0.19&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(0.09&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(0.09&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Weighted average common
 shares used to compute basic and diluted net loss per
 share&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;368,784&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;380,770&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;394,163&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;396,793&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="60%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;March&amp;#xA0;31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;June&amp;#xA0;30&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;September&amp;#xA0;30&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;December&amp;#xA0;31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="14" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;(In thousands, except
 per share data)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Net loss&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(40,965&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(46,124&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(50,818&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(53,582&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Net loss per share
 &amp;#x2014; basic and diluted&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(0.15&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(0.16&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(0.17&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(0.16&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Weighted average common
 shares used to compute basic and diluted net loss per
 share&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;280,058&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;284,044&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;296,386&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;337,284&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:QuarterlyFinancialInformationTextBlock>
  <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_6DA4B4B3-B249-42EC-ACDC-B30F62241459_1_0">&lt;div&gt;
 &lt;em&gt;Research and Development Expenses&amp;#xA0;&lt;/em&gt;&amp;#x2014;
 Research and development expenses consist of costs associated with
 the clinical trials of the Company&amp;#x2019;s product candidates,
 manufacturing supplies and other development materials, including
 raw material purchases of insulin, compensation and other expenses
 for research and development personnel, costs for consultants and
 related contract research, facility costs, and depreciation.
 Research and development costs, which are net of any tax credit
 exchange recognized for the Connecticut state research and
 development credit exchange program, are expensed as incurred
 consistent with ASC 730-10&amp;#xA0;&lt;i style="FONT-SIZE: small; FONT-FAMILY: &apos;Times New Roman&apos;; FONT-VARIANT: normal; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); LETTER-SPACING: normal; LINE-HEIGHT: normal; BACKGROUND-COLOR: rgb(255,255,255); TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;Research
 and Development.&amp;#xA0;&lt;/i&gt;The
 Company began commercial manufacturing in the latter part of the
 fourth quarter of 2014. As such, commercial manufacturing costs
 incurred in the fourth quarter and included in research and
 development as expenses are immaterial for the year ended
 December&amp;#xA0;31, 2014.&lt;/div&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
  <us-gaap:ScheduleOfDebtInstrumentsTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_1CF22B84-5C65-47CA-AA11-8F0B3FE1C7AB_1_0">&lt;div&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;Senior
 convertible notes consist of the following (in
 thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="font-size:6px;margin-top:0px;margin-bottom:0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
 &lt;tr&gt;
 &lt;td width="82%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="6" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;2015 notes&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Principal amount&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;100,000&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;100,000&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Unaccreted debt issuance
 cost&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(645&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(1,561&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Net carrying
 amount&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;99,355&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;98,439&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_5851737_9C19EE16-DF23-445B-A862-EDFEC062A6AF_1_3">3.83</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="pure" decimals="4" id="id_5851737_4891FC0B-C69B-476B-9ABC-3A53D8C25AD9_1_0">0.0164</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_5851737_6588D755-050B-44F0-8864-16C8409EB3BB_1_5">12.48</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_5851737_6588D755-050B-44F0-8864-16C8409EB3BB_1_4">4.54</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_5851737_9C19EE16-DF23-445B-A862-EDFEC062A6AF_1_4">4.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
  <dei:AmendmentFlag contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_07B4ADC0-F6C5-41A3-9832-DCB21B153B06_1_1">false</dei:AmendmentFlag>
  <dei:CurrentFiscalYearEndDate contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_2C560AAF-E0BB-4850-899A-5EF0237561E4_1_400003">--12-31</dei:CurrentFiscalYearEndDate>
  <dei:DocumentFiscalYearFocus contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_07B4ADC0-F6C5-41A3-9832-DCB21B153B06_1_3">2014</dei:DocumentFiscalYearFocus>
  <us-gaap:ConsolidationPolicyTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_69C9F834-3A5E-4912-9B4A-348162918F27_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Principles
 of Consolidation&lt;/i&gt; &amp;#x2014; The consolidated financial statements
 include the accounts of the Company and its wholly-owned
 subsidiaries.&amp;#xA0;Intercompany balances and transactions have been
 eliminated.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
  <us-gaap:IncomeTaxDisclosureTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_FDE310A2-E583-406A-B28A-3BB6DF15C7CF_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;b&gt;16. Income
 taxes&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;There is no
 provision for income taxes because the Company has incurred
 operating losses since inception. At December&amp;#xA0;31, 2014, the
 Company has concluded that it is more likely than not that the
 Company may not realize the benefit of its deferred tax assets due
 to its history of losses. Accordingly, the net deferred tax assets
 have been fully reserved. The provision for income taxes consists
 of the following (in thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="73%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="10" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;Year Ended
 December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Current&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;U.S. federal&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;U.S. state&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Non-U.S.&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Total current&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Deferred&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;U.S. federal&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;57,873&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;59,379&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;51,540&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;U.S. state&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;7,631&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;7,470&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;9,199&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Non-U.S.&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Valuation
 Allowance&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(65,504&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(66,849&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(60,739&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Total deferred&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Total&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Deferred
 income taxes reflect the tax effects of temporary differences
 between the carrying amounts of assets and liabilities for
 financial reporting and income tax purposes. A valuation allowance
 is established when uncertainty exists as to whether all or a
 portion of the net deferred tax assets will be realized. Components
 of the net deferred tax asset as of December&amp;#xA0;31, 2014 and 2013
 are approximately as follows (in thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="80%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="6" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Deferred tax
 assets:&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="5"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Net operating loss
 carryforwards&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;699,997&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;653,896&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Research and development
 credits&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;73,227&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;70,091&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Capitalized
 research&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;28,516&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;30,421&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Payments from
 collaboration&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;19,217&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Milestone
 Rights&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;5,321&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;6,608&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Accrued
 expenses&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;768&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;3,578&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Non-qualified stock
 option expense&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;43,691&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;41,219&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Capitalized patent
 costs&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;8,624&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;7,811&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Other&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;131&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;837&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Depreciation&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;3,010&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;2,539&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Total net deferred tax
 assets&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;882,502&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;817,000&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Valuation
 allowance&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(882,502&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(817,000&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Net deferred tax
 assets&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;As a result
 of certain realization requirements of ASC 718, the table of
 deferred tax assets and liabilities does not include certain
 deferred tax assets as of December 31, 2014 that arose directly
 from tax deductions related to equity compensation which are
 greater than the compensation recognized for financial reporting.
 Equity would be increased by $18.3 million if and when such
 deferred tax assets are ultimately realized. The Company use ASC
 740 ordering when determining when excess tax benefits have been
 realized.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The
 Company&amp;#x2019;s effective income tax rate differs from the
 statutory federal income tax rate as follows for the years ended
 December&amp;#xA0;31, 2014, 2013 and 2012:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="82%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="10" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Federal tax benefit
 rate&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;35.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;35.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;35.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;State tax benefit, net of
 federal benefit&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Permanent
 items&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;0.9&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Intercompany transfer of
 intellectual property&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(4.1&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(4.3&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(4.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Valuation
 allowance&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(31.8&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(30.7&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(31.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Effective income tax
 rate&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;0.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;0.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;0.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;As required
 by ASC 740&amp;#xA0;&lt;i&gt;Income Taxes&amp;#xA0;&lt;/i&gt;(&amp;#x201C;ASC 740&amp;#x201D;),
 formerly FASB Statement No.&amp;#xA0;109&amp;#xA0;&lt;i&gt;Accounting for Income
 Taxes,&lt;/i&gt;&amp;#xA0;management of the Company has
 evaluated the positive and negative evidence bearing upon the
 realizability of its deferred tax assets. Management has concluded,
 in accordance with the applicable accounting standards, that it is
 more likely than not that the Company may not realize the benefit
 of its deferred tax assets. Accordingly, the net deferred tax
 assets have been fully reserved. Management reevaluates the
 positive and negative evidence on an annual basis. During the years
 ended December&amp;#xA0;31, 2014, 2013 and 2012, the change in the
 valuation allowance was $65.5 million, $66.8 million and $60.7
 million, respectively, for income taxes.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;At
 December&amp;#xA0;31, 2014, the Company had federal and state net
 operating loss carryforwards of approximately $1.8 billion and $1.4
 billion available, respectively, to reduce future taxable income
 and which will expire at various dates beginning in 2018 and 2015,
 respectively. As a result of the Company&amp;#x2019;s initial public
 offering, an ownership change within the meaning of Internal
 Revenue Code Section&amp;#xA0;382 occurred in August 2004. As a result,
 federal net operating loss and credit carry forwards of
 approximately $216.0 million are subject to an annual use
 limitation of approximately $13.0 million. The annual limitation is
 cumulative and therefore, if not fully utilized in a year can be
 utilized in future years in addition to the Section&amp;#xA0;382
 limitation for those years. The federal net operating losses
 generated subsequent to the Company&amp;#x2019;s initial public offering
 in August 2004 are currently not subject to any such limitation as
 there have been no ownership changes since August 2004 within the
 meaning of Internal Revenue Code Section&amp;#xA0;382. At
 December&amp;#xA0;31, 2014, the Company had research and development
 credits of $48.0 million and $39.0 million for federal and state
 purposes, respectively. The federal credits begin to expire in
 2024, and the state credits may be carried forward
 indefinitely.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The Company
 has evaluated the impact of ASC 740, previously FIN 48&amp;#xA0;&lt;i&gt;Accounting for Uncertainty
 in Income Taxes&lt;/i&gt;, on its financial statements, which was
 effective beginning January&amp;#xA0;1, 2007. The evaluation of a tax
 position in accordance with this guidance is a two-step process.
 The first step is recognition: the enterprise determines whether it
 is more-likely-than-not that a tax position will be sustained upon
 examination, including resolution of any related appeals or
 litigation processes, based on the technical merits of the
 position. In evaluating whether a tax position has met the
 more-likely-than-not recognition threshold, the enterprise should
 presume that the position will be examined by the appropriate
 taxing authority that would have full knowledge of all relevant
 information. The second step is measurement: a tax position that
 meets the more-likely-than-not recognition threshold is measured to
 determine the amount of benefit to recognize in the financial
 statements. The tax position is measured at the largest amount of
 benefit that is greater than 50 percent likely of being realized
 upon ultimate settlement. Tax positions that previously failed to
 meet the more-likely-than-not recognition threshold should be
 recognized in the first subsequent financial reporting period in
 which that threshold is met. Previously recognized tax positions
 that no longer meet the more-likely-than-not recognition threshold
 should be derecognized in the first subsequent financial reporting
 period in which that threshold is no longer met. The Company
 believes that its income tax filing positions and deductions will
 be sustained on audit and does not anticipate any adjustments that
 will result in a material change to its financial position.
 Therefore, no liabilities for uncertain income tax positions have
 been recorded. Tax years since 2002 remain subject to examination
 by the major tax jurisdictions in which the Company is subject to
 tax.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
  <us-gaap:LongTermDebtTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_B324BA78-28D1-4205-BDC1-E162DCBDD9E9_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;b&gt;8. Senior
 convertible notes&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Senior
 convertible notes consist of the following (in
 thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="82%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="6" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;b&gt;2015
 notes&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Principal
 amount&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;100,000&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;100,000&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Unaccreted debt issuance
 cost&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(645&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(1,561&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Net carrying
 amount&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;99,355&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;98,439&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;On
 August&amp;#xA0;18, 2010, the Company completed a Rule 144A offering of
 $100.0 million aggregate principal amount of 2015 notes. The 2015
 notes are governed by the terms of an indenture dated as of
 August&amp;#xA0;24, 2010 (the &amp;#x201C;2015 Note Indenture&amp;#x201D;). The
 2015 notes bear interest at the rate of 5.75%&amp;#xA0;per year on the
 principal amount, payable in cash semi-annually in arrears on
 February&amp;#xA0;15 and August&amp;#xA0;15 of each year, beginning
 February&amp;#xA0;15, 2011. In connection with the 2015 notes, the
 Company had accrued interest of $2.4 million as of
 December&amp;#xA0;31, 2014 and December&amp;#xA0;31, 2013. The 2015 notes
 are general, unsecured, senior obligations of the Company and
 effectively rank junior in right of payment to all of the
 Company&amp;#x2019;s secured debt, to the extent of the value of the
 assets securing such debt and to the debt and all other liabilities
 of the Company&amp;#x2019;s subsidiaries. The maturity date of the 2015
 notes is August&amp;#xA0;15, 2015 and payment is due in full on that
 date for unconverted securities. Holders of the 2015 notes may
 convert, at any time prior to the close of business on the business
 day immediately preceding the stated maturity date, any outstanding
 principal into shares of the Company&amp;#x2019;s common stock at an
 initial conversion rate of 147.0859 shares per $1,000 principal
 amount, which is equal to a conversion price of approximately $6.80
 per share, subject to adjustment. Except in certain circumstances,
 if the Company undergoes a fundamental change: (1)&amp;#xA0;the Company
 will pay a make-whole premium on the 2015 notes converted in
 connection with a fundamental change by increasing the conversion
 rate on such 2015 notes, which amount, if any, will be based on the
 Company&amp;#x2019;s common stock price and the effective date of the
 fundamental change, and (2)&amp;#xA0;each holder of 2015 notes will
 have the option to require the Company to repurchase all or any
 portion of such holder&amp;#x2019;s 2015 notes at a repurchase price of
 100% of the principal amount of the 2015 notes to be repurchased
 plus accrued and unpaid interest, if any. The Company may elect to
 redeem some or all of the 2015 notes if the closing stock price has
 equaled 150% of the conversion price for at least 20 of the 30
 consecutive trading days ending on the trading day before the
 Company&amp;#x2019;s redemption notice. The redemption price will equal
 100% of the principal amount of the 2015 notes to be redeemed, plus
 accrued and unpaid interest, if any, to, but excluding, the
 redemption date, plus a make-whole payment equal to the sum of the
 present values of the remaining scheduled interest payments through
 and including August&amp;#xA0;15, 2015 (other than interest accrued up
 to, but excluding, the redemption date). The Company will be
 obligated to make the make-whole payment on all the 2015 notes
 called for redemption and converted during the period from the date
 the Company mailed the notice of redemption to and including the
 redemption date. The Company may elect to make the make-whole
 payment in cash or shares of its common stock, subject to certain
 limitations. Under the terms of the 2015 Note Indenture, the
 conversion option can be net-share settled and the maximum number
 of shares that could be required to be delivered under the
 contract, including the make-whole shares, is fixed and less than
 the number of authorized and unissued shares less the maximum
 number of shares that could be required to be delivered during the
 contract period under other existing commitments. Applying the
 Company&amp;#x2019;s sequencing policy, the Company performed an
 analysis at the time of the offering of the 2015 notes and each
 reporting date since and has concluded that the number of available
 authorized shares at the time of the offering and each subsequent
 reporting date was sufficient to deliver the number of shares that
 could be required to be delivered during the contract period under
 existing commitments.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The Company
 incurred approximately $4.2 million in issuance costs which are
 recorded as an offset to the 2015 notes in the accompanying
 consolidated balance sheets. These costs are being accreted to
 interest expense using the effective interest method over the term
 of the 2015 notes.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The 2015
 notes provide that upon an acceleration of certain indebtedness,
 including the 2019 notes and the Tranche B notes described in Note
 17, the holders may elect to accelerate the Company&amp;#x2019;s
 repayment obligations under the 2015 notes if such acceleration is
 not cured, waived, rescinded or annulled. There can be no assurance
 that the holders would not choose to exercise these rights in the
 event such events were to occur.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Accretion of
 debt issuance expense in connection with the 2015 notes during the
 years ended December&amp;#xA0;31, 2014, 2013, and 2012 was $0.9
 million, $0.9 million, and $0.8 million, respectively.&lt;/font&gt;&lt;/p&gt;


 &lt;/div&gt;</us-gaap:LongTermDebtTextBlock>
  <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_2234BEF1-57DB-463B-961F-E5A3B615B98A_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;b&gt;1.
 Description of business and basis of presentation&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Business&amp;#xA0;&lt;/i&gt;&amp;#x2014; MannKind
 Corporation and subsidiaries (the &amp;#x201C;Company&amp;#x201D;) is a
 biopharmaceutical company focused on the discovery and development
 of therapeutic products for diseases such as diabetes. Our only
 approved product, AFREZZA, (insulin human [rDNA origin]) inhalation
 powder , is a rapid-acting inhaled insulin that was approved by the
 U.S. Food and Drug Administration (the &amp;#x201C;FDA&amp;#x201D;) on
 June&amp;#xA0;27, 2014 to improve glycemic control in adult patients
 with diabetes.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Basis of
 Presentation&amp;#xA0;&lt;/i&gt;&amp;#x2014; The
 Company&amp;#x2019;s primary activities since incorporation have been
 establishing its facilities, recruiting personnel, conducting
 research and development, business development, business and
 financial planning, and raising capital. It is costly to develop
 therapeutic products and conduct clinical studies for these
 products. As of and for the year ended December&amp;#xA0;31, 2014, the
 Company has reported an accumulated deficit of $2.5 billion and has
 reported negative cash flow from operations since
 inception.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;At
 December&amp;#xA0;31, 2014, the Company&amp;#x2019;s capital resources
 consisted of cash and cash equivalents of $120.8&amp;#xA0;million. The
 Company expects to continue to incur significant expenditures to
 support commercial manufacturing of AFREZZA and the development of
 other product candidates. In addition, the Company&amp;#x2019;s 5.75%
 Senior Convertible Notes due 2015 (the &amp;#x201C;2015 notes&amp;#x201D;) in
 the aggregate principal amount of $100.0 million have a maturity
 date of August&amp;#xA0;15, 2015, and payment on the outstanding amount
 is due in full on that date (see Note 8 &amp;#x2013; Senior convertible
 notes). The facility agreement (the &amp;#x201C;Facility
 Agreement&amp;#x201D;) with Deerfield Private Design Fund II, L.P.
 (&amp;#x201C;Deerfield Private Design Fund&amp;#x201D;) and Deerfield Private
 Design International II, L.P. (collectively,
 &amp;#x201C;Deerfield&amp;#x201D;) and the First Amendment to Facility
 Agreement and Registration Rights Agreement (the &amp;#x201C;First
 Amendment&amp;#x201D;) additional sales of an additional tranche of
 notes (the &amp;#x201C;Tranche B notes&amp;#x201D;) (see
 Note&amp;#xA0;17&amp;#xA0;&amp;#x2013; Facility Agreement) contains a financial
 covenant that requires the Company&amp;#x2019;s cash and cash
 equivalents, which include available borrowings under this Loan
 Arrangement, on the last day of each fiscal quarter to not be less
 than $25.0 million. Should the holders of the notes not elect to
 convert such notes into the Company&amp;#x2019;s common stock prior to
 their due date, the Company intends to refinance the 2015 notes or
 raise additional funds to settle the 2015 notes. Although the
 Company believes that it can refinance the 2015 notes or obtain
 alternative financing to settle the 2015 notes, inherent
 uncertainty in achieving its projected cashflows and refinancing of
 the 2015 notes raises substantial doubt about the Company&amp;#x2019;s
 ability to continue as a going concern. The financial statements do
 not include any adjustments that might result from the outcome of
 these uncertainties.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;On
 August&amp;#xA0;11, 2014, we executed a license and collaboration
 agreement (the &amp;#x201C;Sanofi License Agreement&amp;#x201D;) with
 Sanofi-Aventis Deutschland GmbH (which subsequently assigned its
 rights and obligations under the agreement to Sanofi-Aventis U.S.
 LLC (&amp;#x201C;Sanofi&amp;#x201D;)), pursuant to which Sanofi is
 responsible for global commercial, regulatory and development
 activities for AFREZZA. The Sanofi License Agreement became
 effective on September&amp;#xA0;23, 2014. We manufacture AFREZZA at our
 manufacturing facility in Danbury, Connecticut to supply
 Sanofi&amp;#x2019;s demand for the product. In addition, we and Sanofi
 are planning to collaborate to expand manufacturing capacity to
 meet global demand as necessary.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Under the
 Sanofi License Agreement, Sanofi paid us an up-front cash payment
 of $150.0 million in the third quarter of 2014. As of
 December&amp;#xA0;31, 2014, we have earned and recorded as Receivables
 from collaboration an additional $50.0 million in milestone
 payments in connection with the satisfaction of specified
 manufacturing milestones. Such payments were received subsequent to
 year end. We are also eligible to receive up to $725.0 million in
 additional milestone payments under the Sanofi License Agreement if
 certain development, regulatory and sales milestones are achieved.
 In addition, worldwide profits and losses, which are determined
 based on the difference between the net sales of AFREZZA and the
 costs and expenses incurred by us and Sanofi that are specifically
 attributable or related to the development, regulatory filings,
 manufacturing, or commercialization of AFREZZA, will be shared 65%
 by Sanofi and 35% by the us. As a result of the loss share
 provision, and because we do not have the ability to estimate the
 amount of costs that would potentially be incurred related to the
 Sanofi License Agreement, the amount of up-front cash payment or
 milestone payments that could be recognized as revenue is not fixed
 or determinable. In connection with the Sanofi License Agreement,
 an affiliate of Sanofi provided us with a secured loan facility
 (the &amp;#x201C;Sanofi Loan Facility&amp;#x201D;) of up to $175.0 million to
 fund our share of net losses under the Sanofi License
 Agreement.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Additional
 funding sources that are, or in certain circumstances may be
 available to the Company, include approximately $30.1&amp;#xA0;million
 principal amount of available borrowings under its loan arrangement
 ( the &amp;#x201C;Loan Arrangement&amp;#x201D;) with The Mann Group LLC
 (&amp;#x201C;The Mann Group&amp;#x201D;) (see note 7 &amp;#x2013; Related-party
 arrangements), potential proceeds from the exercise of warrants
 issued in its February 2012 public offering of approximately $19.5
 million, and the Company&amp;#x2019;s at-the-market issuance sales
 agreements which allow the Company to sell up to $50.0 million in
 common stock. The Company cannot provide assurances that its plans
 will not change or that changed circumstances will not result in
 the depletion of its capital resources more rapidly than it
 currently anticipates. The Company may need to raise additional
 capital, whether through a sale of equity or debt securities, a
 strategic business collaboration with a pharmaceutical company, the
 establishment of other funding facilities, licensing arrangements,
 asset sales or other means, in order to continue the development
 and commercialization of AFREZZA and other product candidates and
 to support its other ongoing activities. However, the Company
 cannot provide assurances that such additional capital will be
 available on acceptable terms or at all.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Principles
 of Consolidation&amp;#xA0;&lt;/i&gt;&amp;#x2014; The consolidated
 financial statements include the accounts of the Company and its
 wholly-owned subsidiaries.&amp;#xA0;Intercompany balances and
 transactions have been eliminated.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Segment
 Information&amp;#xA0;&lt;/i&gt;&amp;#x2014; In accordance with
 Accounting Standards Codification (&amp;#x201C;ASC&amp;#x201D;)
 280-10-50&amp;#xA0;&lt;i&gt;Segment Reporting&lt;/i&gt;,
 operating segments are identified as components of an enterprise
 about which separate discrete financial information is available
 for evaluation by the chief operating decision-maker in making
 decisions regarding resource allocation and assessing performance.
 To date, the Company has viewed its operations and manages its
 business as one segment operating in the United States of
 America.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
  <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_2B307A36-81B3-4156-BCB0-F4BBA93D45A0_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Components of
 the net deferred tax asset as of December&amp;#xA0;31, 2014 and 2013
 are approximately as follows (in thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="80%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Deferred tax
 assets:&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="5"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net operating loss
 carryforwards&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;699,997&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;653,896&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Research and development
 credits&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;73,227&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;70,091&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Capitalized
 research&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;28,516&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;30,421&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Payments from
 collaboration&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;19,217&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Milestone Rights&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5,321&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;6,608&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Accrued expenses&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;768&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,578&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Non-qualified stock option
 expense&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;43,691&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;41,219&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Capitalized patent
 costs&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;8,624&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;7,811&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Other&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;131&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;837&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Depreciation&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,010&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,539&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total net deferred tax
 assets&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;882,502&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;817,000&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Valuation
 allowance&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(882,502&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(817,000&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net deferred tax
 assets&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
  <us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_6A5CE2CA-EA1E-4A20-B345-234090CD8C62_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Summarized
 quarterly financial data for the years ended December&amp;#xA0;31, 2014
 and 2013 are set forth in the following tables:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="60%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;March&amp;#xA0;31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;June&amp;#xA0;30&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;September&amp;#xA0;30&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;December&amp;#xA0;31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="14" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;(In thousands, except
 per share data)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Net loss&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(52,056&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(73,365&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(36,520&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(36,439&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Net loss per share
 &amp;#x2014;&amp;#xA0;basic and diluted&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(0.14&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(0.19&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(0.09&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(0.09&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Weighted average common
 shares used to compute basic and diluted net loss per
 share&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;368,784&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;380,770&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;394,163&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;396,793&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="60%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;March&amp;#xA0;31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;June&amp;#xA0;30&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;September&amp;#xA0;30&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;December&amp;#xA0;31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="14" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;(In thousands, except
 per share data)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Net loss&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(40,965&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(46,124&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(50,818&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(53,582&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Net loss per share
 &amp;#x2014; basic and diluted&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(0.15&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(0.16&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(0.17&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(0.16&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Weighted average common
 shares used to compute basic and diluted net loss per
 share&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;280,058&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;284,044&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;296,386&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;337,284&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;


 &lt;/div&gt;</us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_086354D1-E64C-4DDB-8AF0-2517BB863C11_1_6">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_8F1A5AC1-8BCD-4B25-9FA2-DD3AB5888390_3_2">P6Y9M29D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_5851737_6588D755-050B-44F0-8864-16C8409EB3BB_1_2">7.21</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_CB82507F-2363-45C6-BA2D-49587DB26495_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;b&gt;2. Summary
 of significant accounting policies&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Financial
 Statement Estimates&amp;#xA0;&lt;/i&gt;&amp;#x2014; The preparation of
 financial statements in conformity with accounting principles
 generally accepted in the United States of America
 (&amp;#x201C;GAAP&amp;#x201D;) requires management to make estimates and
 assumptions that affect the amounts reported in the financial
 statements and accompanying notes. Actual results could differ from
 those estimates. Management considers many factors in selecting
 appropriate financial accounting policies, and in developing the
 estimates and assumptions that are used in the preparation of the
 financial statements. Management must apply significant judgment in
 this process. The more significant estimates reflected in these
 accompanying financial statements involve assessing long-lived
 assets for impairment, accrued expenses, including clinical study
 expenses, valuation of forward purchase contracts, valuation of the
 facility financing obligation, commitment asset, milestone rights,
 valuation of stock-based compensation and the determination of the
 provision for income taxes and corresponding deferred tax assets
 and liabilities and any valuation allowance recorded against net
 deferred tax assets.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;License
 and Collaboration and Supply agreements&lt;/i&gt;&amp;#xA0;&amp;#x2014; Pursuant to the Sanofi
 License Agreement and the Sanofi Supply Agreement, we granted to
 Sanofi exclusive, worldwide licenses to certain of our patents,
 trademarks and know-how for the development and commercialization
 of AFREZZA and retained the right to be the exclusive manufacturer
 and supplier of AFREZZA until specified conditions are met upon
 which a portion of the manufacturing activities may be assumed by
 Sanofi. The terms of the Sanofi License Agreement provide for
 consideration to us in the form of a non-refundable up-front
 payment, product sales, manufacturing, regulatory and sales
 milestone payments and profit and loss sharing.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;We analyze
 consideration received under the provisions of ASC 605, Revenue
 Recognition, to determine whether the consideration, or a portion
 thereof, could be recognized as revenue. ASC 605 provides that
 revenue is recognized when there is persuasive evidence that an
 arrangement exists, delivery has occurred or services have been
 rendered, the price is fixed or determinable and collection is
 reasonably assured.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;In
 arrangements involving the delivery of more than one element, each
 required deliverable is evaluated to determine whether it qualifies
 as a separate unit of accounting. This determination is generally
 based on whether the deliverable has &amp;#x201C;stand-alone
 value&amp;#x201D; to the customer. The arrangement&amp;#x2019;s consideration
 that is fixed and determinable is then allocated to each separate
 unit of accounting based on the relative selling price of each
 deliverable. The estimated selling price of each deliverable is
 determined using the following hierarchy of values:
 (i)&amp;#xA0;vendor-specific objective evidence of fair value,
 (ii)&amp;#xA0;third-party evidence of selling price and (iii)&amp;#xA0;best
 estimate of selling price (BESP). The BESP reflects our best
 estimate of what the selling price would be if the deliverable was
 regularly sold by us on a stand-alone basis. In general, the
 consideration allocated to each unit of accounting is recognized as
 the related goods or services are delivered, limited to the
 consideration that is not contingent upon future
 deliverables.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The
 assessment of multiple element arrangements requires judgment in
 order to determine the appropriate units of accounting and the
 points in time that, or periods over which, revenue should be
 recognized. Given that, as of December&amp;#xA0;31, 2014, we did not
 have the ability to estimate the amount of costs that would
 potentially be incurred under the loss share provision related to
 the Sanofi License Agreement and the Sanofi Supply Agreement, we
 believe the fixed and determinable fee requirement for revenue
 recognition was not met.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Cash and
 Cash Equivalents&amp;#xA0;&lt;/i&gt;&amp;#x2014; The Company
 considers all highly liquid investments with original or remaining
 maturities of 90 days or less at the time of purchase, that are
 readily convertible into cash to be cash equivalents. As
 of&amp;#xA0;December&amp;#xA0;31, 2014&amp;#xA0;and&amp;#xA0;2013, cash equivalents
 were comprised of cash and money market accounts with maturities
 less than 90 days from the date of purchase.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Concentration of Credit Risk&amp;#xA0;&lt;/i&gt;&amp;#x2014; Financial
 instruments which potentially subject the Company to concentration
 of credit risk consist of cash and cash equivalents. Cash and cash
 equivalents consist of interest-bearing accounts, which are
 regularly monitored by management and held in high credit quality
 institutions.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;State
 Research and Development Credit Exchange Receivable&amp;#xA0;&lt;/i&gt;&amp;#x2014; The State of
 Connecticut provides certain companies with the opportunity to
 exchange certain research and development income tax credit
 carryforwards for cash in exchange for foregoing the carryforward
 of the research and development credits. The program provides for
 an exchange of research and development income tax credits for cash
 equal to 65% of the value of corporation tax credit available for
 exchange. Estimated amounts receivable under the program are
 recorded as a reduction of research and development
 expenses.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Prepaid
 expenses and other current assets&lt;/i&gt;&amp;#xA0;&amp;#x2014; Prepaid expenses and
 other current assets primarily consist of prepaid expenses for
 goods and services to be received. As of December&amp;#xA0;31, 2014,
 prepaid and other current assets had a balance of $20.2 million,
 mainly comprised of a $15.0 million prepayment for 2015 quantities
 of insulin, and prepaid insurance.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;On
 July&amp;#xA0;31, 2014, the Company entered into a Supply Agreement
 (the &amp;#x201C;Supply Agreement&amp;#x201D;) with Amphastar France
 Pharmaceuticals S.A.S., a French corporation
 (&amp;#x201C;Amphastar&amp;#x201D;), pursuant to which Amphastar will
 manufacture for and supply to the Company certain quantities of
 recombinant human insulin for use in AFREZZA. Under the terms of
 the Supply Agreement, Amphastar will be responsible for
 manufacturing the insulin in accordance with the Company&amp;#x2019;s
 specifications and agreed-upon quality standards. The Company has
 agreed to purchase annual minimum quantities of insulin under the
 Supply Agreement of an aggregate total of approximately
 &amp;#x20AC;120.1&amp;#xA0;million for calendar years 2015 through 2019. The
 remaining annual minimum quantities will be
 &amp;#x20AC;23.2&amp;#xA0;million for 2015 and &amp;#x20AC;23.3&amp;#xA0;million for
 the years ended December&amp;#xA0;31, 2016 through 2019. The Company
 may request to purchase additional quantities of insulin over such
 annual minimum quantities. As part of the Supply Agreement, the
 Company paid a $15.0 million deposit to Amphastar as prepayment for
 2015 quantities of insulin.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Unless
 earlier terminated, the term of the Insulin Supply Agreement
 expires on December&amp;#xA0;31, 2019 and can be renewed for
 additional, successive two year terms upon 12 months&amp;#x2019; written
 notice given prior to the end of the initial term or any additional
 two year term. The Company and Amphastar each have normal and
 customary termination rights, including termination for material
 breach that is not cured within a specific time frame or in the
 event of liquidation, bankruptcy or insolvency of the other party.
 In addition, the Company may terminate the Supply Agreement upon
 two years&amp;#x2019; prior written notice to Amphastar without cause or
 upon 30 days&amp;#x2019; prior written notice to Amphastar if a
 controlling regulatory authority withdraws approval for AFREZZA,
 provided, however, in the event of a termination pursuant to either
 of the latter two scenarios, the provisions of the Supply Agreement
 require the Company to pay the full amount of all unpaid purchase
 commitments due over the initial term within 60 calendar days of
 the effective date of such termination.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Sale of
 intellectual property&lt;/i&gt;&amp;#xA0;&amp;#x2014; On July&amp;#xA0;18, 2014,
 the Company entered into an assignment agreement with a third party
 whereby the third party acquired all proprietary rights, technology
 and know-how that related to a small molecule inhibitor compound
 and all pre-clinical data and results related thereto. Under the
 terms of the assignment agreement, the Company received total
 consideration of $9.3 million and incurred $1.4 million in expense
 for a net amount of $7.9 million recorded as other
 income.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); PADDING-BOTTOM: 0px; FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Milestone
 Rights&lt;/i&gt;&amp;#xA0;&amp;#x2014;
 On July&amp;#xA0;1 2013, in conjunction with the execution of the
 Facility Agreement, the Company issued Milestone Rights to
 Deerfield whereby the Company agreed to provide Deerfield with
 pre-specified Milestone Payments upon the achievement of 13
 specific Milestone Events related to the commercial release and
 future cumulative net sales of AFREZZA&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;sup style="VERTICAL-ALIGN: baseline; POSITION: relative; BOTTOM: 0.8ex"&gt;&amp;#xAE;&lt;/sup&gt;&lt;/font&gt;.
 The Company analyzed the Milestone Rights under the provisions of
 ASC 815 and determined that the agreement does not meet the
 definition of a freestanding derivative. Since the Company has not
 elected to apply the fair value option to the Milestone Rights
 Purchase Agreement, the Company recorded the Milestone Rights at
 their estimated fair value and accounted for the Milestone Rights
 as a liability by applying the indexed debt guidance contained in
 paragraphs ASC 470-10-25-3 and 35-4.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The initial
 fair value estimate of the Milestone Rights was calculated using
 the income approach in which the cash flows associated with the
 specified contractual payments were adjusted for both the expected
 timing and the probability of achieving the milestones and
 discounted to present value using a selected market discount rate.
 The expected timing and probability of achieving the milestones was
 developed with consideration given to both internal data, such as
 progress made to date and assessment of criteria required for
 achievement, and external data, such as market research studies.
 The discount rate was selected based on an estimation of required
 rate of returns for similar investment opportunities using
 available market data. The Milestone Rights liability will be
 remeasured as the specified milestone events are achieved.
 Specifically, as each milestone event is achieved, the portion of
 the initially recorded Milestone Rights liability that pertains to
 the milestone event being achieved, will be remeasured to the
 amount of the specified related milestone payment. The resulting
 change in the balance of the Milestone Rights liability due to
 remeasurement will be recorded in our Statement of Operations as
 interest expense. Furthermore, the Milestone Rights liability will
 be reduced upon the settlement of each milestone payment. As a
 result, each milestone payment would be effectively allocated
 between a reduction of the recorded Milestone Rights liability and
 an expense representing a return on a portion of the Milestone
 Rights liability paid to the investor for the achievement of the
 related milestone event (see&amp;#xA0;Note&amp;#xA0;17).&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Commitment
 Asset&amp;#xA0;&lt;/i&gt;&amp;#x2014;
 In connection with the issuance of the Tranche 1 notes and the
 Milestone Rights, the Company recorded a commitment asset (the
 &amp;#x201C;Commitment Asset&amp;#x201D;) on July&amp;#xA0;1, 2013.&amp;#xA0;As a
 result of the First Amendment, the Company recorded an additional
 Tranche B notes commitment asset (the &amp;#x201C;Tranche B Commitment
 Asset&amp;#x201D;) with an estimated fair value equal to $2.9 million.
 The Commitment Asset is derecognized and recorded as a debt
 discount on the 2019 notes and Tranche B notes, when issued and
 amortized, using the effective interest rate method over the life
 of the respective notes. Prior to derecognition occurring, the
 Company monitors the Commitment Asset on an ongoing basis to
 determine whether an impairment indicator is present that would
 result in a full or partial write down of the Commitment Asset as a
 result of events that may lead to the subsequent tranches of notes
 not being issued. At December&amp;#xA0;31, 2014, Deerfield had
 purchased all four tranches of 2019 notes in the aggregate
 principal amount of $160.0 million, purchased $20.0 million
 aggregate principal amount of Tranche B notes in accordance with
 the provisions of the Facility Agreement, and wrote off the
 remaining portion of the Tranche B Commitment Asset. At
 December&amp;#xA0;31, 2014 the carrying value of the Commitment Assets
 was zero.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Fair Value
 of Financial Instruments&amp;#xA0;&lt;/i&gt;&amp;#x2014; The Company
 utilizes fair value measurement guidance prescribed by GAAP to
 value its financial instruments. The guidance includes a definition
 of fair value, prescribes methods for measuring fair value,
 establishes a fair value hierarchy based on the inputs used to
 measure fair value and expands disclosures about the use of fair
 value measurements. The valuation techniques utilized are based
 upon observable and unobservable inputs. Observable inputs reflect
 market data obtained from independent sources, while unobservable
 inputs reflect internal market assumptions. These two types of
 inputs create the following fair value hierarchy:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-LEFT: 60px; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Level&amp;#xA0;1
 &amp;#x2013; Quoted prices for identical instruments in active
 markets.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-LEFT: 60px; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Level&amp;#xA0;2
 &amp;#x2013; Quoted prices for similar instruments in active markets;
 quoted prices for identical or similar instruments in markets that
 are not active; and model-derived valuations whose inputs are
 observable or whose significant value drivers are
 observable.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-LEFT: 60px; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Level&amp;#xA0;3
 &amp;#x2013; Significant inputs to the valuation model are
 unobservable.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The carrying
 amounts reflected in the consolidated balance sheets for cash
 equivalents, other current assets, accounts payable, and accrued
 expenses and other current liabilities, approximate fair value due
 to their relatively short maturities.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Inventories&lt;/i&gt;&amp;#xA0;&amp;#x2014; Inventories are stated
 at the lower of cost or market. The Company determines the cost of
 inventory using the first-in, first-out, or FIFO, method. The
 Company capitalizes inventory costs associated with the
 Company&amp;#x2019;s products based on management&amp;#x2019;s judgment that
 future economic benefit is expected to be realized; otherwise, such
 costs are expensed as research and development. The Company
 periodically analyzes its inventory levels to identify inventory
 that may expire or has a cost basis in excess of its estimated
 realizable value, and writes-down such inventories as appropriate.
 In addition, the Company&amp;#x2019;s products are subject to strict
 quality control and monitoring which the Company performs
 throughout the manufacturing process. If certain batches or units
 of product no longer meet quality specifications or become obsolete
 due to expiration, the Company will record a charge to write down
 such unmarketable inventory to its estimated realizable
 value.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Property
 and Equipment&amp;#xA0;&lt;/i&gt;&amp;#x2014; Property and
 equipment are recorded at cost and depreciated using the
 straight-line method over the estimated useful lives of the related
 assets. Leasehold improvements are amortized over the term of the
 lease or the service lives of the improvements, whichever is
 shorter. Maintenance and repairs are expensed as incurred. Assets
 under construction are not depreciated until placed into
 service.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Impairment
 of Long-Lived Assets&amp;#xA0;&lt;/i&gt;&amp;#x2014; The Company
 evaluates long-lived assets for impairment whenever events or
 changes in circumstances indicate that the carrying value of an
 asset may not be recoverable in accordance with ASC
 360-10-35&amp;#xA0;&lt;i&gt;Property Plant and
 Equipment.&amp;#xA0;&lt;/i&gt;Assets are considered to
 be impaired if the carrying value may not be recoverable based upon
 management&amp;#x2019;s assessment of the following events or changes in
 circumstances:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="2%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%" align="left"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2022;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p align="left"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;significant changes in the Company&amp;#x2019;s strategic business
 objectives and utilization of the assets;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="2%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%" align="left"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2022;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p align="left"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;a determination that the carrying value of such assets cannot
 be recovered through undiscounted cash flows;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="2%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%" align="left"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2022;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p align="left"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;loss of legal ownership or title to the assets;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="2%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%" align="left"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2022;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p align="left"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;a significant adverse change in legal factors or in the
 business climate that could affect the value of a long-lived asset
 (asset group), including an adverse action or assessment by a
 regulator; or&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="2%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%" align="left"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2022;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p align="left"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;the impact of significant negative industry or economic
 trends.&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;If the
 Company believes an asset to be impaired, the impairment recognized
 is the amount by which the carrying value of the assets exceeds the
 fair value of the assets. Any write-downs would be treated as
 permanent reductions in the carrying amount of the asset and an
 operating loss would be recognized. No asset impairment was
 recognized during the years ended December&amp;#xA0;31, 2014, 2013, and
 2012, respectively.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Income
 Taxes&amp;#xA0;&lt;/i&gt;&amp;#x2014;
 The provisions for federal, foreign, state, and local income taxes
 are calculated on pre-tax income based on current tax law and
 include the cumulative effect of any changes in tax rates from
 those used previously in determining deferred tax assets and
 liabilities. Deferred income tax assets and liabilities are
 measured using enacted tax rates expected to apply to taxable
 income in the year in which the temporary differences are expected
 to be recovered or settled. A valuation allowance is recorded to
 reduce net deferred income tax assets to amounts that are more
 likely than not to be realized.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Income tax
 positions are considered for uncertainty in accordance with ASC
 740-10-25&amp;#xA0;&lt;i&gt;Income
 Taxes,&lt;/i&gt;&amp;#xA0;The
 Company believes that its income tax filing positions and
 deductions will be sustained on audit and does not anticipate any
 adjustments that will result in a material change to its financial
 position. Therefore, no liabilities for uncertain income tax
 positions have been recorded. If a tax position does not meet the
 minimum statutory threshold to avoid payment of penalties, the
 Company recognizes an expense for the amount of the penalty in the
 period the tax position is claimed in the tax return of the
 Company. The Company recognizes interest accrued related to
 unrecognized tax benefits in income tax expense, if any. Penalties,
 if probable and reasonably estimable, are recognized as a component
 of income tax expense.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Significant
 management judgment is involved in determining the provision for
 income taxes, deferred tax assets, deferred tax liabilities, and
 any valuation allowance recorded against deferred tax assets. Due
 to uncertainties related to the realization of the Company&amp;#x2019;s
 deferred tax assets as a result of its history of operating losses,
 a valuation allowance has been established against the total
 deferred tax asset balance. The valuation allowance is based on
 management&amp;#x2019;s estimates of taxable income by jurisdiction in
 which the Company operates and the period over which deferred tax
 assets will be recoverable. In the event that actual results differ
 from these estimates or the Company adjusts these estimates in
 future periods, a change in the valuation allowance may be needed,
 which could materially impact the Company&amp;#x2019;s financial
 position and results of operations.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Contingencies&amp;#xA0;&lt;/i&gt;&amp;#x2014; Contingencies are
 recorded in accordance with ASC 450&amp;#xA0;&lt;i&gt;Contingencies.&lt;/i&gt;&amp;#xA0;Accordingly,
 the Company records a loss contingency for a liability when it is
 both probable that a liability has been incurred and the amount of
 the loss can be reasonably estimated. These accruals represent
 management&amp;#x2019;s best estimate of probable loss. Disclosure also
 is provided when it is reasonably possible that a loss will be
 incurred or when it is reasonably possible that the amount of a
 loss will exceed the recorded provision. On a quarterly basis, the
 Company reviews the status of each significant matter and assesses
 its potential financial exposure.&amp;#xA0;Significant judgment is
 required in both the determination of probability and the
 determination as to whether an exposure is reasonably estimable.
 Because of uncertainties related to these matters, accruals are
 based only on the best information available at the time. As
 additional information becomes available, the Company reassesses
 the potential liability related to pending claims and litigation
 and may revise its estimates. These revisions in the estimates of
 the potential liabilities could have a material impact on our
 consolidated results of operations and financial
 position.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Stock-Based Compensation&amp;#xA0;&lt;/i&gt;&amp;#x2014; As of
 December&amp;#xA0;31, 2014, the Company had three active stock-based
 compensation plans, which are described more fully in Note 12. The
 Company accounts for all share-based payments to employees,
 including grants of stock awards and the compensatory elements of
 the employee stock purchase plan in accordance with ASC
 718&lt;i&gt;.&amp;#xA0;&lt;/i&gt;ASC
 718&amp;#xA0;&lt;i&gt;Compensation
 &amp;#x2014; Stock Compensation&lt;/i&gt;&amp;#xA0;(&amp;#x201C;ASC 718&amp;#x201D;)
 requires all share-based payments to employees, including grants of
 stock options, restricted stock units, performance-based awards and
 the compensatory elements of employee stock purchase plans, to be
 recognized in the statement of operations based upon the fair value
 of the awards at the grant date. The Company uses the Black-Scholes
 option valuation model to estimate the grant date fair value of
 employee stock options and the compensatory elements of employee
 stock purchase plans. Option valuation models require the input of
 assumptions, including the expected life of the stock-based awards,
 the estimated stock price volatility, the risk-free interest rate,
 and the expected dividend yield. Beginning in the third quarter of
 2014, the Company began to assess both historical and implied
 volatility in order to determine its estimated volatility rate.
 Implied volatility is now considered due to the change in the
 Company&amp;#x2019;s business, which occurred with the approval for the
 sale of AFREEZA. The expected volatility assumption is based on an
 assessment of the historical volatility and the implied volatility
 of the Company&amp;#x2019;s common stock, derived from an analysis of
 historical traded and quoted options on the Company&amp;#x2019;s common
 stock. Restricted stock units are valued based on the market price
 on the grant date. The Company evaluates stock awards with
 performance conditions as to the probability that the performance
 conditions will be met and estimates the date at which the
 performance conditions will be met in order to properly recognize
 stock-based compensation expense over the requisite service
 period.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Warrants&lt;/i&gt;&amp;#xA0;&amp;#x2014; The Company has issued
 warrants to purchase shares of its common stock. Warrants have been
 accounted for within equity in accordance with the provisions of
 ASC 815-40, Contracts in an Entity&amp;#x2019;s Own Stock, previously
 EITF Issue No. 00-19:&amp;#xA0;&lt;i&gt;Accounting for Derivative
 Financial Instruments Indexed to, and Potentially Settled in, a
 Company&amp;#x2019;s Own Stock&lt;/i&gt;.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Forward
 Contracts&lt;/i&gt;&amp;#xA0;&amp;#x2014; The Company has entered into agreements
 with The Mann Group whereby the Company agreed to sell and The Mann
 Group agreed to purchase common stock and/or warrants. These
 agreements have been accounted for as forward contracts, having met
 the definition of derivative instruments in accordance with the
 provisions of ASC 815&amp;#xA0;&lt;i&gt;Derivatives and Hedging&lt;/i&gt;. The
 Company determines the fair value of the forward contract upon its
 issuance, records fair value adjustments of the forward contract to
 Other income (expense) during the reporting period and through the
 settlement of the forward contract, and reclassifies the forward
 contract to equity upon settlement of the forward contract. In the
 years ended December&amp;#xA0;31, 2014 and 2013, there were no forward
 purchase contracts.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Comprehensive Loss&amp;#xA0;&lt;/i&gt;&amp;#x2014; Other
 comprehensive loss is recorded in accordance with ASC
 220-10-45&amp;#xA0;&lt;i&gt;Comprehensive
 Income,&amp;#xA0;&lt;/i&gt;which
 requires that all components of comprehensive loss be reported in
 the financial statements in the period in which they are
 recognized. Other comprehensive loss includes certain changes in
 stockholders&amp;#x2019; equity that are excluded from net income.
 Specifically, the Company includes unrealized gains and losses on
 its available-for-sale securities and cumulative translation gains
 and losses in other comprehensive loss.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Research
 and Development Expenses&amp;#xA0;&lt;/i&gt;&amp;#x2014; Research and
 development expenses consist of costs associated with the clinical
 trials of the Company&amp;#x2019;s product candidates, manufacturing
 supplies and other development materials, including raw material
 purchases of insulin, compensation and other expenses for research
 and development personnel, costs for consultants and related
 contract research, facility costs, and depreciation. Research and
 development costs, which are net of any tax credit exchange
 recognized for the Connecticut state research and development
 credit exchange program, are expensed as incurred consistent with
 ASC 730-10&amp;#xA0;&lt;i&gt;Research and
 Development.&amp;#xA0;&lt;/i&gt;The Company began
 commercial manufacturing in the latter part of the fourth quarter
 of 2014. As such, commercial manufacturing costs incurred in the
 fourth quarter and included in research and development as expenses
 are immaterial for the year ended December&amp;#xA0;31,
 2014.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Clinical
 Trial Expenses&amp;#xA0;&lt;/i&gt;&amp;#x2014; Clinical trial
 expenses, which are reflected in research and development expenses
 in the accompanying statements of operations, result from
 obligations under contracts with vendors, consultants, and clinical
 site agreements in connection with conducting clinical trials. The
 financial terms of these contracts are subject to negotiations
 which vary from contract to contract and may result in payment
 flows that do not match the periods over which materials or
 services are provided to the Company under such contracts. The
 appropriate level of trial expenses are reflected in the
 Company&amp;#x2019;s financial statements by matching period expenses
 with period services and efforts expended. These expenses are
 recorded according to the progress of the trial as measured by
 patient progression and the timing of various aspects of the trial.
 Clinical trial accrual estimates are determined through discussions
 with internal clinical personnel and outside service providers as
 to the progress or state of completion of trials, or the services
 completed. Service provider status is then compared to the
 contractually obligated fee to be paid for such services. During
 the course of a clinical trial, the Company may adjust the rate of
 clinical expense recognized if actual results differ from
 management&amp;#x2019;s estimates.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Interest
 Expense&amp;#xA0;&lt;/i&gt;&amp;#x2014;
 Interest costs are expensed as incurred, except to the extent such
 interest is related to construction in progress, in which case
 interest is capitalized. Interest expense, net of interest
 capitalized, for the years ended December&amp;#xA0;31, 2014, 2013 and
 2012 was $20.4 million, $21.5 million, and $21.6 million,
 respectively. Interest costs capitalized for the years ended
 December&amp;#xA0;31, 2014, 2013, and 2012 were $0.8 million, $0.4
 million, and $0.3 million, respectively.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Net Loss
 Per Share of Common Stock&lt;/i&gt;&amp;#xA0;&amp;#x2014; Basic net loss per
 common share is computed by dividing net loss by the
 weighted-average number of common shares outstanding during the
 period. Diluted net loss per common share is computed by dividing
 the net loss by the sum of the weighted-average number of common
 shares outstanding during the period plus the potential dilutive
 effect of stock options, restricted stock units, warrants, and
 shares that could be issued upon conversion of the senior
 convertible notes outstanding during the period calculated in
 accordance with the treasury stock method, but are excluded if
 their effect is anti-dilutive. Because the impact of these items is
 anti-dilutive during periods of net loss, there was no difference
 between basic and diluted loss per common share for the years ended
 December&amp;#xA0;31, 2014, 2013, and 2012.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Recently
 Issued Accounting Standards&amp;#xA0;&lt;/i&gt;&amp;#x2014; From time to time,
 new accounting pronouncements are issued by the Financial
 Accounting Standards Board (FASB) or other standard setting bodies
 that are adopted by the Company as of the specified effective date.
 Unless otherwise discussed, we believe that the impact of recently
 issued standards that are not yet effective will not have a
 material impact on our financial position or results of operations
 upon adoption.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;In
 May&amp;#xA0;2014, a new standard was issued related to revenue
 recognition, which requires an entity to recognize the amount of
 revenue to which it expects to be entitled for the transfer of
 promised goods or services to customers. The new standard will
 replace most of the existing revenue recognition standards in U.S.
 GAAP when it becomes effective on January&amp;#xA0;1, 2017. Early
 adoption is not permitted. The new standard allows for either
 &amp;#x201C;full retrospective&amp;#x201D; adoption, whereby the new standard
 is applied to each prior reporting period presented or
 &amp;#x201C;modified retrospective&amp;#x201D; adoption, whereby the new
 standard is only applied to the most current period presented with
 the cumulative effect of the change recognized at the date of the
 initial application. The Company is assessing the potential impact
 of the new standard on its consolidated statements of financial
 position and results of operations and comprehensive income (loss)
 and has not yet selected a transition method.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;In June 2014,
 the FASB issued ASU No.&amp;#xA0;2014-10, Development Stage Entities
 (Topic 915): Elimination of Certain Financial Reporting
 Requirements, Including an Amendment to Variable Interest Entities
 Guidance in Topic 810, Consolidation.&amp;#xA0;The amendments in this
 ASU remove all incremental financial reporting requirements from
 GAAP for development stage entities, including the removal of Topic
 915, Development Stage Entities,&amp;#xA0;from the FASB Accounting
 Standards Codification. In addition, the ASU: (a)&amp;#xA0;adds an
 example disclosure in Topic 275, Risks and Uncertainties,&amp;#xA0;to
 illustrate one way that an entity that has not begun planned
 principal operations could provide information about the risks and
 uncertainties related to the company&amp;#x2019;s current activities;
 and (b)&amp;#xA0;removes an exception provided to development stage
 entities in Topic 810, Consolidation,&amp;#xA0;for determining whether
 an entity is a variable interest entity. The presentation and
 disclosure requirements in Topic 915 will no longer be required for
 the first annual period beginning after December&amp;#xA0;15, 2014. The
 revised consolidation standards are effective one year later, in
 annual periods beginning after December&amp;#xA0;15, 2015. Early
 adoption is permitted. The Company early adopted ASU 2014-10
 resulting in the elimination of certain presentation and disclosure
 requirements previously required by topic 915.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;On
 August&amp;#xA0;27, 2014, the FASB issued ASU 2014-15, which provides
 guidance on determining when and how reporting entities must
 disclose going-concern uncertainties in their financial statements.
 The new standard requires management to perform interim and annual
 assessments of an entity&amp;#x2019;s ability to continue as a going
 concern within one year of the date of issuance of the
 entity&amp;#x2019;s financial statements (or within one year after the
 date on which the financial statements are available to be issued,
 when applicable). Further, an entity must provide certain
 disclosures if there is &amp;#x201C;substantial doubt about the
 entity&amp;#x2019;s ability to continue as a going concern.&amp;#x201D; The
 ASU is effective for annual periods ending after December&amp;#xA0;15,
 2016, and interim periods thereafter; early adoption is permitted.
 The Company is evaluating the impact the adoption of ASU 2014-15
 will have on its consolidated financial statements.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
  <dei:EntityCentralIndexKey contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_2C560AAF-E0BB-4850-899A-5EF0237561E4_1_400002">0000899460</dei:EntityCentralIndexKey>
  <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_FA4DB374-2423-4F7B-95DA-CFF62CD6CE6F_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;b&gt;13. Stock
 award plans&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;On
 May&amp;#xA0;23, 2013, the Company adopted the 2013 Equity Incentive
 Plan (the &amp;#x201C;2013 Plan&amp;#x201D;) as the successor to and
 continuation of the 2004 Equity Incentive Plan (the &amp;#x201C;2004
 Plan&amp;#x201D;). The 2013 Plan consists of 21.5&amp;#xA0;million newly
 requested shares and the number of unallocated shares remaining
 available for grant for new awards under the 2004 Plan. The 2013
 Plan provides for the granting of stock awards including stock
 options and restricted stock units, to employees, directors and
 consultants. The Plan also provides for the automatic,
 non-discretionary grant of options to the Company&amp;#x2019;s
 non-employee directors. No additional awards will be granted under
 the 2004 Plan or under the 2004 Non-Employee Directors&amp;#x2019; Stock
 Option Plan (the &amp;#x201C;NED Plan&amp;#x201D;) as all future awards will
 be made out of the 2013 Plan.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;As of
 December&amp;#xA0;31, 2014, the Company has two active stock-based
 compensation plans &amp;#x2014; the 2013 Plan and the 2004 Employee
 Stock Purchase Plan (the &amp;#x201C;ESPP&amp;#x201D;). The following table
 summarizes information about the Company&amp;#x2019;s stock-based award
 plans as of December&amp;#xA0;31, 2014:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="65%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;Outstanding&lt;br /&gt;
 Options&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;Outstanding&lt;br /&gt;
 Restricted&lt;br /&gt;
 Stock Units&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;Shares&amp;#xA0;Available&lt;br /&gt;
 for&lt;br /&gt;
 Future Issuance&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;2004 Equity Incentive
 Plan&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;13,629,994&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;1,219,915&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;2013 Equity Incentive
 Plan&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;7,380,839&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;1,390,805&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;15,506,488&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;2004 Non-Employee
 Directors&amp;#x2019; Stock Option Plan&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;530,831&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Total&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;21,541,664&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;2,610,720&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;15,506,488&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;In March
 2004, the Company&amp;#x2019;s board of directors approved the ESPP,
 which became effective upon the closing of the Company&amp;#x2019;s
 initial public offering. Initially, the aggregate number of shares
 that could be sold under the 2004 Plan was 2,000,000 shares of
 common stock. On January&amp;#xA0;1 of each year, for a period of ten
 years beginning January&amp;#xA0;1, 2005, the share reserve
 automatically increases by the lesser of: 700,000 shares, 1% of the
 total number of shares of common stock outstanding on that date, or
 an amount as may be determined by the board of directors. However,
 under no event can the annual increase cause the total number of
 shares reserved under the ESPP to exceed 10% of the total number of
 shares of capital stock outstanding on December&amp;#xA0;31 of the
 prior year. On January&amp;#xA0;1, 2012, 2013 and 2014 the ESPP share
 reserve was increased by 700,000, 700,000 and 700,000 shares,
 respectively. As of December&amp;#xA0;31, 2014, 3,073,931 shares were
 available for issuance under the ESPP. For the years ended
 December&amp;#xA0;31, 2012, 2013 and 2014 the Company sold 422,260,
 463,290 and 305,076&amp;#xA0;shares, respectively, of its common stock
 to employees participating in the ESPP. The ESPP purchase for the
 period ending December&amp;#xA0;31, 2014 was initiated prior to year
 end but did not settle until January&amp;#xA0;5, 2015. As a result, the
 shares sold are reflected in the ESPP share reserves but is
 excluded from common stock outstanding as of December&amp;#xA0;31,
 2014.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The
 Company&amp;#x2019;s board of directors determines eligibility, vesting
 schedules and exercise prices for stock awards granted under the
 2013 Plan. Options and other stock awards under the 2013 Plan
 expire not more than ten years from the date of the grant and are
 exercisable upon vesting. Stock options generally vest over four
 years. Current stock option grants vest and become exercisable at
 the rate of 25% after one year and ratably on a monthly basis over
 a period of 36 months thereafter. Restricted stock units generally
 vest at a rate of 25%&amp;#xA0;per year over four years with
 consideration satisfied by service to the Company.
 Performance-based awards vest upon achieving pre-determined
 performance milestones, which are expected to occur over periods
 ranging from 11 months to 96 months from the date of grant. Only
 one milestone had not yet been achieved as of December&amp;#xA0;31,
 2014, but is considered probable at such date. The 2013 Plan
 provides for full acceleration of vesting if an employee is
 terminated within three months of a change in control, as defined
 in the 2013 Plan. Subsequent to December&amp;#xA0;31, 2014, the company
 achieved the last performance-based milestone on February&amp;#xA0;3,
 2015.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;In accordance
 with ASC 718, share-based payment transactions are recognized as
 compensation cost based on the fair value of the instrument on the
 date of grant. The Company accounts for non-employee stock-based
 compensation expense based on the estimated fair value of the
 options, which is determined using the Black-Scholes option
 valuation model and amortizes such expense on a straight-line basis
 over the service period for time-based awards and over the expected
 dates of achievement for performance-based awards. These awards are
 subject to re-measurement until service is complete. As of
 December&amp;#xA0;31, 2014, there were options to purchase 552,516
 shares of common stock outstanding to consultants.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;During the
 years ended December&amp;#xA0;31, 2014, 2013 and 2012 the Company
 recorded stock-based compensation expense related to its stock
 award plans and the ESPP of $48.6 million, $45.2 million, and $13.3
 million, respectively.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;On
 June&amp;#xA0;30, 2014, the Company modified certain performance grants
 to allow 124 employees to withhold in excess of the minimum
 statutory requirements for specific performance-based restricted
 stock units at the employee&amp;#x2019;s discretion through
 December&amp;#xA0;31, 2014. The modification resulted in the
 reclassification of these performance grants from equity awards to
 liability awards, which require re-measurement at the end of each
 reporting period through settlement. For the year ended
 December&amp;#xA0;31, 2014, the reclassification and re-measurement of
 these performance-based restricted stock units through settlement
 resulted in an increase in stock-based compensation expense of
 $23.0 million.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Total
 stock-based compensation expense recognized in the accompanying
 statements of operations is as follows (in thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="76%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="10" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;Year Ended
 December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Employee-related&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;48,622&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;45,181&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;13,224&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Consultant-related&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;5&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;68&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Total&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;48,622&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;45,186&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;13,292&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Total
 stock-based compensation expense recognized in the accompanying
 statements of operations is included in the following categories
 (in thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="76%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="10" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;Year Ended
 December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Research and
 development&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;22,357&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;20,409&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;6,167&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;General and
 administrative&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;26,265&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;24,777&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;7,125&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Total&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;48,622&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;45,186&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;13,292&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The Company
 uses the Black-Scholes option valuation model to estimate the grant
 date fair value of employee stock options. The expected term of an
 option granted is based on combining historical exercise data with
 expected weighted time outstanding. Expected weighted time
 outstanding is calculated by assuming the settlement of outstanding
 awards is at the midpoint between the remaining weighted average
 vesting date and the expiration date.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Beginning in
 the third quarter of 2014, the Company began to assess both
 historical and implied volatility in order to determine its
 estimated volatility rate. Implied volatility is now considered due
 to the change in the Company&amp;#x2019;s business, which occurred with
 the approval for the sale of AFREEZA. The Company has selected
 risk-free interest rates based on U.S. Treasury securities with an
 equivalent expected term in effect on the date the options were
 granted. Additionally, the Company uses historical data and
 management judgment to estimate stock option exercise behavior and
 employee turnover rates to estimate the number of stock option
 awards that will eventually vest. The Company calculated the fair
 value of employee stock options granted during the years ended
 December&amp;#xA0;31, 2014, 2013 and 2012 using the following
 assumptions:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="48%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="10" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;Year Ended
 December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Risk-free interest
 rate&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;1.64%&amp;#xA0;&amp;#x2014;&amp;#xA0;2.11%&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;0.94%&amp;#xA0;&amp;#x2014;&amp;#xA0;1.82%&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;0.32%&amp;#xA0;&amp;#x2014;1.16%&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Expected lives&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;5.77&amp;#xA0;&amp;#x2014;&amp;#xA0;6.09&amp;#xA0;years&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;2.64&amp;#xA0;&amp;#x2014;&amp;#xA0;5.77&amp;#xA0;years&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;1.4&amp;#xA0;&amp;#x2014;&amp;#xA0;6.1
 years&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Volatility&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;73.98%&amp;#xA0;&amp;#x2014;&amp;#xA0;84.85%&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;75.83%&amp;#xA0;&amp;#x2014;&amp;#xA0;86.26%&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;70%&amp;#xA0;&amp;#x2014;&amp;#xA0;84%&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Dividends&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The following
 table summarizes information about stock options
 outstanding:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="69%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;Number&lt;br /&gt;
 of&lt;br /&gt;
 Shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;Weighted&lt;br /&gt;
 Average&lt;br /&gt;
 Exercise&lt;br /&gt;
 Price&lt;br /&gt;
 per&amp;#xA0;Share&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;Aggregate&lt;br /&gt;
 Intrinsic&lt;br /&gt;
 Value&amp;#xA0;($000)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Outstanding at
 January&amp;#xA0;1, 2014&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;24,237,940&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;4.35&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;40,972&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Granted&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;1,326,800&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;7.21&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Exercised&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(3,250,149&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;3.37&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Forfeit&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(417,223&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;4.54&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Expired&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(355,704&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;12.48&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Outstanding at
 December&amp;#xA0;31, 2014&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;21,541,664&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;4.53&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;33,495&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Vested and expected to
 vest at December&amp;#xA0;31, 2014&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;21,307,827&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;4.52&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;33,253&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Exercisable at
 December&amp;#xA0;31, 2014&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;18,439,472&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;4.42&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;30,356&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The weighted
 average grant date fair value of the stock options granted during
 the years ended December&amp;#xA0;31, 2014, 2013 and 2012 was $4.76,
 $3.26, and $0.99 per option, respectively. The total intrinsic
 value of options exercised during the years ended December&amp;#xA0;31,
 2014, 2013 and 2012 was $14.9 million, $3.1 million, and $1,000,
 respectively. Intrinsic value is measured using the fair market
 value at the date of exercise (for options exercised) or at
 December&amp;#xA0;31 (for outstanding options), less the applicable
 exercise price.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Cash received
 from the exercise of options during the years ended
 December&amp;#xA0;31, 2014, 2013 and 2012 was approximately $11.0
 million, $2.3 million, and $9,200, respectively. The
 weighted-average remaining contractual terms for options
 outstanding, vested and expected to vest, and exercisable at
 December&amp;#xA0;31, 2014 was 7.07 years, 7.06 years and 6.83 years,
 respectively.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;A summary of
 restricted stock unit activity for the year ended December&amp;#xA0;31,
 2014 is presented below:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="80%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;Number&lt;br /&gt;
 of&lt;br /&gt;
 Shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;Weighted&lt;br /&gt;
 Average&lt;br /&gt;
 Grant&amp;#xA0;Date&lt;br /&gt;
 Fair Value&lt;br /&gt;
 per Share&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Outstanding at January 1,
 2014&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;9,115,821&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;3.90&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Granted&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;954,127&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;7.14&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Vested&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(6,982,707&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;3.83&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Forfeited&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(476,521&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;4.30&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Outstanding at December
 31, 2014&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;2,610,720&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;5.20&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The total
 restricted stock units expected to vest as of December&amp;#xA0;31,
 2014 was 2,386,061 with a weighted average grant date fair value of
 $5.23. The total intrinsic value of restricted stock units expected
 to vest as of December&amp;#xA0;31, 2014 was $12.5 million. Intrinsic
 value of restricted stock units expected to vest is measured using
 the closing share price at December&amp;#xA0;31, 2014.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Total
 intrinsic value of restricted stock units vested during the years
 ended December&amp;#xA0;31, 2014, 2013 and 2012 was $62.7 million,
 $13.9 million and $2.9 million, respectively. Intrinsic value of
 restricted stock units vested is measured using the closing share
 price on the day prior to the vest date. The total grant date fair
 value of restricted stock units vested during the years ended
 December&amp;#xA0;31, 2014, 2013 and 2012 was $36.4 million,
 $14.9&amp;#xA0;million and $3.0&amp;#xA0;million, respectively.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;As of
 December&amp;#xA0;31, 2014, there was $9.0 million and $10.6 million of
 unrecognized compensation expense related to options and restricted
 stock units, respectively, which is expected to be recognized over
 the weighted average vesting period of 2.9 years. The Company
 evaluates stock awards with performance conditions as to the
 probability that the performance conditions will be met and
 estimates the date at which the performance conditions will be met
 in order to properly recognize stock-based compensation expense
 over the requisite service period. As of December&amp;#xA0;31, 2014,
 all milestones are considered probable of achievement.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_5851737_4373895D-6E6F-41A5-A449-A8691F7E803C_1_13">-0.51</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="pure" decimals="INF" id="id_5851737_B6F3E2C8-A6E4-4D0D-8044-F1D8F2BFBEF5_1_0">0.350</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
  <us-gaap:FairValueDisclosuresTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_7037B4A7-ABF4-4BDB-8344-46FA715C1F3F_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;b&gt;10. Fair
 Value of Financial Instruments&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The carrying
 amounts of financial instruments, which include cash equivalents
 and accounts payable, approximate their fair values due to their
 relatively short maturities. The fair value of the note payable to
 our principal stockholder cannot be reasonably estimated as the
 Company would not be able to obtain a similar credit arrangement in
 the current economic environment.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;As of
 December&amp;#xA0;31, 2014 and 2013, the Company held $120.8 million
 and $70.8 million, respectively of cash and cash equivalents,
 consisting of money market funds of $118.5 million and $67.7
 million, respectively, and the remaining funds in non-interest
 bearing checking accounts. The fair value of these money market
 funds was determined by using quoted prices for identical
 investments in an active market (Level 1 in the fair value
 hierarchy).&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The following
 is a summary of the carrying values and estimated fair values of
 the 2015 notes and the facility financing obligation (i.e., the
 2019 notes and Trance B notes) (in millions):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="69%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="6" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,
 2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="6" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,
 2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;Carrying&lt;br /&gt;
 value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;Estimated&lt;br /&gt;
 fair value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;Carrying&lt;br /&gt;
 value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;Estimated&lt;br /&gt;
 fair value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;2015 notes&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;99.4&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;102.9&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;98.4&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;102.2&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Facility financing
 obligation&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;73.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;75.1&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;102.3&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;107.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-LEFT: 28px; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Senior
 convertible notes&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The estimated
 fair value of the 2015 notes was calculated based on model derived
 valuations whose inputs were observable, such as the
 Company&amp;#x2019;s stock price, and non-observable, such as the
 Company&amp;#x2019;s long-term historical volatility, which was
 estimated to be 55% (Level&amp;#xA0;3 in the fair value hierarchy) in
 2014 compared to the 65% in 2013. As there is no current observable
 market for the 2015 notes, the Company determined the estimated
 fair value using a convertible bond valuation model within a
 lattice framework. The convertible bond valuation model combined
 expected cash outflows with market-based assumptions regarding
 risk-adjusted yields, stock price volatility and recent price
 quotes and trading information regarding Company issued debt
 instruments and shares of common stock into which the 2015 notes
 are convertible.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-LEFT: 28px; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Facility
 financing agreement&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;As discussed
 in Note 17 &amp;#x2014; Facility Agreement, in connection with the
 Facility Agreement, the Company issued 2019 notes and Milestone
 Rights and recorded the Commitment Asset on July&amp;#xA0;1, 2013. In
 addition, on February&amp;#xA0;28, 2014, the Company entered into the
 First Amendment, and recorded the Tranche B Commitment Asset, which
 represented the increase in borrowing capacity that the Company
 received as consideration for the modifications made to the
 Facility Agreement and the Tranche 1 notes and Tranche 3 notes. As
 there is no current observable market for the 2019 notes or Tranche
 B notes, the Company determined the estimated fair value using a
 bond valuation model based on a discounted cash flow methodology.
 The bond valuation model combined expected cash flows associated
 with principal repayment and interest based on the contractual
 terms of the debt agreement discounted to present value using a
 selected market discount rate of 12.4% at December&amp;#xA0;31, 2014
 for the 2019 notes and a selected market discount rate of 11.9% at
 the inception of the Tranche B notes (Level 3 in the fair value
 hierarchy). On December&amp;#xA0;31, 2014, the market discount rate was
 recalculated at 12.3%, 12.2%, and 11.8% for the Tranche 1 notes,
 the Tranche 4 notes and the Tranche B notes, respectively. The
 Tranche 2 and Tranche 3 notes were fully converted by the end of
 the first quarter of 2014. On December&amp;#xA0;31, 2013, the market
 discount rate for Tranche 1 notes was 12.7%.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The estimated
 fair value of the Milestone Rights was calculated using the income
 approach in which the cash flows associated with the specified
 contractual payments were adjusted for both the expected timing and
 the probability of achieving the milestones discounted to present
 value using a selected market discount rate (Level 3 in the fair
 value hierarchy). The expected timing and probability of achieving
 the milestones, starting in 2014, was developed with consideration
 given to both internal data, such as progress made to date and
 assessment of criteria required for achievement, and external data,
 such as market research studies. The discount rate (15.0%)&amp;#xA0;was
 selected based on an estimation of required rate of returns for
 similar investment opportunities using available market data. As of
 December&amp;#xA0;31, 2014, the carrying value of the Milestone Rights
 is $13.1 million with an estimated fair value of $27.9
 million.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The fair
 value of the Commitment Asset was estimated using the income
 approach by estimating the fair value of the future tranches using
 a market debt rate (12.0%)&amp;#xA0;commensurate with the risk of the
 future tranches and the fair value of the cash expected to be
 received by the Company and assessing the probability of the
 commitments being funded in the future based on the operational
 hurdles required for funding being met (Level 3 in the fair value
 hierarchy).&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The fair
 value of the Tranche B Commitment Asset was estimated using a
 discounted cash flow analysis under the income approach.
 Specifically, the fair value was determined by estimating the fair
 value of the future tranche using a market yield
 (11.8%)&amp;#xA0;commensurate with the risk of the future tranche and
 the fair value of the cash expected to be received by the Company
 and assessing the probability of the commitment being funded in the
 future based on the operational hurdles required for funding being
 met as well as consideration of alternative funding options (Level
 3 in the fair value hierarchy). As of the date it was recorded, the
 Tranche B Commitment Asset was valued at $2.9 million.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;On
 May&amp;#xA0;6, 2014, Deerfield purchased $20.0 million aggregate
 principal amount of Tranche B notes in accordance with the
 provisions of the Facility Agreement, as amended. Accordingly, the
 $1.2 million portion of the Commitment Asset associated with the
 $20.0 million purchased was derecognized and recorded as debt
 discount on the Tranche B notes.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;At
 December&amp;#xA0;31, 2014, as Deerfield had purchased all four
 tranches of 2019 notes in the aggregate principal amount of $160.0
 million, purchased $20.0 million aggregate principal amount of
 Tranche B notes in accordance with the provisions of the Facility
 Agreement, and wrote off the remaining portion of the Tranche B
 Commitment Asset. As such, at December&amp;#xA0;31, 2014 the carrying
 value of the Commitment Assets was zero.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;There were no
 material re-measurements to fair value during the twelve months
 ended December&amp;#xA0;31, 2014 and 2013 of financial assets and
 liabilities that are not measured at fair value on a recurring
 basis.&amp;#xA0;There were no transfers of assets or liabilities
 between the fair value measurement levels during the twelve months
 ended December&amp;#xA0;31, 2014, 2013, and 2012.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-LEFT: 28px; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Derivatives&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Four embedded
 features that required bifurcation and separate accounting were
 identified in the facility financing obligation and the Company
 determined should be bundled together as a single, compound
 embedded derivative, bifurcated from the host contract, and
 accounted for at fair value, with changes in fair value being
 recorded in the Statement of Operations. The four embedded
 derivatives contained in the facility financing obligation were the
 Conversion Option, Major Transaction Put Option, Acceleration upon
 a Legal Judgment against the Company in Excess of $100,000, and Tax
 Gross-Up.&amp;#xA0;The four embedded features were evaluated together
 as a single compound derivative to determine the fair value of the
 derivative.&amp;#xA0;The estimated fair value of the embedded
 derivative was calculated using Level 3 inputs and by applying a
 cumulative probability percentage to the values derived from a
 Black-Karasinski lattice model for the major transaction put option
 (0.8%), the conversion option feature (0.0%), and the acceleration
 upon a legal judgment against the Company in excess of $100,000
 feature (0.1%). The Tax Gross-Up feature was evaluated using a
 Level 2 analysis based on the withholding requirements (i.e., the
 tax laws) on interest payments between the US and the British
 Virgin Islands and was determined to be de minimus. As of
 December&amp;#xA0;31, 2014 and 2013, management determined the impact
 of the valuation of the embedded derivative was immaterial (see
 Note 17).&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The
 Company&amp;#x2019;s derivative financial instruments are not designated
 as hedging instruments, and gains or losses resulting from changes
 in the fair value are reported in other income (expense), in the
 consolidated statements of operations. Derivative financial
 instruments are recognized as other assets or other current
 liabilities in the financial statements and measured at fair
 value.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The estimated
 fair values in connection with the February 2012 The Mann Group
 Common Stock Purchase Agreement (&amp;#x201C;The February 2012 Forward
 Purchase Contract&amp;#x201D;) and the October 2012 The Mann Group
 Common Stock and Warrant Purchase Agreement (&amp;#x201C;The October
 2012 Forward Purchase Contract&amp;#x201D;) was based on forward
 purchase contract valuations (Level 3 in the fair value hierarchy)
 (see Note 11).&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The following
 roll-forward provides a summary of the changes in fair value of the
 Company&amp;#x2019;s Level 3 forward purchase contracts during the year
 ended December&amp;#xA0;31, 2012 (in thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="61%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="11%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="11%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="11%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;The&amp;#xA0;February&amp;#xA0;2012&lt;br /&gt;
 Forward Purchase&lt;br /&gt;
 Contract&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;The&amp;#xA0;October&amp;#xA0;2012&lt;br /&gt;
 Forward&amp;#xA0;Purchase&lt;br /&gt;
 Contract&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Beginning
 Balance&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Issuance&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;1,080&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;28,237&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;29,317&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Adjustments to fair value
 included in other income (expense)&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;12,011&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(13,248&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(1,237&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Transfers to additional
 paid-in-capital&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(13,091&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(14,989&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;(28,080&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Ending Balance&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
  <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_789AB63E-6674-4789-BC41-CD6AA6F814CB_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Impairment
 of Long-Lived Assets&lt;/i&gt; &amp;#x2014; The Company evaluates long-lived
 assets for impairment whenever events or changes in circumstances
 indicate that the carrying value of an asset may not be recoverable
 in accordance with ASC 360-10-35 &lt;i&gt;Property Plant and
 Equipment.&lt;/i&gt; Assets are considered to be impaired if the carrying
 value may not be recoverable based upon management&amp;#x2019;s
 assessment of the following events or changes in
 circumstances:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="2%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2022;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;significant changes in the Company&amp;#x2019;s strategic business
 objectives and utilization of the assets;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="2%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2022;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;a determination that the carrying value of such assets cannot
 be recovered through undiscounted cash flows;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="2%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2022;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;loss of legal ownership or title to the assets;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="2%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2022;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;a significant adverse change in legal factors or in the
 business climate that could affect the value of a long-lived asset
 (asset group), including an adverse action or assessment by a
 regulator; or&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="2%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2022;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;the impact of significant negative industry or economic
 trends.&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;If the Company
 believes an asset to be impaired, the impairment recognized is the
 amount by which the carrying value of the assets exceeds the fair
 value of the assets. Any write-downs would be treated as permanent
 reductions in the carrying amount of the asset and an operating
 loss would be recognized. No asset impairment was recognized during
 the years ended December&amp;#xA0;31, 2014, 2013 and 2012,
 respectively.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
  <us-gaap:LineOfCreditFacilityDateOfFirstRequiredPayment1 contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_6180B978-0728-4896-9559-A1ED213196A8_1_4">2016-07-01</us-gaap:LineOfCreditFacilityDateOfFirstRequiredPayment1>
  <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_068F456A-B073-4B7D-BDEB-7B5ECB11A3EF_1_0">&lt;div&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;15. Employee benefit
 plans&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;The Company
 administers a 401(k) Savings Retirement Plan (the &amp;#x201C;MannKind
 Retirement Plan&amp;#x201D;) for its employees. For the years ended
 December&amp;#xA0;31, 2014, 2013 and 2012, the Company contributed
 $623,000, $533,000 and $571,000 respectively, to the MannKind
 Retirement Plan.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
  <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_B573BC90-86D1-41E6-A144-851FCCD996F3_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 12px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;5. Property and
 equipment&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Property and
 equipment consist of the following (dollar amounts in
 thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="72%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" rowspan="2" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Estimated&lt;br /&gt;
 Useful&lt;br /&gt;
 Life&lt;br /&gt;
 (Years)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" rowspan="2"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Land&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5,273&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5,273&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Buildings&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;39-40&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;54,948&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;54,948&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Building
 improvements&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5-40&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;114,131&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;114,099&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Machinery and
 equipment&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3-15&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;80,919&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;82,189&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Furniture, fixtures and
 office equipment&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5-10&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5,015&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5,046&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Computer equipment and
 software&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;10,465&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;11,289&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Leasehold
 improvements&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;17&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;17&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Construction in
 progress&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;39,580&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;14,756&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;310,348&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;287,617&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Less accumulated
 depreciation and amortization&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(118,221&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(111,060&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total property and
 equipment, net&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;192,127&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;176,557&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Leasehold
 improvements are amortized over four years which is the shorter of
 the term or the service lives of the improvements. Depreciation and
 amortization expense related to property and equipment for the
 years ended December&amp;#xA0;31, 2014, 2013, and 2012, was $9.8
 million, $11.5 million, and $13.0 million, respectively.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
  <us-gaap:ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_953158F6-E780-47DD-AB25-819AD7D8CE15_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Accretion of
 debt issuance cost and debt discount in connection with the
 Deerfield financing during the year ended December&amp;#xA0;31, 2014
 and 2013 are as follows (in thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="86%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Accretion expense- debt
 issuance cost&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;326&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;42&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Accretion expense- debt
 discount&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;7,550&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1,113&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock>
  <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_C8CB2DD6-1B54-4E1E-91C2-D8F5CA7C9A2E_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Segment
 Information&lt;/i&gt; &amp;#x2014; In accordance with Accounting Standards
 Codification (&amp;#x201C;ASC&amp;#x201D;) 280-10-50 &lt;i&gt;Segment
 Reporting&lt;/i&gt;, operating segments are identified as components of
 an enterprise about which separate discrete financial information
 is available for evaluation by the chief operating decision-maker
 in making decisions regarding resource allocation and assessing
 performance. To date, the Company has viewed its operations and
 manages its business as one segment operating in the United States
 of America.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="pure" decimals="4" id="id_5851737_4891FC0B-C69B-476B-9ABC-3A53D8C25AD9_1_5">0.8485</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="pure" decimals="4" id="id_5851737_4891FC0B-C69B-476B-9ABC-3A53D8C25AD9_1_1">0.0211</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
  <dei:DocumentFiscalPeriodFocus contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_07B4ADC0-F6C5-41A3-9832-DCB21B153B06_1_4">FY</dei:DocumentFiscalPeriodFocus>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="shares" decimals="INF" id="id_5851737_127E2ACD-5D85-413D-A09E-8F8110ADED0E_1_4">51463340</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:ConcentrationRiskCreditRisk contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_2FCEAF67-3B7B-4EA4-9D05-5CA549890CB5_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Concentration of Credit Risk&lt;/i&gt; &amp;#x2014; Financial
 instruments which potentially subject the Company to concentration
 of credit risk consist of cash and cash equivalents. Cash and cash
 equivalents consist of interest-bearing accounts, which are
 regularly monitored by management and held in high credit quality
 institutions.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
  <us-gaap:DebtPolicyTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_D4A46E1E-ED0A-43B3-B64F-EA982DD335C6_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; PADDING-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Milestone
 Rights&lt;/i&gt; &amp;#x2014; On July&amp;#xA0;1 2013, in conjunction with the
 execution of the Facility Agreement, the Company issued Milestone
 Rights to Deerfield whereby the Company agreed to provide Deerfield
 with pre-specified Milestone Payments upon the achievement of 13
 specific Milestone Events related to the commercial release and
 future cumulative net sales of AFREZZA&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;sup style="VERTICAL-ALIGN: baseline; POSITION: relative; BOTTOM: 0.8ex"&gt;&amp;#xAE;&lt;/sup&gt;&lt;/font&gt;.
 The Company analyzed the Milestone Rights under the provisions of
 ASC 815 and determined that the agreement does not meet the
 definition of a freestanding derivative. Since the Company has not
 elected to apply the fair value option to the Milestone Rights
 Purchase Agreement, the Company recorded the Milestone Rights at
 their estimated fair value and accounted for the Milestone Rights
 as a liability by applying the indexed debt guidance contained in
 paragraphs ASC 470-10-25-3 and 35-4.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The initial
 fair value estimate of the Milestone Rights was calculated using
 the income approach in which the cash flows associated with the
 specified contractual payments were adjusted for both the expected
 timing and the probability of achieving the milestones and
 discounted to present value using a selected market discount rate.
 The expected timing and probability of achieving the milestones was
 developed with consideration given to both internal data, such as
 progress made to date and assessment of criteria required for
 achievement, and external data, such as market research studies.
 The discount rate was selected based on an estimation of required
 rate of returns for similar investment opportunities using
 available market data. The Milestone Rights liability will be
 remeasured as the specified milestone events are achieved.
 Specifically, as each milestone event is achieved, the portion of
 the initially recorded Milestone Rights liability that pertains to
 the milestone event being achieved, will be remeasured to the
 amount of the specified related milestone payment. The resulting
 change in the balance of the Milestone Rights liability due to
 remeasurement will be recorded in our Statement of Operations as
 interest expense. Furthermore, the Milestone Rights liability will
 be reduced upon the settlement of each milestone payment. As a
 result, each milestone payment would be effectively allocated
 between a reduction of the recorded Milestone Rights liability and
 an expense representing a return on a portion of the Milestone
 Rights liability paid to the investor for the achievement of the
 related milestone event (see&amp;#xA0;Note&amp;#xA0;17).&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:DebtPolicyTextBlock>
  <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_B9DEC955-1752-4E2B-87E7-E3EC4711D2F4_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Fair Value
 of Financial Instruments&lt;/i&gt; &amp;#x2014; The Company utilizes fair
 value measurement guidance prescribed by GAAP to value its
 financial instruments. The guidance includes a definition of fair
 value, prescribes methods for measuring fair value, establishes a
 fair value hierarchy based on the inputs used to measure fair value
 and expands disclosures about the use of fair value measurements.
 The valuation techniques utilized are based upon observable and
 unobservable inputs. Observable inputs reflect market data obtained
 from independent sources, while unobservable inputs reflect
 internal market assumptions. These two types of inputs create the
 following fair value hierarchy:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 6px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Level&amp;#xA0;1
 &amp;#x2013; Quoted prices for identical instruments in active
 markets.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 6px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Level&amp;#xA0;2
 &amp;#x2013; Quoted prices for similar instruments in active markets;
 quoted prices for identical or similar instruments in markets that
 are not active; and model-derived valuations whose inputs are
 observable or whose significant value drivers are
 observable.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 6px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Level&amp;#xA0;3
 &amp;#x2013; Significant inputs to the valuation model are
 unobservable.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The carrying
 amounts reflected in the consolidated balance sheets for cash
 equivalents, other current assets, accounts payable, and accrued
 expenses and other current liabilities, approximate fair value due
 to their relatively short maturities.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
  <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_E9714A45-DEB2-4FAF-B44D-063D60A90F07_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Property and
 equipment consist of the following (dollar amounts in
 thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="72%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" rowspan="2" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Estimated&lt;br /&gt;
 Useful&lt;br /&gt;
 Life&lt;br /&gt;
 (Years)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" rowspan="2"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Land&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5,273&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5,273&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Buildings&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;39-40&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;54,948&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;54,948&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Building
 improvements&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5-40&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;114,131&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;114,099&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Machinery and
 equipment&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3-15&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;80,919&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;82,189&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Furniture, fixtures and
 office equipment&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5-10&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5,015&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5,046&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Computer equipment and
 software&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;10,465&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;11,289&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Leasehold
 improvements&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;17&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;17&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Construction in
 progress&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;39,580&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;14,756&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;310,348&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;287,617&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Less accumulated
 depreciation and amortization&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(118,221&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(111,060&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total property and
 equipment, net&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;192,127&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;176,557&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
  <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_FDE6AEDC-8CE6-4EDB-BD7C-24DA7BFB6AB8_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;A summary of
 restricted stock unit activity for the year ended December&amp;#xA0;31,
 2014 is presented below:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="80%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Number&lt;br /&gt;
 of&lt;br /&gt;
 Shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Weighted&lt;br /&gt;
 Average&lt;br /&gt;
 Grant&amp;#xA0;Date&lt;br /&gt;
 Fair Value&lt;br /&gt;
 per Share&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Outstanding at January 1,
 2014&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;9,115,821&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.90&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Granted&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;954,127&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;7.14&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Vested&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(6,982,707&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.83&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Forfeited&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(476,521&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4.30&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Outstanding at December 31,
 2014&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,610,720&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5.20&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="shares" decimals="INF" id="id_5851737_143C52D3-CB9D-4730-A9E6-7C6A29401131_1_3">3250149</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <dei:EntityCurrentReportingStatus contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_2C560AAF-E0BB-4850-899A-5EF0237561E4_1_400005">Yes</dei:EntityCurrentReportingStatus>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_9006_900034">-26908000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-5" id="id_5851737_4FEAEA63-925D-4828-849A-287F8F314E3B_3_0">65500000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_90D3F4A0-1EBD-40FE-9C68-173795AC8270_1_6">-10000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="INF" id="id_5851737_7A23EAFD-38E9-4829-ABCF-DAE75D55D931_1_1">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_9006_900040">22962000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_1_17">14721000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_1_18">615000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
  <us-gaap:IncreaseDecreaseInInventories contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_1_15">9670000</us-gaap:IncreaseDecreaseInInventories>
  <us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_1_16">50436000</us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4373895D-6E6F-41A5-A449-A8691F7E803C_1_10">-198382000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_9006_900039">1363000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_9006_900033">10978000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:OperatingIncomeLoss contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4373895D-6E6F-41A5-A449-A8691F7E803C_1_5">-179627000</us-gaap:OperatingIncomeLoss>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_90D3F4A0-1EBD-40FE-9C68-173795AC8270_1_7">-198392000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:DebtConversionOriginalDebtAmount1 contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_1_44">93500000</us-gaap:DebtConversionOriginalDebtAmount1>
  <us-gaap:OtherNonoperatingIncomeExpense contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4373895D-6E6F-41A5-A449-A8691F7E803C_1_6">1679000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_9006_900042">-10000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
  <us-gaap:LoansAssumed1 contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_1_50">3034000</us-gaap:LoansAssumed1>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_1_25">24097000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:OtherNoncashIncomeExpense contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_1_12">10000</us-gaap:OtherNoncashIncomeExpense>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4373895D-6E6F-41A5-A449-A8691F7E803C_1_12">-198382000</us-gaap:NetIncomeLoss>
  <us-gaap:InvestmentIncomeInterest contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4373895D-6E6F-41A5-A449-A8691F7E803C_1_9">9000</us-gaap:InvestmentIncomeInterest>
  <us-gaap:InterestPaid contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_1_43">11218000</us-gaap:InterestPaid>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_9006_900041">25660000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_1_37">26908000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
  <us-gaap:ConstructionInProgressExpendituresIncurredButNotYetPaid contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_1_45">1768000</us-gaap:ConstructionInProgressExpendituresIncurredButNotYetPaid>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_5CF4DCBF-958A-4C2E-84FF-736CEF523791_1_0">48622000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_FF1422D9-4F07-4EC2-A2EF-D2BD529666C7_1_10">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-5" id="id_5851737_9DDD7803-FC6B-4DBD-94E8-64434E7A1B04_1_0">9800000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:InterestCostsCapitalized contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-5" id="id_5851737_1322FBBF-CCB2-4059-9D68-2AC5451BAB41_1_1">800000</us-gaap:InterestCostsCapitalized>
  <us-gaap:InterestExpense contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-5" id="id_5851737_1322FBBF-CCB2-4059-9D68-2AC5451BAB41_1_0">20400000</us-gaap:InterestExpense>
  <us-gaap:OperatingExpenses contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4373895D-6E6F-41A5-A449-A8691F7E803C_1_4">179627000</us-gaap:OperatingExpenses>
  <us-gaap:ProceedsFromIssuanceOfDebt contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_1_32">40000000</us-gaap:ProceedsFromIssuanceOfDebt>
  <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4373895D-6E6F-41A5-A449-A8691F7E803C_1_7">2894000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-5" id="id_5851737_78F5C120-82A4-4A68-A5A4-4EFB90BCC73A_3_1">36400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
  <us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-5" id="id_5851737_6C5177C9-5366-4D13-941E-B0303FCF50EA_1_0">900000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
  <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_FF1422D9-4F07-4EC2-A2EF-D2BD529666C7_1_7">7631000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
  <us-gaap:IncreaseDecreaseInDeferredLiabilities contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_1_21">200436000</us-gaap:IncreaseDecreaseInDeferredLiabilities>
  <us-gaap:InterestExpenseDebt contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4373895D-6E6F-41A5-A449-A8691F7E803C_1_8">17549000</us-gaap:InterestExpenseDebt>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_1_39">50051000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_FF1422D9-4F07-4EC2-A2EF-D2BD529666C7_1_8">0</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
  <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_1_20">2276000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
  <us-gaap:OperatingLeasesRentExpenseNet contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="0" id="id_5851737_215C1445-5489-4219-BC45-8D91F36914C4_1_0">737000</us-gaap:OperatingLeasesRentExpenseNet>
  <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_FF1422D9-4F07-4EC2-A2EF-D2BD529666C7_1_1">0</us-gaap:CurrentFederalTaxExpenseBenefit>
  <us-gaap:DeferredOtherTaxExpenseBenefit contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_FF1422D9-4F07-4EC2-A2EF-D2BD529666C7_1_9">-65504000</us-gaap:DeferredOtherTaxExpenseBenefit>
  <us-gaap:DepreciationAndAmortization contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_1_3">18575000</us-gaap:DepreciationAndAmortization>
  <us-gaap:EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-5" id="id_5851737_8F1A5AC1-8BCD-4B25-9FA2-DD3AB5888390_3_1">11000000</us-gaap:EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions>
  <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_1_38">70062000</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
  <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_FF1422D9-4F07-4EC2-A2EF-D2BD529666C7_1_2">0</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="INF" id="id_5851737_7A23EAFD-38E9-4829-ABCF-DAE75D55D931_1_0">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
  <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_1_27">-24097000</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
  <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4373895D-6E6F-41A5-A449-A8691F7E803C_1_2">100244000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
  <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_FF1422D9-4F07-4EC2-A2EF-D2BD529666C7_1_3">0</us-gaap:CurrentForeignTaxExpenseBenefit>
  <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_FF1422D9-4F07-4EC2-A2EF-D2BD529666C7_1_4">0</us-gaap:CurrentIncomeTaxExpenseBenefit>
  <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="0" id="id_5851737_A5EFB79E-1DD7-45F0-A8F1-82325FD3AE31_1_0">623000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
  <us-gaap:GeneralAndAdministrativeExpense contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4373895D-6E6F-41A5-A449-A8691F7E803C_1_3">79383000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_1_19">3622000</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_1_4">48622000</us-gaap:ShareBasedCompensation>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-5" id="id_5851737_78F5C120-82A4-4A68-A5A4-4EFB90BCC73A_3_0">62700000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-5" id="id_5851737_9C0D5787-E738-4506-A65E-31334D531A9D_3_2">14900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
  <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_FF1422D9-4F07-4EC2-A2EF-D2BD529666C7_1_6">57873000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
  <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_1_22">2915000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
  <mnkd:IncreaseDecreaseInStockBasedCompensationExpense contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-5" id="id_5851737_E2015A48-766A-4993-A668-692B8BFC8420_2_1">23000000</mnkd:IncreaseDecreaseInStockBasedCompensationExpense>
  <mnkd:CommonAndPreferredStockTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_7E8212B6-6ED8-4ABA-97E8-386A75033418_1_0">&lt;div&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;11. Common and preferred
 stock&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;The Company is
 authorized to issue 550,000,000 shares of common stock, par value
 $0.01 per share, and 10,000,000 shares of undesignated preferred
 stock, par value $0.01 per share, issuable in one or more series
 designated by the Company&amp;#x2019;s board of directors. No other
 class of capital stock is authorized. As of December&amp;#xA0;31, 2014
 and 2013, 406,059,089 and 369,391,972 shares of common stock,
 respectively, were issued and outstanding and no shares of
 preferred stock were outstanding.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%;padding-bottom:0px;"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;Included in the
 common stock outstanding as of December&amp;#xA0;31, 2014, 2013 and
 2012 are 9,000,000 shares of common stock loaned to Bank of America
 under a share lending agreement in connection with the offering of
 the $100.0 million aggregate principal amount of 2015 notes (see
 Note 8). Bank of America is obligated to return the borrowed shares
 (or, in certain circumstances, the cash value thereof) to the
 Company on or about the 45&lt;/font&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;sup style="vertical-align:baseline; position:relative; bottom:.8ex"&gt;th&lt;/sup&gt;&lt;/font&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;business day following the date as of which the
 entire principal amount of the 2015 notes ceases to be outstanding,
 subject to extension or acceleration in certain circumstances or
 early termination at Bank of America&amp;#x2019;s option. The Company
 did not receive any proceeds from the sale of the borrowed shares
 by Bank of America, but the Company did receive a nominal lending
 fee of $0.01 per share from Bank of America for the use of borrowed
 shares.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;On
 February&amp;#xA0;8, 2012, the Company sold 35,937,500 units in an
 underwritten public offering, including 4,687,500 units sold
 pursuant to the full exercise of an over-allotment option granted
 to the underwriters, with each unit consisting of one share of
 common stock and a warrant to purchase 0.6 of a share of common
 stock. All of the securities were offered by the Company at a
 combined price to the public of $2.40 per unit and the underwriters
 purchased the units at a price of $2.256 per unit. Net proceeds
 from this offering were approximately $80.6 million, excluding any
 warrant exercises. The 21,562,500 shares of common stock underlying
 the warrants are exercisable at $2.40 per share and expire four
 years from the date of the issuance. The shares of common stock and
 warrants are immediately separable and were issued separately.
 Concurrent with the February 2012 underwritten public offering, the
 Company entered into a common stock purchase agreement with The
 Mann Group, pursuant to which the Company agreed to sell and The
 Mann Group agreed to purchase 31,250,000 shares of the
 Company&amp;#x2019;s restricted common stock at a price of $2.47 per
 share, the closing of which was subject to the expiration or
 termination of the waiting period under the Hart-Scott-Rodino
 Antitrust Improvements Act of 1976, as amended (&amp;#x201C;HSR
 Clearance&amp;#x201D;), and the Company&amp;#x2019;s receipt of stockholder
 approval to increase the authorized number of shares of our common
 stock. In June 2012, following HSR Clearance and the
 Company&amp;#x2019;s receipt of such stockholder approval, The Mann
 Group purchased $77.2 million worth of restricted shares of common
 stock which were paid through the cancellation of principal
 indebtedness under the amended loan arrangement with The Mann Group
 (see Note 7). For the twelve months ended December&amp;#xA0;31, 2014,
 the Company received $27.8 million in proceeds from the exercise of
 the February 2012 public offering warrants, with $19.5 million
 remaining unexercised.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;The Company
 concluded that The Mann Group common stock purchase agreement
 represented a contingent forward purchase contract that met the
 definition of a derivative instrument in accordance with ASC
 815&lt;i&gt;.&lt;/i&gt; Of the 31,250,000 shares issuable pursuant to the
 common stock purchase agreement, the portion of the derivative
 instrument representing 14.7&amp;#xA0;million shares were recorded as
 equity (&amp;#x201C;Equity Portion&amp;#x201D;) as they met the criteria for
 equity classification under ASC 815-40 &lt;i&gt;Derivatives and Hedging,
 Contracts in an Entity&amp;#x2019;s Own Stock.&amp;#xA0;&lt;/i&gt;The remaining
 16.5&amp;#xA0;million shares (&amp;#x201C;Non-Equity Portion&amp;#x201D;)
 required classification outside of equity as the Company did not
 have sufficient available shares at the time of issuance.&amp;#xA0;The
 Company revalued the Non-Equity Portion of the forward purchase
 contract at each reporting date and recorded a fair value
 adjustment within &amp;#x201C;Other income (expense)&amp;#x201D;.&amp;#xA0;At the
 time of issuance, the fair value of the forward purchase contract
 was $2.0 million. The Equity Portion of $0.9 million
 was&amp;#xA0;classified as equity, and the Non-Equity Portion of $1.1
 million was initially recorded to&amp;#xA0;&amp;#x201C;Prepaid expenses and
 other current assets.&amp;#x201D;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;On May&amp;#xA0;17,
 2012, the Company&amp;#x2019;s stockholders approved an increase in its
 authorized shares of common stock from 250,000,000 to 350,000,000.
 Accordingly, the shares of common stock needed to consummate The
 Mann Group common stock purchase agreement dated February&amp;#xA0;2,
 2012 became available.&amp;#xA0;As of May&amp;#xA0;17, 2012, the fair value
 of the Non-Equity Portion was $13.1 million.&amp;#xA0;As a result of
 receiving stockholder approval of the increase in authorized
 shares, the Non-Equity Portion met the criteria for equity
 classification. Consequently, the Company reclassified the $13.1
 million from &amp;#x201C;Prepaid expenses and other current
 assets&amp;#x201D; to &amp;#x201C;Additional paid-in
 capital.&amp;#x201D;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;The fair value
 of the forward purchase contract was highly sensitive to the
 discount applied for lack of marketability and the stock price, and
 changes in this discount and/or the stock price caused the value of
 the forward purchase contract to change significantly. As of and
 for the year ended December&amp;#xA0;31, 2012, the Company recognized
 the change in fair value of $12.0 million in &amp;#x201C;Other income
 (expense).&amp;#x201D; The Company revalued the Non-Equity Portion using
 a forward contract valuation formula, in which the forward contract
 was estimated to be equal to the valuation date stock price of
 $2.40 at issuance and $1.69 at May&amp;#xA0;17, 2012 minus the strike
 price discounted to the valuation date using a risk-free rate of
 0.08% at issuance and 0.18% at May&amp;#xA0;17, 2012.&amp;#xA0;As the
 shares which would be received upon settlement were unregistered,
 the Company applied a discount for lack of marketability of 2.57%
 at issuance and 0.42% at May&amp;#xA0;17, 2012 based on quantitative
 put models, adjusted to take into account qualitative factors,
 including the fact that the Company&amp;#x2019;s stock was publicly
 traded and the fact that there was no contractual restriction on
 the unregistered shares being registered.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;In October 2012,
 pursuant to a previously filed Shelf Registration, which was
 declared effective by the SEC on September&amp;#xA0;24, 2012, the
 Company sold in an underwritten public offering 40,000,000 shares
 of its common stock, together with warrants to purchase up to
 30,000,000 shares of the Company&amp;#x2019;s common stock. In addition,
 the Company sold pursuant to the full exercise of an over-allotment
 option granted to the underwriters, an additional 6,000,000 shares
 of common stock, together with warrants to purchase up to an
 aggregate of 4,500,000&amp;#xA0;shares of common stock. All of the
 securities were sold together with a warrant for a combined
 purchase price of $2.00 per unit. The shares of common stock and
 warrants are immediately separable and were issued separately. Net
 proceeds from this offering were approximately $86.3 million (after
 deducting discounts and commissions to the underwriters and
 offering expenses), excluding any future proceeds from the exercise
 of the warrants. Each warrant entitles the holder to purchase 0.75
 of a share of common stock. The warrants were exercisable at $2.60
 per share and expired in October 2013. The Company received $89.7
 million in proceeds from the exercise of such warrants prior to
 their expiration.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;Concurrently
 with the underwritten public offering, the Company entered into a
 Common Stock and Warrant Purchase agreement, in which the Company
 was required to issue and sell and The Mann Group was obligated to
 purchase 40,000,000 restricted shares of the Company&amp;#x2019;s common
 stock and 40,000,000 warrants to purchase up to an aggregate of
 30,000,000 restricted shares of the Company&amp;#x2019;s common stock in
 a separate private placement. The restricted shares were sold to
 The Mann Group at $2.59 per share (the consolidated closing bid
 price of the Company&amp;#x2019;s common stock on October&amp;#xA0;17,
 2012), and the warrants were sold to The Mann Group at a purchase
 price of $0.125 for each share of the Company&amp;#x2019;s common stock
 underlying the warrants, in exchange for cancellation of
 outstanding principal under the $350.0 million amended and restated
 promissory note with The Mann Group. The restricted shares and
 warrants were sold to The Mann Group for an aggregate purchase
 price of $107.4 million. Following receipt of stockholder approval,
 in December 2012, to increase the Company&amp;#x2019;s authorized shares
 of common stock from 350,000,000 to 550,000,000, the Common Stock
 and Warrant Purchase agreement was consummated, and the shares of
 common stock and warrants were issued to The Mann Group.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;On the date the
 Common Stock and Warrant Purchase agreement was entered into with
 The Mann Group, the Company did not have a sufficient number of
 authorized, unissued and available common shares to satisfy their
 commitments under this agreement. The Company characterized the
 Common Stock and Warrant Purchase agreement as a forward contract,
 in accordance with ASC 815-40, to deliver a single unit comprising
 40,000,000&amp;#xA0;shares of restricted common stock and 40,000,000
 warrants to purchase 30,000,000 shares of restricted common stock
 that should be classified as assets or liabilities accounted for at
 fair value.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;At the time of
 issuance, the Company determined the fair value of the forward
 contract to be $28.2 million and recorded a current asset. On
 December&amp;#xA0;20, 2012, the date at which a sufficient number of
 authorized and unissued common shares became available following
 approval by the stockholders to increase its authorized shares of
 common stock, the Company re-valued the forward contract and
 recorded a fair value adjustment to &amp;#x201C;Other income
 (expense)&amp;#x201D; of $13.2 million expense. Therefore, having met
 the criteria for equity classification, the Company reclassified
 the remaining balance of the forward contract of $15.0 million to
 additional paid in capital. In addition, the Company performed an
 analysis of the warrants to determine their appropriate
 classification once the forward contract settled and concluded that
 the warrants should be classified within equity.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;The fair value
 of the forward purchase contract was highly sensitive to the
 discount applied for lack of marketability and the stock price, and
 changes in this discount and/or the stock price caused the value of
 the Forward Contract to change significantly. The value of the
 derivative instrument was calculated using a forward contract
 valuation formula in which the forward contract was estimated to be
 equal to the valuation date stock price minus the strike price
 discounted to the valuation date using a risk-free rate of 0.11% at
 issuance on October&amp;#xA0;18, 2012 and 0.00% at closing on
 December&amp;#xA0;20, 2012.&amp;#xA0;As the shares which would be received
 upon settlement are currently unregistered, the Company applied a
 discount for lack of marketability of 2.3% at October&amp;#xA0;18, 2012
 and 1.5% at December&amp;#xA0;20, 2012 to reflect this lack of
 marketability based on quantitative put models, adjusted to take
 into account qualitative factors, including the fact that the
 Company&amp;#x2019;s stock is publicly traded and the fact that there is
 no contractual restriction on the unregistered shares being
 registered.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;The Company then
 determined that upon the settlement of the forward contracts, the
 common stock and warrants represent freestanding financial
 instruments and should be initially recorded at their relative fair
 values based on the total consideration received. The total
 consideration received equaled the $107.4 million principal amount
 of indebtedness cancelled less the recorded value of the forward
 contracts on December&amp;#xA0;20, 2012, the date immediately before
 settlement.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</mnkd:CommonAndPreferredStockTextBlock>
  <mnkd:StockIssuedDuringPeriodValueWarrantExercises contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_9006_900036">27779000</mnkd:StockIssuedDuringPeriodValueWarrantExercises>
  <mnkd:WarrantsPolicyTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_A538E032-9A48-4320-BF85-7CF3E9EC7F7D_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Warrants&lt;/i&gt;
 &amp;#x2014; The Company has issued warrants to purchase shares of its
 common stock. Warrants have been accounted for within equity in
 accordance with the provisions of ASC 815-40, Contracts in an
 Entity&amp;#x2019;s Own Stock, previously EITF Issue No. 00-19:
 &lt;i&gt;Accounting for Derivative Financial Instruments Indexed to, and
 Potentially Settled in, a Company&amp;#x2019;s Own Stock&lt;/i&gt;.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</mnkd:WarrantsPolicyTextBlock>
  <mnkd:MaturityPeriodOfCashEquivalents contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_20B61921-3952-48E9-878C-33456C22754D_1_0">90 days or less at the time of  purchase</mnkd:MaturityPeriodOfCashEquivalents>
  <mnkd:BasisOfPresentationPolicyTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_5E3EF255-6263-42AB-9077-8548927C2411_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Basis of
 Presentation&amp;#xA0;&lt;/i&gt;&amp;#x2014; The
 Company&amp;#x2019;s primary activities since incorporation have been
 establishing its facilities, recruiting personnel, conducting
 research and development, business development, business and
 financial planning, and raising capital. It is costly to develop
 therapeutic products and conduct clinical studies for these
 products. As of and for the year ended December&amp;#xA0;31, 2014, the
 Company has reported an accumulated deficit of $2.5 billion and has
 reported negative cash flow from operations since
 inception.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;At
 December&amp;#xA0;31, 2014, the Company&amp;#x2019;s capital resources
 consisted of cash and cash equivalents of $120.8&amp;#xA0;million. The
 Company expects to continue to incur significant expenditures to
 support commercial manufacturing of AFREZZA and the development of
 other product candidates. In addition, the Company&amp;#x2019;s 5.75%
 Senior Convertible Notes due 2015 (the &amp;#x201C;2015 notes&amp;#x201D;) in
 the aggregate principal amount of $100.0 million have a maturity
 date of August&amp;#xA0;15, 2015, and payment on the outstanding amount
 is due in full on that date (see Note 8 &amp;#x2013; Senior convertible
 notes). The facility agreement (the &amp;#x201C;Facility
 Agreement&amp;#x201D;) with Deerfield Private Design Fund II, L.P.
 (&amp;#x201C;Deerfield Private Design Fund&amp;#x201D;) and Deerfield Private
 Design International II, L.P. (collectively,
 &amp;#x201C;Deerfield&amp;#x201D;) and the First Amendment to Facility
 Agreement and Registration Rights Agreement (the &amp;#x201C;First
 Amendment&amp;#x201D;) additional sales of an additional tranche of
 notes (the &amp;#x201C;Tranche B notes&amp;#x201D;) (see
 Note&amp;#xA0;17&amp;#xA0;&amp;#x2013; Facility Agreement) contains a financial
 covenant that requires the Company&amp;#x2019;s cash and cash
 equivalents, which include available borrowings under this Loan
 Arrangement, on the last day of each fiscal quarter to not be less
 than $25.0 million. Should the holders of the notes not elect to
 convert such notes into the Company&amp;#x2019;s common stock prior to
 their due date, the Company intends to refinance the 2015 notes or
 raise additional funds to settle the 2015 notes. Although the
 Company believes that it can refinance the 2015 notes or obtain
 alternative financing to settle the 2015 notes, inherent
 uncertainty in achieving its projected cashflows and refinancing of
 the 2015 notes raises substantial doubt about the Company&amp;#x2019;s
 ability to continue as a going concern. The financial statements do
 not include any adjustments that might result from the outcome of
 these uncertainties.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;On
 August&amp;#xA0;11, 2014, we executed a license and collaboration
 agreement (the &amp;#x201C;Sanofi License Agreement&amp;#x201D;) with
 Sanofi-Aventis Deutschland GmbH (which subsequently assigned its
 rights and obligations under the agreement to Sanofi-Aventis U.S.
 LLC (&amp;#x201C;Sanofi&amp;#x201D;)), pursuant to which Sanofi is
 responsible for global commercial, regulatory and development
 activities for AFREZZA. The Sanofi License Agreement became
 effective on September&amp;#xA0;23, 2014. We manufacture AFREZZA at our
 manufacturing facility in Danbury, Connecticut to supply
 Sanofi&amp;#x2019;s demand for the product. In addition, we and Sanofi
 are planning to collaborate to expand manufacturing capacity to
 meet global demand as necessary.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Under the
 Sanofi License Agreement, Sanofi paid us an up-front cash payment
 of $150.0 million in the third quarter of 2014. As of
 December&amp;#xA0;31, 2014, we have earned and recorded as Receivables
 from collaboration an additional $50.0 million in milestone
 payments in connection with the satisfaction of specified
 manufacturing milestones. Such payments were received subsequent to
 year end. We are also eligible to receive up to $725.0 million in
 additional milestone payments under the Sanofi License Agreement if
 certain development, regulatory and sales milestones are achieved.
 In addition, worldwide profits and losses, which are determined
 based on the difference between the net sales of AFREZZA and the
 costs and expenses incurred by us and Sanofi that are specifically
 attributable or related to the development, regulatory filings,
 manufacturing, or commercialization of AFREZZA, will be shared 65%
 by Sanofi and 35% by the us. As a result of the loss share
 provision, and because we do not have the ability to estimate the
 amount of costs that would potentially be incurred related to the
 Sanofi License Agreement, the amount of up-front cash payment or
 milestone payments that could be recognized as revenue is not fixed
 or determinable. In connection with the Sanofi License Agreement,
 an affiliate of Sanofi provided us with a secured loan facility
 (the &amp;#x201C;Sanofi Loan Facility&amp;#x201D;) of up to $175.0 million to
 fund our share of net losses under the Sanofi License
 Agreement.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Additional
 funding sources that are, or in certain circumstances may be
 available to the Company, include approximately $30.1&amp;#xA0;million
 principal amount of available borrowings under its loan arrangement
 ( the &amp;#x201C;Loan Arrangement&amp;#x201D;) with The Mann Group LLC
 (&amp;#x201C;The Mann Group&amp;#x201D;) (see note 7 &amp;#x2013; Related-party
 arrangements), potential proceeds from the exercise of warrants
 issued in its February 2012 public offering of approximately $19.5
 million, and the Company&amp;#x2019;s at-the-market issuance sales
 agreements which allow the Company to sell up to $50.0 million in
 common stock. The Company cannot provide assurances that its plans
 will not change or that changed circumstances will not result in
 the depletion of its capital resources more rapidly than it
 currently anticipates. The Company may need to raise additional
 capital, whether through a sale of equity or debt securities, a
 strategic business collaboration with a pharmaceutical company, the
 establishment of other funding facilities, licensing arrangements,
 asset sales or other means, in order to continue the development
 and commercialization of AFREZZA and other product candidates and
 to support its other ongoing activities. However, the Company
 cannot provide assurances that such additional capital will be
 available on acceptable terms or at all.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</mnkd:BasisOfPresentationPolicyTextBlock>
  <mnkd:ClinicalTrialExpensePolicyTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_B9C37672-E715-4098-9D50-E2F63221FABC_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Clinical
 Trial Expenses&lt;/i&gt; &amp;#x2014; Clinical trial expenses, which are
 reflected in research and development expenses in the accompanying
 statements of operations, result from obligations under contracts
 with vendors, consultants, and clinical site agreements in
 connection with conducting clinical trials. The financial terms of
 these contracts are subject to negotiations which vary from
 contract to contract and may result in payment flows that do not
 match the periods over which materials or services are provided to
 the Company under such contracts. The appropriate level of trial
 expenses are reflected in the Company&amp;#x2019;s financial statements
 by matching period expenses with period services and efforts
 expended. These expenses are recorded according to the progress of
 the trial as measured by patient progression and the timing of
 various aspects of the trial. Clinical trial accrual estimates are
 determined through discussions with internal clinical personnel and
 outside service providers as to the progress or state of completion
 of trials, or the services completed. Service provider status is
 then compared to the contractually obligated fee to be paid for
 such services. During the course of a clinical trial, the Company
 may adjust the rate of clinical expense recognized if actual
 results differ from management&amp;#x2019;s estimates.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</mnkd:ClinicalTrialExpensePolicyTextBlock>
  <mnkd:IncomeTaxExpenseBenefitNet contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_FF1422D9-4F07-4EC2-A2EF-D2BD529666C7_1_11">0</mnkd:IncomeTaxExpenseBenefitNet>
  <mnkd:DeferredTaxAssetIncreaseDecreaseInEquity contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-5" id="id_5851737_C2465539-73F5-47CC-8023-7F234090CFB5_1_0">18300000</mnkd:DeferredTaxAssetIncreaseDecreaseInEquity>
  <mnkd:ValueOfRestrictedStockUnitsVested contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-5" id="id_5851737_031A067D-0E9E-4A90-9AB4-0CBCCE394F5F_1_2">12500000</mnkd:ValueOfRestrictedStockUnitsVested>
  <mnkd:BusinessPolicyTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_C60C463D-A471-4546-BFE2-815278E6C65E_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Business&lt;/i&gt;
 &amp;#x2014; MannKind Corporation and subsidiaries (the
 &amp;#x201C;Company&amp;#x201D;) is a biopharmaceutical company focused on
 the discovery and development of therapeutic products for diseases
 such as diabetes. Our only approved product, AFREZZA, (insulin
 human [rDNA origin]) inhalation powder , is a rapid-acting inhaled
 insulin that was approved by the U.S. Food and Drug Administration
 (the &amp;#x201C;FDA&amp;#x201D;) on June&amp;#xA0;27, 2014 to improve glycemic
 control in adult patients with diabetes.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</mnkd:BusinessPolicyTextBlock>
  <mnkd:RecentlyIssuedAccountingStandardsPolicyTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_7BA676E1-6356-4C81-8F9F-FC8E7B7433BE_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Recently
 Issued Accounting Standards&lt;/i&gt; &amp;#x2014; From time to time, new
 accounting pronouncements are issued by the Financial Accounting
 Standards Board (FASB) or other standard setting bodies that are
 adopted by the Company as of the specified effective date. Unless
 otherwise discussed, we believe that the impact of recently issued
 standards that are not yet effective will not have a material
 impact on our financial position or results of operations upon
 adoption.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In
 May&amp;#xA0;2014, a new standard was issued related to revenue
 recognition, which requires an entity to recognize the amount of
 revenue to which it expects to be entitled for the transfer of
 promised goods or services to customers. The new standard will
 replace most of the existing revenue recognition standards in U.S.
 GAAP when it becomes effective on January&amp;#xA0;1, 2017. Early
 adoption is not permitted. The new standard allows for either
 &amp;#x201C;full retrospective&amp;#x201D; adoption, whereby the new standard
 is applied to each prior reporting period presented or
 &amp;#x201C;modified retrospective&amp;#x201D; adoption, whereby the new
 standard is only applied to the most current period presented with
 the cumulative effect of the change recognized at the date of the
 initial application. The Company is assessing the potential impact
 of the new standard on its consolidated statements of financial
 position and results of operations and comprehensive income (loss)
 and has not yet selected a transition method.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In June 2014,
 the FASB issued ASU No.&amp;#xA0;2014-10, Development Stage Entities
 (Topic 915): Elimination of Certain Financial Reporting
 Requirements, Including an Amendment to Variable Interest Entities
 Guidance in Topic 810, Consolidation.&amp;#xA0;The amendments in this
 ASU remove all incremental financial reporting requirements from
 GAAP for development stage entities, including the removal of Topic
 915, Development Stage Entities,&amp;#xA0;from the FASB Accounting
 Standards Codification. In addition, the ASU: (a)&amp;#xA0;adds an
 example disclosure in Topic 275, Risks and Uncertainties,&amp;#xA0;to
 illustrate one way that an entity that has not begun planned
 principal operations could provide information about the risks and
 uncertainties related to the company&amp;#x2019;s current activities;
 and (b)&amp;#xA0;removes an exception provided to development stage
 entities in Topic 810, Consolidation,&amp;#xA0;for determining whether
 an entity is a variable interest entity. The presentation and
 disclosure requirements in Topic 915 will no longer be required for
 the first annual period beginning after December&amp;#xA0;15, 2014. The
 revised consolidation standards are effective one year later, in
 annual periods beginning after December&amp;#xA0;15, 2015. Early
 adoption is permitted. The Company early adopted ASU 2014-10
 resulting in the elimination of certain presentation and disclosure
 requirements previously required by topic 915.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
 August&amp;#xA0;27, 2014, the FASB issued ASU 2014-15, which provides
 guidance on determining when and how reporting entities must
 disclose going-concern uncertainties in their financial statements.
 The new standard requires management to perform interim and annual
 assessments of an entity&amp;#x2019;s ability to continue as a going
 concern within one year of the date of issuance of the
 entity&amp;#x2019;s financial statements (or within one year after the
 date on which the financial statements are available to be issued,
 when applicable). Further, an entity must provide certain
 disclosures if there is &amp;#x201C;substantial doubt about the
 entity&amp;#x2019;s ability to continue as a going concern.&amp;#x201D; The
 ASU is effective for annual periods ending after December&amp;#xA0;15,
 2016, and interim periods thereafter; early adoption is permitted.
 The Company is evaluating the impact the adoption of ASU 2014-15
 will have on its consolidated financial statements.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</mnkd:RecentlyIssuedAccountingStandardsPolicyTextBlock>
  <mnkd:LongTermPurchaseCommitmentExpirationDate contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_DAE49233-92E4-4399-A547-15E9B28B8350_1_0">2019-12-31</mnkd:LongTermPurchaseCommitmentExpirationDate>
  <mnkd:AmortizationPeriodOfLeaseHoldImprovements contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_8D543AAB-2B6D-4CFF-AB28-408B0769C798_1_0">P4Y</mnkd:AmortizationPeriodOfLeaseHoldImprovements>
  <mnkd:PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_ABB94EE2-53AB-4BEF-B9ED-546B541BF4BC_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Prepaid
 expenses and other current assets&lt;/i&gt;&amp;#xA0;&amp;#x2014; Prepaid expenses and
 other current assets primarily consist of prepaid expenses for
 goods and services to be received. As of December&amp;#xA0;31, 2014,
 prepaid and other current assets had a balance of $20.2 million,
 mainly comprised of a $15.0 million prepayment for 2015 quantities
 of insulin, and prepaid insurance.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;On
 July&amp;#xA0;31, 2014, the Company entered into a Supply Agreement
 (the &amp;#x201C;Supply Agreement&amp;#x201D;) with Amphastar France
 Pharmaceuticals S.A.S., a French corporation
 (&amp;#x201C;Amphastar&amp;#x201D;), pursuant to which Amphastar will
 manufacture for and supply to the Company certain quantities of
 recombinant human insulin for use in AFREZZA. Under the terms of
 the Supply Agreement, Amphastar will be responsible for
 manufacturing the insulin in accordance with the Company&amp;#x2019;s
 specifications and agreed-upon quality standards. The Company has
 agreed to purchase annual minimum quantities of insulin under the
 Supply Agreement of an aggregate total of approximately
 &amp;#x20AC;120.1&amp;#xA0;million for calendar years 2015 through 2019. The
 remaining annual minimum quantities will be
 &amp;#x20AC;23.2&amp;#xA0;million for 2015 and &amp;#x20AC;23.3&amp;#xA0;million for
 the years ended December&amp;#xA0;31, 2016 through 2019. The Company
 may request to purchase additional quantities of insulin over such
 annual minimum quantities. As part of the Supply Agreement, the
 Company paid a $15.0 million deposit to Amphastar as prepayment for
 2015 quantities of insulin.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Unless
 earlier terminated, the term of the Insulin Supply Agreement
 expires on December&amp;#xA0;31, 2019 and can be renewed for
 additional, successive two year terms upon 12 months&amp;#x2019; written
 notice given prior to the end of the initial term or any additional
 two year term. The Company and Amphastar each have normal and
 customary termination rights, including termination for material
 breach that is not cured within a specific time frame or in the
 event of liquidation, bankruptcy or insolvency of the other party.
 In addition, the Company may terminate the Supply Agreement upon
 two years&amp;#x2019; prior written notice to Amphastar without cause or
 upon 30 days&amp;#x2019; prior written notice to Amphastar if a
 controlling regulatory authority withdraws approval for AFREZZA,
 provided, however, in the event of a termination pursuant to either
 of the latter two scenarios, the provisions of the Supply Agreement
 require the Company to pay the full amount of all unpaid purchase
 commitments due over the initial term within 60 calendar days of
 the effective date of such termination.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</mnkd:PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock>
  <mnkd:LongtermPurchaseCommitmentRenewalTimePeriod contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_DAE49233-92E4-4399-A547-15E9B28B8350_1_1">P2Y</mnkd:LongtermPurchaseCommitmentRenewalTimePeriod>
  <mnkd:ScheduleOfShareBasedCompensationActivityByCategoryTableTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_EF9999A6-4013-4ABC-BEFA-B4C1F535CFBB_1_0">&lt;div&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;Total
 stock-based compensation expense recognized in the accompanying
 statements of operations is included in the following categories
 (in thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="font-size:6px;margin-top:0px;margin-bottom:0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
 &lt;tr&gt;
 &lt;td width="76%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="10" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;Year Ended
 December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Research and
 development&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;22,357&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;20,409&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;6,167&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;General and
 administrative&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;26,265&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;24,777&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;7,125&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Total&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;48,622&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;45,186&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;13,292&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</mnkd:ScheduleOfShareBasedCompensationActivityByCategoryTableTextBlock>
  <mnkd:StockOptionsGrantedVestingRate contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="pure" decimals="2" id="id_5851737_086354D1-E64C-4DDB-8AF0-2517BB863C11_1_0">0.25</mnkd:StockOptionsGrantedVestingRate>
  <mnkd:CommitmentAssetPolicyTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_DD143094-2B4B-4218-9971-DF0459C56452_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Commitment
 Asset&lt;/i&gt; &amp;#x2014; In connection with the issuance of the Tranche 1
 notes and the Milestone Rights, the Company recorded a commitment
 asset (the &amp;#x201C;Commitment Asset&amp;#x201D;) on July&amp;#xA0;1,
 2013.&amp;#xA0;As a result of the First Amendment, the Company recorded
 an additional Tranche B notes commitment asset (the &amp;#x201C;Tranche
 B Commitment Asset&amp;#x201D;) with an estimated fair value equal to
 $2.9 million. The Commitment Asset is derecognized and recorded as
 a debt discount on the 2019 notes and Tranche B notes, when issued
 and amortized, using the effective interest rate method over the
 life of the respective notes. Prior to derecognition occurring, the
 Company monitors the Commitment Asset on an ongoing basis to
 determine whether an impairment indicator is present that would
 result in a full or partial write down of the Commitment Asset as a
 result of events that may lead to the subsequent tranches of notes
 not being issued. At December&amp;#xA0;31, 2014, Deerfield had
 purchased all four tranches of 2019 notes in the aggregate
 principal amount of $160.0 million, purchased $20.0 million
 aggregate principal amount of Tranche B notes in accordance with
 the provisions of the Facility Agreement, and wrote off the
 remaining portion of the Tranche B Commitment Asset. At
 December&amp;#xA0;31, 2014 the carrying value of the Commitment Assets
 was zero.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</mnkd:CommitmentAssetPolicyTextBlock>
  <mnkd:PercentageOfCreditExchangeReceivable contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="pure" decimals="2" id="id_5851737_56405426-3A5A-4B79-B9D0-46D42C81835A_1_0">0.65</mnkd:PercentageOfCreditExchangeReceivable>
  <mnkd:StateResearchAndDevelopmentCreditExchangeReceivableTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_6EBDF0C4-D28C-4EA4-8771-09E2EC7A6F98_1_0">&lt;div&gt;
 &lt;p style="margin-top:0px;margin-bottom:0px"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;3. State research and
 development credit exchange receivable&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;The State of
 Connecticut provides certain companies with the opportunity to
 exchange certain research and development income tax credit
 carryforwards for cash in exchange for forgoing the carryforward of
 the research and development income tax credits. The program
 provides for an exchange of research and development income tax
 credits for cash equal to 65% of the value of corporation tax
 credit available for exchange. Estimated amounts receivable under
 the program are recorded as a reduction of research and development
 expenses. During the years ended December&amp;#xA0;31, 2014, 2013 and
 2012, research and development expenses were offset by $816,000,
 $282,000, and $289,000, respectively.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</mnkd:StateResearchAndDevelopmentCreditExchangeReceivableTextBlock>
  <mnkd:StateResearchAndDevelopmentCreditExchangeReceivable contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_1_14">-13000</mnkd:StateResearchAndDevelopmentCreditExchangeReceivable>
  <mnkd:GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_1_5">-97000</mnkd:GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment>
  <mnkd:StockIssuedDuringPeriodValueForDebtExchange contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_9006_900038">93501000</mnkd:StockIssuedDuringPeriodValueForDebtExchange>
  <mnkd:ForwardContractsPolicyTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_5BC61B2D-A341-4C07-9776-890BAC23DF93_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Forward
 Contracts&lt;/i&gt;&amp;#xA0;&amp;#x2014; The Company has entered into agreements
 with The Mann Group whereby the Company agreed to sell and The Mann
 Group agreed to purchase common stock and/or warrants. These
 agreements have been accounted for as forward contracts, having met
 the definition of derivative instruments in accordance with the
 provisions of ASC 815&amp;#xA0;&lt;i&gt;Derivatives and Hedging&lt;/i&gt;. The
 Company determines the fair value of the forward contract upon its
 issuance, records fair value adjustments of the forward contract to
 Other income (expense) during the reporting period and through the
 settlement of the forward contract, and reclassifies the forward
 contract to equity upon settlement of the forward contract. In the
 years ended December&amp;#xA0;31, 2014 and 2013, there were no forward
 purchase contracts.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</mnkd:ForwardContractsPolicyTextBlock>
  <mnkd:EffectiveIncomeTaxRateReconciliationPermanentItems contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="pure" decimals="3" id="id_5851737_B6F3E2C8-A6E4-4D0D-8044-F1D8F2BFBEF5_1_2">0.009</mnkd:EffectiveIncomeTaxRateReconciliationPermanentItems>
  <mnkd:MilestonePayments contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_1_35">-3150000</mnkd:MilestonePayments>
  <mnkd:PaymentsForUseOfAircrafts contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="0" id="id_5851737_EE6F1B00-1AF9-470E-B601-EE07C528EEDD_1_0">79000</mnkd:PaymentsForUseOfAircrafts>
  <mnkd:ProceedsFromIssuanceOfCommonStockAndWarrantsNet contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_1_29">40120000</mnkd:ProceedsFromIssuanceOfCommonStockAndWarrantsNet>
  <mnkd:WriteOffOfDerivativeLiability contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_1_7">363000</mnkd:WriteOffOfDerivativeLiability>
  <mnkd:SaleOfIntellectualPropertyPolicyTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_D2D7715F-2FF4-4ED9-8C51-236B5D36B288_1_0">&lt;div&gt;&lt;em&gt;Sale of intellectual property&lt;/em&gt;&amp;#xA0;&amp;#x2014;
 On July&amp;#xA0;18, 2014, the Company entered into an assignment
 agreement with a third party whereby the third party acquired all
 proprietary rights, technology and know-how that related to a small
 molecule inhibitor compound and all pre-clinical data and results
 related thereto. Under the terms of the assignment agreement, the
 Company received total consideration of $9.3 million and incurred
 $1.4 million in expense for a net amount of $7.9 million recorded
 as other income.&lt;/div&gt;</mnkd:SaleOfIntellectualPropertyPolicyTextBlock>
  <mnkd:LicenseCollaborationAndSupplyAgreementsPolicyTextBlock contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0" id="id_5851737_E8A0ECE9-89A4-4D08-8F5F-7E9BA4CF4064_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;License
 and Collaboration and Supply agreements&lt;/i&gt;&amp;#xA0;&amp;#x2014; Pursuant to the Sanofi
 License Agreement and the Sanofi Supply Agreement, we granted to
 Sanofi exclusive, worldwide licenses to certain of our patents,
 trademarks and know-how for the development and commercialization
 of AFREZZA and retained the right to be the exclusive manufacturer
 and supplier of AFREZZA until specified conditions are met upon
 which a portion of the manufacturing activities may be assumed by
 Sanofi. The terms of the Sanofi License Agreement provide for
 consideration to us in the form of a non-refundable up-front
 payment, product sales, manufacturing, regulatory and sales
 milestone payments and profit and loss sharing.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6px &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;We analyze
 consideration received under the provisions of ASC 605, Revenue
 Recognition, to determine whether the consideration, or a portion
 thereof, could be recognized as revenue. ASC 605 provides that
 revenue is recognized when there is persuasive evidence that an
 arrangement exists, delivery has occurred or services have been
 rendered, the price is fixed or determinable and collection is
 reasonably assured.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;In
 arrangements involving the delivery of more than one element, each
 required deliverable is evaluated to determine whether it qualifies
 as a separate unit of accounting. This determination is generally
 based on whether the deliverable has &amp;#x201C;stand-alone
 value&amp;#x201D; to the customer. The arrangement&amp;#x2019;s consideration
 that is fixed and determinable is then allocated to each separate
 unit of accounting based on the relative selling price of each
 deliverable. The estimated selling price of each deliverable is
 determined using the following hierarchy of values:
 (i)&amp;#xA0;vendor-specific objective evidence of fair value,
 (ii)&amp;#xA0;third-party evidence of selling price and (iii)&amp;#xA0;best
 estimate of selling price (BESP). The BESP reflects our best
 estimate of what the selling price would be if the deliverable was
 regularly sold by us on a stand-alone basis. In general, the
 consideration allocated to each unit of accounting is recognized as
 the related goods or services are delivered, limited to the
 consideration that is not contingent upon future
 deliverables.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The
 assessment of multiple element arrangements requires judgment in
 order to determine the appropriate units of accounting and the
 points in time that, or periods over which, revenue should be
 recognized. Given that, as of December&amp;#xA0;31, 2014, we did not
 have the ability to estimate the amount of costs that would
 potentially be incurred under the loss share provision related to
 the Sanofi License Agreement and the Sanofi Supply Agreement, we
 believe the fixed and determinable fee requirement for revenue
 recognition was not met.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</mnkd:LicenseCollaborationAndSupplyAgreementsPolicyTextBlock>
  <mnkd:IncreaseDecreaseInLoanCommitmentAsset contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_1002086x925878" unitRef="iso4217_USD" decimals="-5" id="id_5851737_975B510B-EA52-4383-832A-70184A02A19C_1002_2">-6300000</mnkd:IncreaseDecreaseInLoanCommitmentAsset>
  <mnkd:IncreaseDecreaseInLoanCommitmentAsset contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_1002086x999842" unitRef="iso4217_USD" decimals="-5" id="id_5851737_975B510B-EA52-4383-832A-70184A02A19C_2002_1">2900000</mnkd:IncreaseDecreaseInLoanCommitmentAsset>
  <us-gaap:FairValueInputsDiscountRate contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_1033890x1060390_900547x907189_904933x910565" unitRef="pure" decimals="3" id="id_5851737_58DFDE34-36ED-4806-A925-893A2876207F_1001_0">0.150</us-gaap:FairValueInputsDiscountRate>
  <mnkd:DebtExpense contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_1036892x937198_910720x1029473_912827x1060185" unitRef="iso4217_USD" decimals="-5" id="id_5851737_6180B978-0728-4896-9559-A1ED213196A8_1001_3">6800000</mnkd:DebtExpense>
  <us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_1060593x1082329_911417x1029301" unitRef="iso4217_USD" decimals="-5" id="id_5851737_CE906C8B-48B8-40FE-95E9-87C0AE487D8B_1003_7">50000000</us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_900196x900353" unitRef="shares" decimals="INF" id="id_5851737_127E2ACD-5D85-413D-A09E-8F8110ADED0E_1001_1">17323080</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_900196x902719" unitRef="shares" decimals="INF" id="id_5851737_127E2ACD-5D85-413D-A09E-8F8110ADED0E_2001_3">2610720</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_900196x904951" unitRef="shares" decimals="INF" id="id_5851737_127E2ACD-5D85-413D-A09E-8F8110ADED0E_3001_2">9987876</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_900196x907138" unitRef="shares" decimals="INF" id="id_5851737_127E2ACD-5D85-413D-A09E-8F8110ADED0E_4001_0">21541664</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:FairValueInputsDiscountRate contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_900547x907189_904933x910565_907178x995537" unitRef="pure" decimals="3" id="id_5851737_EAE706B4-C3D8-4759-89E5-C051BB1712C3_1001_0">0.120</us-gaap:FairValueInputsDiscountRate>
  <us-gaap:FairValueInputsDiscountRate contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_900547x907189_904933x910565_910720x1029473" unitRef="pure" decimals="3" id="id_5851737_3AA3F10F-E8A1-4988-8AD1-6981226115CA_4001_0">0.124</us-gaap:FairValueInputsDiscountRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_901032x907457" id="id_5851737_086354D1-E64C-4DDB-8AF0-2517BB863C11_1001_7">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_901032x907457" id="id_5851737_4891FC0B-C69B-476B-9ABC-3A53D8C25AD9_1001_3">P6Y1M2D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <mnkd:ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformancePeriod contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_901032x907457" id="id_5851737_086354D1-E64C-4DDB-8AF0-2517BB863C11_1001_5">P96M</mnkd:ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformancePeriod>
  <mnkd:RelatedPartyTransactionDebtInstrumentPrepayment contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_901032x907457_906053x953384_910940x910864" unitRef="iso4217_USD" decimals="-5" id="id_5851737_D96BB647-38A8-43C1-802E-855461D66638_1001_4">200000000</mnkd:RelatedPartyTransactionDebtInstrumentPrepayment>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_901032x907457_907645x901833" id="id_5851737_BFF18F52-0532-4905-AB98-720A834D2E40_1001_3">P40Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_901032x907457_907645x905205" id="id_5851737_BFF18F52-0532-4905-AB98-720A834D2E40_2001_1">P40Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_901032x907457_907645x907438" id="id_5851737_BFF18F52-0532-4905-AB98-720A834D2E40_3001_5">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_901032x907457_907645x948369" id="id_5851737_BFF18F52-0532-4905-AB98-720A834D2E40_4001_7">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_901032x909105" id="id_5851737_4891FC0B-C69B-476B-9ABC-3A53D8C25AD9_2001_2">P5Y9M7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <mnkd:ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformancePeriod contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_901032x909105" id="id_5851737_086354D1-E64C-4DDB-8AF0-2517BB863C11_2001_4">P11M</mnkd:ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformancePeriod>
  <mnkd:NumberOfMonthsAdvancesOutstanding contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_901032x909105_906053x953384_910940x910864" id="id_5851737_D96BB647-38A8-43C1-802E-855461D66638_2001_5">P12M</mnkd:NumberOfMonthsAdvancesOutstanding>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_901032x909105_907645x901833" id="id_5851737_BFF18F52-0532-4905-AB98-720A834D2E40_5001_2">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_901032x909105_907645x905205" id="id_5851737_BFF18F52-0532-4905-AB98-720A834D2E40_6001_0">P39Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_901032x909105_907645x907438" id="id_5851737_BFF18F52-0532-4905-AB98-720A834D2E40_7001_4">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_901032x909105_907645x948369" id="id_5851737_BFF18F52-0532-4905-AB98-720A834D2E40_8001_6">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_901822x902719" id="id_5851737_086354D1-E64C-4DDB-8AF0-2517BB863C11_3001_3">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_901822x907138" id="id_5851737_086354D1-E64C-4DDB-8AF0-2517BB863C11_4001_2">P36M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_904892x1063447" unitRef="iso4217_USD" decimals="-3" id="id_5851737_57D2ECBE-392C-4E6E-B247-92B8CD9C9C0C_1001_0">48622000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_905668x928369" unitRef="iso4217_USD" decimals="-3" id="id_5851737_110C905F-68E2-4183-AA9B-0466B600C0DE_1001_1">26265000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_905668x974237" unitRef="iso4217_USD" decimals="-3" id="id_5851737_110C905F-68E2-4183-AA9B-0466B600C0DE_2001_0">22357000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:RecognitionOfDeferredRevenue contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_906053x1068897_911417x1029301" unitRef="iso4217_USD" decimals="INF" id="id_5851737_03AE6AA1-363E-4109-BC0D-C39F23C11FFD_1001_0">0</us-gaap:RecognitionOfDeferredRevenue>
  <mnkd:LossSharingAgreementAmount contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_906053x1068897_911417x1029301" unitRef="iso4217_USD" decimals="-5" id="id_5851737_03AE6AA1-363E-4109-BC0D-C39F23C11FFD_1001_4">3000000</mnkd:LossSharingAgreementAmount>
  <mnkd:ProfitLossSharingAgreementAllocationPercentage contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_906053x1068897_911417x1029301" unitRef="pure" decimals="2" id="id_5851737_26292A2B-AB52-412F-9BF3-C6A1D3BB3506_2002_3">0.65</mnkd:ProfitLossSharingAgreementAllocationPercentage>
  <us-gaap:DebtInstrumentDescriptionOfVariableRateBasis contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_906053x1069222_910940x1004388" id="id_5851737_D96BB647-38A8-43C1-802E-855461D66638_3001_9">The interest rate will increase to the one-year LIBOR rate  calculated on the date of the initial advance or in effect on the date of  default, whichever is greater, plus 5% per annum.</us-gaap:DebtInstrumentDescriptionOfVariableRateBasis>
  <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_906053x1069222_910940x1004388_913052x909043" unitRef="pure" decimals="2" id="id_5851737_D96BB647-38A8-43C1-802E-855461D66638_4001_8">0.05</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
  <mnkd:RelatedPartyTransactionPrepaymentPeriod contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_906053x953384_910940x910864" id="id_5851737_D96BB647-38A8-43C1-802E-855461D66638_5001_6">P90D</mnkd:RelatedPartyTransactionPrepaymentPeriod>
  <mnkd:AvailableLoanBalanceCancelled contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_906053x953384_910940x910864" unitRef="iso4217_USD" decimals="-5" id="id_5851737_D96BB647-38A8-43C1-802E-855461D66638_5001_7">105000000</mnkd:AvailableLoanBalanceCancelled>
  <mnkd:PaymentForContingentLiabilities contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_906969x1060390_910720x1029473_912827x1060185" unitRef="iso4217_USD" decimals="-5" id="id_5851737_A9A14771-211A-486F-92BA-41AF20629C04_1001_1">5000000</mnkd:PaymentForContingentLiabilities>
  <us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_906969x1077046_910720x1029473_912827x1060185" unitRef="iso4217_USD" decimals="-5" id="id_5851737_0BF15F05-6701-40FB-AE4A-793DCF13F994_1001_10">20000000</us-gaap:DebtConversionConvertedInstrumentAmount1>
  <mnkd:DebtExpense contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_906969x1077046_910720x1029473_912827x1060185" unitRef="iso4217_USD" decimals="-5" id="id_5851737_0BF15F05-6701-40FB-AE4A-793DCF13F994_1001_6">1200000</mnkd:DebtExpense>
  <mnkd:DebtExpense contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_906969x1077048_910720x1029473_912827x1060185" unitRef="iso4217_USD" decimals="-5" id="id_5851737_0BF15F05-6701-40FB-AE4A-793DCF13F994_2001_7">3000000</mnkd:DebtExpense>
  <us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_906969x1077049_910720x1029473_912827x1060185" unitRef="iso4217_USD" decimals="-5" id="id_5851737_0BF15F05-6701-40FB-AE4A-793DCF13F994_3001_9">40000000</us-gaap:DebtConversionConvertedInstrumentAmount1>
  <mnkd:DebtExpense contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_906969x1077049_910720x1029473_912827x1060185" unitRef="iso4217_USD" decimals="-5" id="id_5851737_0BF15F05-6701-40FB-AE4A-793DCF13F994_3001_8">2200000</mnkd:DebtExpense>
  <us-gaap:ProceedsFromIssuanceOfDebt contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_906969x950672" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_1001_33">20000000</us-gaap:ProceedsFromIssuanceOfDebt>
  <mnkd:WriteOffOfCommitmentAsset contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_906969x950672" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_1001_8">1753000</mnkd:WriteOffOfCommitmentAsset>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_907645x1039325" id="id_5851737_BFF18F52-0532-4905-AB98-720A834D2E40_9001_8">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_907645x908991" id="id_5851737_BFF18F52-0532-4905-AB98-720A834D2E40_10001_9">P4Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_907910x1042177" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_9005_800043">-198382000</us-gaap:NetIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_907910x901931" unitRef="shares" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_9001_400039">324000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
  <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_907910x901931" unitRef="shares" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_9001_400034">3996000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_907910x901931" unitRef="shares" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_9001_400033">3251000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_907910x901931" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_9001_500034">38000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_907910x901931" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_9001_500039">2000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_907910x901931" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_9001_500033">35000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <mnkd:StockIssuedDuringPeriodSharesWarrantExercises contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_907910x901931" unitRef="shares" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_9001_400035">11575000</mnkd:StockIssuedDuringPeriodSharesWarrantExercises>
  <mnkd:StockIssuedDuringPeriodSharesForDebtExchange contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_907910x901931" unitRef="shares" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_9001_400037">17521000</mnkd:StockIssuedDuringPeriodSharesForDebtExchange>
  <mnkd:StockIssuedDuringPeriodValueWarrantExercises contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_907910x901931" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_9001_500036">115000</mnkd:StockIssuedDuringPeriodValueWarrantExercises>
  <mnkd:StockIssuedDuringPeriodValueForDebtExchange contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_907910x901931" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_9001_500038">174000</mnkd:StockIssuedDuringPeriodValueForDebtExchange>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_907910x905139" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_9003_600034">-26946000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_907910x905139" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_9003_600040">22962000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_907910x905139" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_9003_600039">1361000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_907910x905139" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_9003_600033">10943000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_907910x905139" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_9003_600041">25660000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <mnkd:StockIssuedDuringPeriodValueWarrantExercises contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_907910x905139" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_9003_600036">27664000</mnkd:StockIssuedDuringPeriodValueWarrantExercises>
  <mnkd:StockIssuedDuringPeriodValueForDebtExchange contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_907910x905139" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_9003_600038">93327000</mnkd:StockIssuedDuringPeriodValueForDebtExchange>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_907910x910799" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_9004_700042">-10000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
  <us-gaap:FairValueInputsComparabilityAdjustments contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_910288x1000328" unitRef="pure" decimals="3" id="id_5851737_AD5B6C9F-D98C-4C0B-B8C7-35AF696E4FE9_1001_2">0.008</us-gaap:FairValueInputsComparabilityAdjustments>
  <us-gaap:FairValueInputsComparabilityAdjustments contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_910288x1047918" unitRef="pure" decimals="3" id="id_5851737_AD5B6C9F-D98C-4C0B-B8C7-35AF696E4FE9_2001_4">0.001</us-gaap:FairValueInputsComparabilityAdjustments>
  <us-gaap:FairValueInputsComparabilityAdjustments contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_910288x998075" unitRef="pure" decimals="3" id="id_5851737_AD5B6C9F-D98C-4C0B-B8C7-35AF696E4FE9_3001_3">0.000</us-gaap:FairValueInputsComparabilityAdjustments>
  <us-gaap:DebtConversionConvertedInstrumentSharesIssued1 contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_910720x1029473_912827x1060185" unitRef="shares" decimals="INF" id="id_5851737_0BF15F05-6701-40FB-AE4A-793DCF13F994_4001_4">17323080</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
  <us-gaap:LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_910720x1029473_912827x1060185" unitRef="iso4217_USD" decimals="-5" id="id_5851737_6180B978-0728-4896-9559-A1ED213196A8_2001_0">180000000</us-gaap:LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod>
  <mnkd:DebtExpense contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_910720x1029473_912827x1060185" unitRef="iso4217_USD" decimals="-5" id="id_5851737_0BF15F05-6701-40FB-AE4A-793DCF13F994_4001_5">6400000</mnkd:DebtExpense>
  <us-gaap:DebtInstrumentMaturityDate contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_910720x966327" id="id_5851737_93BF2236-34CE-4342-B4E7-933F20C3A092_1001_3">2015-08-15</us-gaap:DebtInstrumentMaturityDate>
  <mnkd:ProfitLossSharingAgreementAllocationPercentage contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_911417x1029301" unitRef="pure" decimals="2" id="id_5851737_26292A2B-AB52-412F-9BF3-C6A1D3BB3506_3002_4">0.35</mnkd:ProfitLossSharingAgreementAllocationPercentage>
  <mnkd:NetOperatingLossCarryforwardsBeginsToExpire contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_912160x907907" id="id_5851737_9AC30204-7B96-4D29-9AF1-1B18DEEF98BC_1001_3">2015</mnkd:NetOperatingLossCarryforwardsBeginsToExpire>
  <mnkd:NetOperatingLossCarryforwardsBeginsToExpire contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_912160x912202" id="id_5851737_9AC30204-7B96-4D29-9AF1-1B18DEEF98BC_2001_2">2018</mnkd:NetOperatingLossCarryforwardsBeginsToExpire>
  <mnkd:ResearchAndDevelopmentCreditsBeginToExpire contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_912160x912202" id="id_5851737_9AC30204-7B96-4D29-9AF1-1B18DEEF98BC_2001_8">2024</mnkd:ResearchAndDevelopmentCreditsBeginToExpire>
  <us-gaap:AmortizationOfFinancingCosts contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_912827x1060185" unitRef="iso4217_USD" decimals="-3" id="id_5851737_D65369DE-2D89-43B7-9DB3-60A1295CEEA4_1001_0">326000</us-gaap:AmortizationOfFinancingCosts>
  <us-gaap:AmortizationOfDebtDiscountPremium contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_912827x1060185" unitRef="iso4217_USD" decimals="-3" id="id_5851737_D65369DE-2D89-43B7-9DB3-60A1295CEEA4_1001_1">7550000</us-gaap:AmortizationOfDebtDiscountPremium>
  <mnkd:LegalSettlementsAndCommitments contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_912827x1060185" unitRef="iso4217_USD" decimals="0" id="id_5851737_AD5B6C9F-D98C-4C0B-B8C7-35AF696E4FE9_4001_1">100000</mnkd:LegalSettlementsAndCommitments>
  <us-gaap:ProceedsFromWarrantExercises contextRef="eol_PE126000--1410-K0014_STD_365_20141231_0_937864x1068343" unitRef="iso4217_USD" decimals="-5" id="id_5851737_429B49A9-C033-44B1-988D-CF2707D8A469_3003_13">27800000</us-gaap:ProceedsFromWarrantExercises>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="pure" decimals="4" id="id_5851737_4891FC0B-C69B-476B-9ABC-3A53D8C25AD9_3_4">0.7000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_5851737_9C0D5787-E738-4506-A65E-31334D531A9D_1_0">0.99</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="pure" decimals="3" id="id_5851737_B6F3E2C8-A6E4-4D0D-8044-F1D8F2BFBEF5_3_5">0.000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_3_23">-119860000</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="pure" decimals="2" id="id_5851737_4891FC0B-C69B-476B-9ABC-3A53D8C25AD9_3_6">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="pure" decimals="2" id="id_5851737_B6F3E2C8-A6E4-4D0D-8044-F1D8F2BFBEF5_3_1">0.00</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
  <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="shares" decimals="INF" id="id_5851737_82C71537-FFD8-4EBE-ACB8-0B2CD6BF8AA1_2_5">422260</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="shares" decimals="-3" id="id_5851737_4373895D-6E6F-41A5-A449-A8691F7E803C_3_14">180855000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="pure" decimals="3" id="id_5851737_B6F3E2C8-A6E4-4D0D-8044-F1D8F2BFBEF5_3_4">-0.310</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
  <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="pure" decimals="3" id="id_5851737_B6F3E2C8-A6E4-4D0D-8044-F1D8F2BFBEF5_3_3">-0.040</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="pure" decimals="4" id="id_5851737_4891FC0B-C69B-476B-9ABC-3A53D8C25AD9_3_0">0.0032</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" id="id_5851737_8F1A5AC1-8BCD-4B25-9FA2-DD3AB5888390_1_2">P7Y26D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_5851737_4373895D-6E6F-41A5-A449-A8691F7E803C_3_13">-0.94</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="pure" decimals="INF" id="id_5851737_B6F3E2C8-A6E4-4D0D-8044-F1D8F2BFBEF5_3_0">0.350</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="pure" decimals="4" id="id_5851737_4891FC0B-C69B-476B-9ABC-3A53D8C25AD9_3_5">0.8400</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="pure" decimals="4" id="id_5851737_4891FC0B-C69B-476B-9ABC-3A53D8C25AD9_3_1">0.0116</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="shares" decimals="INF" id="id_5851737_127E2ACD-5D85-413D-A09E-8F8110ADED0E_3_4">128324123</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:UnrealizedGainLossOnDerivatives contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_3_9">-1237000</us-gaap:UnrealizedGainLossOnDerivatives>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_4006_900003">-906000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-5" id="id_5851737_4FEAEA63-925D-4828-849A-287F8F314E3B_1_0">60700000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_90D3F4A0-1EBD-40FE-9C68-173795AC8270_3_6">-50000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="INF" id="id_5851737_7A23EAFD-38E9-4829-ABCF-DAE75D55D931_3_1">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet>
  <us-gaap:AvailableForSaleSecuritiesGrossRealizedGainLossNet contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_3_6">-117000</us-gaap:AvailableForSaleSecuritiesGrossRealizedGainLossNet>
  <us-gaap:SalesRevenueNet contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4373895D-6E6F-41A5-A449-A8691F7E803C_3_0">35000</us-gaap:SalesRevenueNet>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_3_17">1545000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4373895D-6E6F-41A5-A449-A8691F7E803C_3_10">-169774000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_4006_900012">862000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_4006_900002">9000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_90D3F4A0-1EBD-40FE-9C68-173795AC8270_3_5">-48000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
  <us-gaap:OperatingIncomeLoss contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4373895D-6E6F-41A5-A449-A8691F7E803C_3_5">-146960000</us-gaap:OperatingIncomeLoss>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_90D3F4A0-1EBD-40FE-9C68-173795AC8270_3_7">-169416000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:OtherNonoperatingIncomeExpense contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4373895D-6E6F-41A5-A449-A8691F7E803C_3_6">-1191000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_4006_900014">-2000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_4006_900006">184537000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_3_25">637000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:OtherNoncashIncomeExpense contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_3_12">2000</us-gaap:OtherNoncashIncomeExpense>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4373895D-6E6F-41A5-A449-A8691F7E803C_3_12">-169366000</us-gaap:NetIncomeLoss>
  <us-gaap:InvestmentIncomeInterest contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4373895D-6E6F-41A5-A449-A8691F7E803C_3_9">7000</us-gaap:InvestmentIncomeInterest>
  <us-gaap:InterestPaid contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_3_43">9755000</us-gaap:InterestPaid>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_4006_900013">13292000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_3_37">906000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
  <us-gaap:InterestPaidCapitalized contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_3_46">14219000</us-gaap:InterestPaidCapitalized>
  <us-gaap:ConstructionInProgressExpendituresIncurredButNotYetPaid contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_3_45">4072000</us-gaap:ConstructionInProgressExpendituresIncurredButNotYetPaid>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_5CF4DCBF-958A-4C2E-84FF-736CEF523791_3_0">13292000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_FF1422D9-4F07-4EC2-A2EF-D2BD529666C7_3_10">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-5" id="id_5851737_9DDD7803-FC6B-4DBD-94E8-64434E7A1B04_3_0">13000000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:InterestCostsCapitalized contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-5" id="id_5851737_1322FBBF-CCB2-4059-9D68-2AC5451BAB41_3_1">300000</us-gaap:InterestCostsCapitalized>
  <us-gaap:InterestExpense contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-5" id="id_5851737_1322FBBF-CCB2-4059-9D68-2AC5451BAB41_3_0">21600000</us-gaap:InterestExpense>
  <us-gaap:OperatingExpenses contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4373895D-6E6F-41A5-A449-A8691F7E803C_3_4">146995000</us-gaap:OperatingExpenses>
  <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4373895D-6E6F-41A5-A449-A8691F7E803C_3_7">10491000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-5" id="id_5851737_78F5C120-82A4-4A68-A5A4-4EFB90BCC73A_1_1">3000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
  <us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-5" id="id_5851737_6C5177C9-5366-4D13-941E-B0303FCF50EA_3_0">800000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
  <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_FF1422D9-4F07-4EC2-A2EF-D2BD529666C7_3_7">9199000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
  <us-gaap:InterestExpenseDebt contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4373895D-6E6F-41A5-A449-A8691F7E803C_3_8">11139000</us-gaap:InterestExpenseDebt>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_3_39">59159000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_FF1422D9-4F07-4EC2-A2EF-D2BD529666C7_3_8">0</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
  <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_3_20">15075000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
  <us-gaap:IncomeTaxExpenseBenefit contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4373895D-6E6F-41A5-A449-A8691F7E803C_3_11">-408000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:OperatingLeasesRentExpenseNet contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_5851737_215C1445-5489-4219-BC45-8D91F36914C4_3_0">675000</us-gaap:OperatingLeasesRentExpenseNet>
  <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_FF1422D9-4F07-4EC2-A2EF-D2BD529666C7_3_1">0</us-gaap:CurrentFederalTaxExpenseBenefit>
  <us-gaap:DeferredOtherTaxExpenseBenefit contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_FF1422D9-4F07-4EC2-A2EF-D2BD529666C7_3_9">-60739000</us-gaap:DeferredOtherTaxExpenseBenefit>
  <us-gaap:DepreciationAndAmortization contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_3_3">14402000</us-gaap:DepreciationAndAmortization>
  <us-gaap:EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_5851737_8F1A5AC1-8BCD-4B25-9FA2-DD3AB5888390_1_0">9200</us-gaap:EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions>
  <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_3_38">179579000</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
  <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_3_26">77000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
  <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_FF1422D9-4F07-4EC2-A2EF-D2BD529666C7_3_2">0</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="INF" id="id_5851737_7A23EAFD-38E9-4829-ABCF-DAE75D55D931_3_0">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
  <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_3_27">-560000</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
  <us-gaap:ProceedsFromRelatedPartyDebt contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_3_36">12750000</us-gaap:ProceedsFromRelatedPartyDebt>
  <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4373895D-6E6F-41A5-A449-A8691F7E803C_3_2">101522000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
  <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_FF1422D9-4F07-4EC2-A2EF-D2BD529666C7_3_3">0</us-gaap:CurrentForeignTaxExpenseBenefit>
  <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_FF1422D9-4F07-4EC2-A2EF-D2BD529666C7_3_4">0</us-gaap:CurrentIncomeTaxExpenseBenefit>
  <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_5851737_A5EFB79E-1DD7-45F0-A8F1-82325FD3AE31_3_0">571000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
  <us-gaap:OtherOperatingActivitiesCashFlowStatement contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_3_11">6056000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
  <us-gaap:GeneralAndAdministrativeExpense contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4373895D-6E6F-41A5-A449-A8691F7E803C_3_3">45473000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_3_19">44000</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_3_4">13292000</us-gaap:ShareBasedCompensation>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-5" id="id_5851737_78F5C120-82A4-4A68-A5A4-4EFB90BCC73A_1_0">2900000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_5851737_9C0D5787-E738-4506-A65E-31334D531A9D_1_1">1000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
  <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_FF1422D9-4F07-4EC2-A2EF-D2BD529666C7_3_6">51540000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
  <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_4006_900015">48000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
  <mnkd:AdjustmentsToAdditionalPaidInCapitalNetShareSettlementOfEquityAwards contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_4006_900010">6056000</mnkd:AdjustmentsToAdditionalPaidInCapitalNetShareSettlementOfEquityAwards>
  <mnkd:ChangeInFairValueOfForwardExchangeRateContracts contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_4006_900007">-1237000</mnkd:ChangeInFairValueOfForwardExchangeRateContracts>
  <mnkd:IncomeTaxExpenseBenefitNet contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_FF1422D9-4F07-4EC2-A2EF-D2BD529666C7_3_11">0</mnkd:IncomeTaxExpenseBenefitNet>
  <mnkd:ForwardPurchaseContractContributionToAdditionalPaidInCapital contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_3_48">29317000</mnkd:ForwardPurchaseContractContributionToAdditionalPaidInCapital>
  <mnkd:StockIssuedDuringPeriodValueIssuedRelatedToLegalSettlement contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_4006_900009">438000</mnkd:StockIssuedDuringPeriodValueIssuedRelatedToLegalSettlement>
  <mnkd:NominalLendingFee contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_5851737_0795CE6B-B194-471C-B435-49D38406C872_1_2">0.01</mnkd:NominalLendingFee>
  <mnkd:ReclassificationOfForwardPurchaseContractToAdditionalPaidInCapital contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_3_49">28080000</mnkd:ReclassificationOfForwardPurchaseContractToAdditionalPaidInCapital>
  <mnkd:CancellationOfPrincipalOnNotePayableToRelatedParty contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_3_47">184537000</mnkd:CancellationOfPrincipalOnNotePayableToRelatedParty>
  <mnkd:StateResearchAndDevelopmentCreditExchangeReceivable contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_3_14">-290000</mnkd:StateResearchAndDevelopmentCreditExchangeReceivable>
  <mnkd:StockIssuedDuringPeriodValueInitialPublicOffering contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_4006_900005">166864000</mnkd:StockIssuedDuringPeriodValueInitialPublicOffering>
  <mnkd:GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_3_5">-682000</mnkd:GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment>
  <mnkd:PaymentsForUseOfAircrafts contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_5851737_EE6F1B00-1AF9-470E-B601-EE07C528EEDD_3_0">200000</mnkd:PaymentsForUseOfAircrafts>
  <mnkd:CommonSharesIssuedPursuantToLitigationSettlement contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_3_10">438000</mnkd:CommonSharesIssuedPursuantToLitigationSettlement>
  <mnkd:ProceedsFromIssuanceOfCommonStockAndWarrantsNet contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_4E8DF80F-C961-4352-9522-77B29B1825EF_3_29">167735000</mnkd:ProceedsFromIssuanceOfCommonStockAndWarrantsNet>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0_900196x900353" unitRef="shares" decimals="INF" id="id_5851737_127E2ACD-5D85-413D-A09E-8F8110ADED0E_1003_1">19826113</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0_900196x902719" unitRef="shares" decimals="INF" id="id_5851737_127E2ACD-5D85-413D-A09E-8F8110ADED0E_2003_3">3761031</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0_900196x904951" unitRef="shares" decimals="INF" id="id_5851737_127E2ACD-5D85-413D-A09E-8F8110ADED0E_3003_2">86062440</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0_900196x907138" unitRef="shares" decimals="INF" id="id_5851737_127E2ACD-5D85-413D-A09E-8F8110ADED0E_4003_0">18674539</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquityTransfersIntoLevel3 contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0_900547x907189" unitRef="iso4217_USD" decimals="-3" id="id_5851737_209678D4-4A86-4A27-A605-EAFADF70C75D_5003_2">29317000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquityTransfersIntoLevel3>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquityGainLossIncludedInOtherComprehensiveIncomeLoss contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0_900547x907189" unitRef="iso4217_USD" decimals="-3" id="id_5851737_209678D4-4A86-4A27-A605-EAFADF70C75D_5003_3">-1237000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquityGainLossIncludedInOtherComprehensiveIncomeLoss>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquitySettlements contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0_900547x907189" unitRef="iso4217_USD" decimals="-3" id="id_5851737_209678D4-4A86-4A27-A605-EAFADF70C75D_5003_4">28080000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquitySettlements>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquityTransfersIntoLevel3 contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0_900547x907189_903654x1037100" unitRef="iso4217_USD" decimals="-3" id="id_5851737_209678D4-4A86-4A27-A605-EAFADF70C75D_5002_2">28237000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquityTransfersIntoLevel3>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquityGainLossIncludedInOtherComprehensiveIncomeLoss contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0_900547x907189_903654x1037100" unitRef="iso4217_USD" decimals="-3" id="id_5851737_209678D4-4A86-4A27-A605-EAFADF70C75D_5002_3">-13248000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquityGainLossIncludedInOtherComprehensiveIncomeLoss>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquitySettlements contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0_900547x907189_903654x1037100" unitRef="iso4217_USD" decimals="-3" id="id_5851737_209678D4-4A86-4A27-A605-EAFADF70C75D_5002_4">14989000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquitySettlements>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquityTransfersIntoLevel3 contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0_900547x907189_903654x1069097" unitRef="iso4217_USD" decimals="-3" id="id_5851737_209678D4-4A86-4A27-A605-EAFADF70C75D_5001_2">1080000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquityTransfersIntoLevel3>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquityGainLossIncludedInOtherComprehensiveIncomeLoss contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0_900547x907189_903654x1069097" unitRef="iso4217_USD" decimals="-3" id="id_5851737_209678D4-4A86-4A27-A605-EAFADF70C75D_5001_3">12011000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquityGainLossIncludedInOtherComprehensiveIncomeLoss>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquitySettlements contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0_900547x907189_903654x1069097" unitRef="iso4217_USD" decimals="-3" id="id_5851737_209678D4-4A86-4A27-A605-EAFADF70C75D_5001_4">13091000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquitySettlements>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0_901032x907457" id="id_5851737_4891FC0B-C69B-476B-9ABC-3A53D8C25AD9_1003_3">P6Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0_901032x909105" id="id_5851737_4891FC0B-C69B-476B-9ABC-3A53D8C25AD9_2003_2">P1Y4M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0_904892x1063447" unitRef="iso4217_USD" decimals="-3" id="id_5851737_57D2ECBE-392C-4E6E-B247-92B8CD9C9C0C_1003_0">13224000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0_904892x921908" unitRef="iso4217_USD" decimals="-3" id="id_5851737_57D2ECBE-392C-4E6E-B247-92B8CD9C9C0C_2003_1">68000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0_905668x928369" unitRef="iso4217_USD" decimals="-3" id="id_5851737_110C905F-68E2-4183-AA9B-0466B600C0DE_1003_1">7125000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0_905668x974237" unitRef="iso4217_USD" decimals="-3" id="id_5851737_110C905F-68E2-4183-AA9B-0466B600C0DE_2003_0">6167000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0_907910x1042177" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_4005_800016">-169366000</us-gaap:NetIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0_907910x901931" unitRef="shares" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_4001_400011">211000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0_907910x901931" unitRef="shares" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_4001_400006">71250000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0_907910x901931" unitRef="shares" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_4001_400003">886000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0_907910x901931" unitRef="shares" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_4001_400002">3000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0_907910x901931" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_4001_500003">9000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0_907910x901931" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_4001_500012">2000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0_907910x901931" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_4001_500006">713000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <mnkd:StockIssuedDuringPeriodSharesIssuedRelatedToLegalSettlement contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0_907910x901931" unitRef="shares" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_4001_400008">225000</mnkd:StockIssuedDuringPeriodSharesIssuedRelatedToLegalSettlement>
  <mnkd:StockIssuedDuringPeriodSharesInitialPublicOffering contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0_907910x901931" unitRef="shares" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_4001_400004">81938000</mnkd:StockIssuedDuringPeriodSharesInitialPublicOffering>
  <mnkd:StockIssuedDuringPeriodValueIssuedRelatedToLegalSettlement contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0_907910x901931" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_4001_500009">2000</mnkd:StockIssuedDuringPeriodValueIssuedRelatedToLegalSettlement>
  <mnkd:StockIssuedDuringPeriodValueInitialPublicOffering contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0_907910x901931" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_4001_500005">819000</mnkd:StockIssuedDuringPeriodValueInitialPublicOffering>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0_907910x905139" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_4003_600003">-915000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0_907910x905139" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_4003_600012">860000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0_907910x905139" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_4003_600002">9000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0_907910x905139" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_4003_600006">183824000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0_907910x905139" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_4003_600013">13292000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <mnkd:AdjustmentsToAdditionalPaidInCapitalNetShareSettlementOfEquityAwards contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0_907910x905139" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_4003_600010">6056000</mnkd:AdjustmentsToAdditionalPaidInCapitalNetShareSettlementOfEquityAwards>
  <mnkd:ChangeInFairValueOfForwardExchangeRateContracts contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0_907910x905139" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_4003_600007">-1237000</mnkd:ChangeInFairValueOfForwardExchangeRateContracts>
  <mnkd:StockIssuedDuringPeriodValueIssuedRelatedToLegalSettlement contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0_907910x905139" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_4003_600009">436000</mnkd:StockIssuedDuringPeriodValueIssuedRelatedToLegalSettlement>
  <mnkd:StockIssuedDuringPeriodValueInitialPublicOffering contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0_907910x905139" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_4003_600005">166045000</mnkd:StockIssuedDuringPeriodValueInitialPublicOffering>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0_907910x910799" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_4004_700014">-2000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax contextRef="eol_PE126000--1410-K0014_STD_366_20121231_0_907910x910799" unitRef="iso4217_USD" decimals="-3" id="id_5851737_403D4A06-8EB2-44A5-98F4-FC096A1F8F64_4004_700015">48000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE126000--1410-K0014_STD_90_20130331_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_5851737_5B1E4ECA-5A2F-4C3F-BD29-29378C565FA9_1_2">-0.15</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1410-K0014_STD_90_20130331_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_5B1E4ECA-5A2F-4C3F-BD29-29378C565FA9_1_0">-40965000</us-gaap:NetIncomeLoss>
  <mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding contextRef="eol_PE126000--1410-K0014_STD_90_20130331_0" unitRef="shares" decimals="-3" id="id_5851737_5B1E4ECA-5A2F-4C3F-BD29-29378C565FA9_1_3">280058000</mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE126000--1410-K0014_STD_90_20140331_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_5851737_FCA05E8F-F1F9-4522-9A62-3AED864C3374_1_2">-0.14</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1410-K0014_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_FCA05E8F-F1F9-4522-9A62-3AED864C3374_1_0">-52056000</us-gaap:NetIncomeLoss>
  <mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding contextRef="eol_PE126000--1410-K0014_STD_90_20140331_0" unitRef="shares" decimals="-3" id="id_5851737_FCA05E8F-F1F9-4522-9A62-3AED864C3374_1_3">368784000</mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE126000--1410-K0014_STD_91_20130630_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_5851737_5B1E4ECA-5A2F-4C3F-BD29-29378C565FA9_2_2">-0.16</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1410-K0014_STD_91_20130630_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_5B1E4ECA-5A2F-4C3F-BD29-29378C565FA9_2_0">-46124000</us-gaap:NetIncomeLoss>
  <mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding contextRef="eol_PE126000--1410-K0014_STD_91_20130630_0" unitRef="shares" decimals="-3" id="id_5851737_5B1E4ECA-5A2F-4C3F-BD29-29378C565FA9_2_3">284044000</mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE126000--1410-K0014_STD_91_20140630_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_5851737_FCA05E8F-F1F9-4522-9A62-3AED864C3374_2_2">-0.19</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1410-K0014_STD_91_20140630_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_FCA05E8F-F1F9-4522-9A62-3AED864C3374_2_0">-73365000</us-gaap:NetIncomeLoss>
  <mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding contextRef="eol_PE126000--1410-K0014_STD_91_20140630_0" unitRef="shares" decimals="-3" id="id_5851737_FCA05E8F-F1F9-4522-9A62-3AED864C3374_2_3">380770000</mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE126000--1410-K0014_STD_92_20130930_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_5851737_5B1E4ECA-5A2F-4C3F-BD29-29378C565FA9_3_2">-0.17</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1410-K0014_STD_92_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_5B1E4ECA-5A2F-4C3F-BD29-29378C565FA9_3_0">-50818000</us-gaap:NetIncomeLoss>
  <mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding contextRef="eol_PE126000--1410-K0014_STD_92_20130930_0" unitRef="shares" decimals="-3" id="id_5851737_5B1E4ECA-5A2F-4C3F-BD29-29378C565FA9_3_3">296386000</mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE126000--1410-K0014_STD_92_20140930_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_5851737_FCA05E8F-F1F9-4522-9A62-3AED864C3374_3_2">-0.09</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1410-K0014_STD_92_20140930_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_FCA05E8F-F1F9-4522-9A62-3AED864C3374_3_0">-36520000</us-gaap:NetIncomeLoss>
  <mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding contextRef="eol_PE126000--1410-K0014_STD_92_20140930_0" unitRef="shares" decimals="-3" id="id_5851737_FCA05E8F-F1F9-4522-9A62-3AED864C3374_3_3">394163000</mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding>
  <mnkd:UpfrontFee contextRef="eol_PE126000--1410-K0014_STD_92_20140930_0_911417x1029301" unitRef="iso4217_USD" decimals="-5" id="id_5851737_CE906C8B-48B8-40FE-95E9-87C0AE487D8B_3001_0">150000000</mnkd:UpfrontFee>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE126000--1410-K0014_STD_92_20131231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_5851737_5B1E4ECA-5A2F-4C3F-BD29-29378C565FA9_4_2">-0.16</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1410-K0014_STD_92_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_5B1E4ECA-5A2F-4C3F-BD29-29378C565FA9_4_0">-53582000</us-gaap:NetIncomeLoss>
  <mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding contextRef="eol_PE126000--1410-K0014_STD_92_20131231_0" unitRef="shares" decimals="-3" id="id_5851737_5B1E4ECA-5A2F-4C3F-BD29-29378C565FA9_4_3">337284000</mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE126000--1410-K0014_STD_92_20141231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_5851737_FCA05E8F-F1F9-4522-9A62-3AED864C3374_4_2">-0.09</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1410-K0014_STD_92_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_5851737_FCA05E8F-F1F9-4522-9A62-3AED864C3374_4_0">-36439000</us-gaap:NetIncomeLoss>
  <mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding contextRef="eol_PE126000--1410-K0014_STD_92_20141231_0" unitRef="shares" decimals="-3" id="id_5851737_FCA05E8F-F1F9-4522-9A62-3AED864C3374_4_3">396793000</mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding>
  <context id="eol_PE126000--1410-K0014_STD_92_20141231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2014-10-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_92_20131231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_92_20140930_0_911417x1029301">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-07-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_92_20140930_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2014-07-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_92_20130930_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2013-07-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_91_20140630_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2014-04-01</startDate>
      <endDate>2014-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_91_20130630_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2013-04-01</startDate>
      <endDate>2013-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_90_20140331_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_90_20130331_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_366_20121231_0_907910x910799">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_366_20121231_0_907910x905139">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_366_20121231_0_907910x901931">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_366_20121231_0_907910x1042177">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_366_20121231_0_905668x974237">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:ResearchAndDevelopmentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_366_20121231_0_905668x928369">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:GeneralAndAdministrativeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_366_20121231_0_904892x921908">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">mnkd:ConsultantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_366_20121231_0_904892x1063447">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">mnkd:EmployeeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_366_20121231_0_901032x909105">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_366_20121231_0_901032x907457">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_366_20121231_0_900547x907189_903654x1069097">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeByNatureAxis">mnkd:FebruaryTwentyTwelveForwardContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_366_20121231_0_900547x907189_903654x1037100">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeByNatureAxis">mnkd:OctoberTwentyTwelveForwardContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_366_20121231_0_900547x907189">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_366_20121231_0_900196x907138">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_366_20121231_0_900196x904951">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_366_20121231_0_900196x902719">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_366_20121231_0_900196x900353">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_366_20121231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_937864x1068343">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:CommonStockIssuanceTypeAxis">mnkd:PublicOfferingMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_912827x1060185">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_912160x912202">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_912160x907907">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_911417x1029301">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_910720x966327">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:SeniorConvertibleNotesDueTwoThousandFifteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_910720x1029473_912827x1060185">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_910288x998075">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mnkd:ConversionRightFeatureOfConvertibleNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_910288x1047918">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mnkd:AccelerationUponLegalJudgmentInExcessOfOneHundredThousandDollarMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_910288x1000328">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mnkd:MajorTransactionPutOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_907910x910799">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_907910x905139">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_907910x901931">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_907910x1042177">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_907645x908991">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_907645x1039325">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_906969x950672">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:TrancheBMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_906969x1077049_910720x1029473_912827x1060185">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:TrancheThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_906969x1077048_910720x1029473_912827x1060185">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:TrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_906969x1077046_910720x1029473_912827x1060185">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:TrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_906969x1060390_910720x1029473_912827x1060185">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MilestoneRightsLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_906053x953384_910940x910864">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:LoanArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:PrincipalOwnerMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_906053x1069222_910940x1004388_913052x909043">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:LetterAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:RelatedPartyDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_906053x1069222_910940x1004388">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:LetterAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:RelatedPartyDebtMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_906053x1068897_911417x1029301">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:SanofiAventisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_905668x974237">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:ResearchAndDevelopmentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_905668x928369">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:GeneralAndAdministrativeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_904892x1063447">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">mnkd:EmployeeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_901822x907138">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_901822x902719">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_901032x909105_907645x948369">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:FurnitureFixturesAndOfficeEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_901032x909105_907645x907438">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_901032x909105_907645x905205">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_901032x909105_907645x901833">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_901032x909105_906053x953384_910940x910864">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:LoanArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:PrincipalOwnerMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_901032x909105">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_901032x907457_907645x948369">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:FurnitureFixturesAndOfficeEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_901032x907457_907645x907438">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_901032x907457_907645x905205">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_901032x907457_907645x901833">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_901032x907457_906053x953384_910940x910864">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:LoanArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:PrincipalOwnerMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_901032x907457">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_900547x907189_904933x910565_910720x1029473">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_900547x907189_904933x910565_907178x995537">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">mnkd:CommitmentAssetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_900196x907138">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_900196x904951">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_900196x902719">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_900196x900353">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_1060593x1082329_911417x1029301">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:MilestoneEventsAxis">mnkd:DevelopmentAndManufacturingMilestoneEventsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_1036892x937198_910720x1029473_912827x1060185">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="mnkd:DebtInstrumentConditionAxis">mnkd:AdditionalDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_1033890x1060390_900547x907189_904933x910565">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:CreditAgreementAxis">mnkd:MilestoneRightsLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_1002086x999842">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:CommitmentsAxis">mnkd:CommitmentFeeOneMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0_1002086x925878">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:CommitmentsAxis">mnkd:CommitmentFeeTwoMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20141231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20131231_0_912827x1060185">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20131231_0_907910x910799">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20131231_0_907910x905139">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20131231_0_907910x901931">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20131231_0_907910x1042177">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20131231_0_906053x953384_910940x910864">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:LoanArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:PrincipalOwnerMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20131231_0_905668x974237">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:ResearchAndDevelopmentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20131231_0_905668x928369">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:GeneralAndAdministrativeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20131231_0_904892x921908">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">mnkd:ConsultantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20131231_0_904892x1063447">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">mnkd:EmployeeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20131231_0_901032x909105">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20131231_0_901032x907457">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20131231_0_900196x907138">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20131231_0_900196x904951">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20131231_0_900196x902719">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20131231_0_900196x900353">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_365_20131231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_31_20121231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2012-12-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_31_20131031_0_910940x910864">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:PrincipalOwnerMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2013-10-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_31_20131031_0_906053x1051648_910940x910864">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:AmendedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:PrincipalOwnerMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2013-10-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_31_20131031_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2013-10-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_31_20121031_0_901822x904951_902891x909228">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2012-10-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_31_20121031_0_901822x902719_902891x909228">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2012-10-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_31_20121031_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2012-10-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_31_20071031_0_910940x910864">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:PrincipalOwnerMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2007-10-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_31_20040831_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2004-08-01</startDate>
      <endDate>2004-08-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_31_20040331_0_912473x1033376">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mnkd:EmployeeStockPurchasePlansMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-03-01</startDate>
      <endDate>2004-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_31_20040331_0_901032x907457">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-03-01</startDate>
      <endDate>2004-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_31_20040331_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2004-03-01</startDate>
      <endDate>2004-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_28_20090228_0_906053x953384_910940x910864">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:LoanArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:PrincipalOwnerMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-02-01</startDate>
      <endDate>2009-02-28</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_1_20141231_0_900547x907189_904933x910565_906969x950672_910720x1029473">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:TrancheBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-12-31</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_1_20141231_0_900547x907189_904933x910565_906969x1077046_910720x1029473">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:TrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-12-31</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_1_20141231_0_900547x907189_904933x910565_906969x1021115_910720x1029473">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:TrancheFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-12-31</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_1_20141230_0_906969x950672_910720x1029473">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:TrancheBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-12-30</startDate>
      <endDate>2014-12-30</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_1_20131231_0_900547x907189_904933x910565_906969x1077046_910720x1029473">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:TrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-12-31</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_1_20121220_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2012-12-20</startDate>
      <endDate>2012-12-20</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_1_20140923_0_911417x1029301">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-09-23</startDate>
      <endDate>2014-09-23</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_1_20121018_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2012-10-18</startDate>
      <endDate>2012-10-18</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_1_20140718_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2014-07-18</startDate>
      <endDate>2014-07-18</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_1_20130701_0_906969x1060390_910720x1029473_912827x1060185">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MilestoneRightsLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-07-01</startDate>
      <endDate>2013-07-01</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_1_20130701_0_906969x1012963_910720x1029473_912827x1060185">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:NotesIssuedInFourEqualTranchesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-07-01</startDate>
      <endDate>2013-07-01</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_1_20130701_0_900547x907189_904933x910565_906969x950672_910720x1029473">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:TrancheBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-07-01</startDate>
      <endDate>2013-07-01</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_1_20140811_0_911417x1029301">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-08-11</startDate>
      <endDate>2014-08-11</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_1_20140811_0_906053x1068897_911417x1029301">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:SanofiAventisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-08-11</startDate>
      <endDate>2014-08-11</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_1_20140228_0_906969x950672_910720x1029473_912827x1060185">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:TrancheBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-02-28</startDate>
      <endDate>2014-02-28</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_1_20120517_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2012-05-17</startDate>
      <endDate>2012-05-17</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_1_20120208_0_910940x936286">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:RelatedPartyMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-02-08</startDate>
      <endDate>2012-02-08</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_1_20120208_0_910484x1005038">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mnkd:WarrantLiabilityMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-02-08</startDate>
      <endDate>2012-02-08</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_1_20120208_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2012-02-08</startDate>
      <endDate>2012-02-08</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_1_20100818_0_910720x966327">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:SeniorConvertibleNotesDueTwoThousandFifteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-08-18</startDate>
      <endDate>2010-08-18</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20141231_0_946648x921908">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:StockAwardPlanTypeAxis">mnkd:ConsultantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20141231_0_937864x1068343">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:CommonStockIssuanceTypeAxis">mnkd:PublicOfferingMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20141231_0_912473x994805">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mnkd:TwoThousandFourNonEmployeeDirectorsStockOptionPlanMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20141231_0_912473x978282">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mnkd:TwoThousandFourEquityIncentivePlanMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20141231_0_912473x1033376">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mnkd:EmployeeStockPurchasePlansMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20141231_0_912473x1029406">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mnkd:EquityIncentivePlanTwentyThirteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20141231_0_912160x912202">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20141231_0_912160x907907">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20141231_0_911417x1029301">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20141231_0_910720x966327">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:SeniorConvertibleNotesDueTwoThousandFifteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20141231_0_910720x1077866">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:FacilityFinancingObligationMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20141231_0_910720x1029473_912827x1060185">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20141231_0_910484x1069197_910940x1029276">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mnkd:ForwardPurchaseContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:MannGroupMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20141231_0_910113x986444">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mnkd:CurrentAssetMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20141231_0_907910x910799">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20141231_0_907910x905139">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20141231_0_907910x901931">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20141231_0_907910x1042177">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20141231_0_907645x948369">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:FurnitureFixturesAndOfficeEquipmentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20141231_0_907645x908991">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20141231_0_907645x907438">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20141231_0_907645x907375">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20141231_0_907645x906950">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20141231_0_907645x905205">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20141231_0_907645x901833">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20141231_0_907645x1039325">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20141231_0_906969x950672_910720x1029473_912827x1060185">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:TrancheBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20141231_0_906969x934075_910720x1029473_912827x1060185">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:TrancheOneAndTrancheThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20141231_0_906969x1077049_910720x1029473_912827x1060185">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:TrancheThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20141231_0_906969x1077048_910720x1029473_912827x1060185">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:TrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20141231_0_906969x1077046_910720x1029473_912827x1060185">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:TrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20141231_0_906969x1060390_910720x1029473_912827x1060185">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MilestoneRightsLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20141231_0_906969x1012963_910720x1029473_912827x1060185">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:NotesIssuedInFourEqualTranchesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20141231_0_906053x953384_910940x910864">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:LoanArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:PrincipalOwnerMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20141231_0_906053x1068897_911417x1029301">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:SanofiAventisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20141231_0_905668x1057783">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:OtherIncomeExpenseMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20141231_0_905594x989565_910484x1069197_910940x1029276">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mnkd:ForwardPurchaseContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ForwardContractIndexedToIssuersEquityTypeAxis">mnkd:OtherThanEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:MannGroupMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20141231_0_905594x1021475_910484x1069197_910940x1029276">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mnkd:ForwardPurchaseContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ForwardContractIndexedToIssuersEquityTypeAxis">mnkd:EquityComponentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:MannGroupMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20141231_0_901822x907138">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20141231_0_901822x902721">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20141231_0_901032x909105_906969x950672_910720x1029473_912827x1060185_961988x969356">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="mnkd:AgreementsAxis">mnkd:FacilityAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:TrancheBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20141231_0_901032x907457_945025x943266">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:AgreementTypeAxis">mnkd:AtMarketSalesAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20141231_0_901032x907457_906969x1060390_910720x1029473_912827x1060185">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MilestoneRightsLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20141231_0_900547x907189_906969x950672_910720x1029473">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:TrancheBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20141231_0_1033890x1060390_900547x907189">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:CreditAgreementAxis">mnkd:MilestoneRightsLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20141231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20141230_0_901032x907457_906969x950672_910720x1029473">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:TrancheBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-30</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20131231_0_910720x966327">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:SeniorConvertibleNotesDueTwoThousandFifteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20131231_0_910720x1077866">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:FacilityFinancingObligationMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20131231_0_910720x1029473_912827x1060185">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20131231_0_907910x910799">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20131231_0_907910x905139">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20131231_0_907910x901931">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20131231_0_907910x1042177">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20131231_0_907645x948369">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:FurnitureFixturesAndOfficeEquipmentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20131231_0_907645x908991">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20131231_0_907645x907438">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20131231_0_907645x907375">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20131231_0_907645x906950">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20131231_0_907645x905205">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20131231_0_907645x901833">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20131231_0_907645x1039325">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20131231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20121231_0_907910x910799">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20121231_0_907910x905139">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20121231_0_907910x901931">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20121231_0_907910x1042177">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20121231_0_900547x907189_903654x1069097">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeByNatureAxis">mnkd:FebruaryTwentyTwelveForwardContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20121231_0_900547x907189_903654x1037100">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeByNatureAxis">mnkd:OctoberTwentyTwelveForwardContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20121231_0_900547x907189">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20121231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20111231_0_907910x910799">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20111231_0_907910x905139">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20111231_0_907910x901931">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20111231_0_907910x1042177">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20111231_0_900547x907189_903654x1069097">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeByNatureAxis">mnkd:FebruaryTwentyTwelveForwardContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20111231_0_900547x907189_903654x1037100">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeByNatureAxis">mnkd:OctoberTwentyTwelveForwardContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20111231_0_900547x907189">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20111231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20140923_0_911417x1029301">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-09-23</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20140923_0_906969x950672_910720x1029473_912827x1060185">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:TrancheBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-09-23</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20140923_0_904843x1047235_906969x950672_910720x1029473_912827x1060185">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:TrancheBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">mnkd:CollaborationAgreementWithThirdPartyMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-09-23</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20140630_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>2014-06-30</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20140331_0_906969x1077049_910720x1029473_912827x1060185">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:TrancheThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20140331_0_906969x1077046_910720x1029473_912827x1060185">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:TrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20131031_0_906053x1051648_910940x910864">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:AmendedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:PrincipalOwnerMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-10-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20121031_0_910940x1029276">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:MannGroupMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-10-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20121031_0_901822x904951_910940x1029276">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:MannGroupMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-10-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20121031_0_901822x904951">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-10-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20121031_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>2012-10-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20040831_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>2004-08-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20130701_0_910720x1029473">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-07-01</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20130701_0_906969x1060390_910720x1029473_912827x1060185">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MilestoneRightsLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-07-01</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20130701_0_906969x1012963_910720x1029473_912827x1060185">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:NotesIssuedInFourEqualTranchesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-07-01</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20130701_0_901032x907457_906969x1060390_912827x1060185">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MilestoneRightsLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-07-01</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20120630_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>2012-06-30</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20140430_0_906969x1077046_910720x1029473_912827x1060185">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:TrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-04-30</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20120317_0_905594x989565">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ForwardContractIndexedToIssuersEquityTypeAxis">mnkd:OtherThanEquityMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-03-17</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20040331_0_912473x1033376">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mnkd:EmployeeStockPurchasePlansMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2004-03-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20150223_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>2015-02-23</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20140811_0_911417x1029301">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-08-11</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20140811_0_1060593x1082329_911417x1029301">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:MilestoneEventsAxis">mnkd:DevelopmentAndManufacturingMilestoneEventsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-08-11</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20140811_0_1060593x1082327_911417x1029301">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:MilestoneEventsAxis">mnkd:FilingAndCompletionOfRegulatoryApprovalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-08-11</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20140811_0_1060593x1082326_911417x1029301">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:MilestoneEventsAxis">mnkd:AchievementOfProductSalesMilestoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-08-11</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20140506_0_906969x950672_910720x1029473_912827x1060185">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:TrancheBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-05-06</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20140228_0_910720x1029473_912827x1060185">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-02-28</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20140228_0_906969x950672_910720x1029473_912827x1060185">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:TrancheBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-02-28</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20140228_0_901032x907457_910720x1029473_912827x1060185">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-02-28</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20140228_0_901032x907457_906969x950672_910720x1029473_912827x1060185">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:TrancheBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-02-28</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20130523_0_912473x1029406">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mnkd:EquityIncentivePlanTwentyThirteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-05-23</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20120517_0_910484x1069197_910940x1029276">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mnkd:ForwardPurchaseContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:MannGroupMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-05-17</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20120517_0_905594x989565_910484x1069197_910940x1029276">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mnkd:ForwardPurchaseContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ForwardContractIndexedToIssuersEquityTypeAxis">mnkd:OtherThanEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:MannGroupMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-05-17</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20120517_0_905594x989565">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ForwardContractIndexedToIssuersEquityTypeAxis">mnkd:OtherThanEquityMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-05-17</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20120517_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>2012-05-17</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20120208_0_993561x942638">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:CommonStockIssuedToByPartyAxis">mnkd:PublicMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-02-08</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20120208_0_993561x1021251">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:CommonStockIssuedToByPartyAxis">mnkd:UnderwritersMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-02-08</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20120208_0_910940x1029276">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:MannGroupMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-02-08</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20120208_0_910484x1005038">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mnkd:WarrantLiabilityMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-02-08</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20120208_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>2012-02-08</instant>
    </period>
  </context>
  <context id="eol_PE126000--1410-K0014_STD_0_20100818_0_910720x966327">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:SeniorConvertibleNotesDueTwoThousandFifteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-08-18</instant>
    </period>
  </context>
  <unit id="pure">
    <measure>pure</measure>
  </unit>
  <unit id="iso4217_USD_per_shares">
    <divide>
      <unitNumerator>
        <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>
        <measure>shares</measure>
      </unitDenominator>
    </divide>
  </unit>
  <unit id="iso4217_USD">
    <measure>iso4217:USD</measure>
  </unit>
  <unit id="iso4217_USD_per_Right">
    <divide>
      <unitNumerator>
        <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>
        <measure>mnkd:Right</measure>
      </unitDenominator>
    </divide>
  </unit>
  <unit id="shares">
    <measure>shares</measure>
  </unit>
  <unit id="Employee">
    <measure>mnkd:Employee</measure>
  </unit>
  <unit id="Derivative">
    <measure>mnkd:Derivative</measure>
  </unit>
  <unit id="iso4217_EUR">
    <measure>iso4217:EUR</measure>
  </unit>
  <unit id="D">
    <measure>utr:D</measure>
  </unit>
  <unit id="Tranche">
    <measure>mnkd:Tranche</measure>
  </unit>
</xbrl>
